ࡱ>  G bjbj k  dDDD D#N,(d."...G0r0<0 vMxMxMxMxMxMxM,PySM91%0"G011M<..sM<<<1b..vM<1vM<<Hh>Ipu9w9RHbMM0#N I4T<T >I<>I\I111MM<111#NT111111111 :   UNIVERSITY OF SOUTH FLORIDA COLLEGE OF NURSING  Student: Miguel MartinezFundamental Patient Assessment Tool .Assignment Date: July, 13, 14 ( 1 PATIENT INFORMATION Agency: SJHPatient Initials: M. P.Age: 57 Year OldAdmission Date: 07/ 17/14Gender: FemaleMarital Status: MarriedPrimary Medical Diagnosis with ICD-10 code:Primary Language: SpanishPneumonia, Organism Unspecified. ICD-10 Code J18.1Level of Education: 8th GradeOther Medical Diagnoses: (new on this admission)Occupation (if retired, what from?): Retired. Care Taker.Number/ages children/siblings: Sons: 31 yrs, 33 yrs, and 36yrs. Daughters: 38 yrs. Brothers: 55 yrs and 57 yrs Sisters: 37yrs, 38 yrs, 53 yrs, 50 yrs, 56 yrs, and 60 yrs.  Served/Veteran: No serviceCode Status: Full CodeLiving Arrangements: Patient lives in house with husband.Advanced Directives: None If no, do they want to fill them out? Patient states "not interested" Surgery Date: Procedure:Culture/ Ethnicity /Nationality: Hispanic, Puerto Rican.Religion: Pentecost Type of Insurance: No insurance. ( 1 CHIEF COMPLAINT: Patient states " I felt like I couldnt breathe"( 3 HISTORY OF PRESENT ILLNESS: (Be sure to OLDCART the symptoms in addition to the hospital course)The patient is a 57 year old female Hispanic who presented to the St. Josephs Hospital emergency room with complaints of not being able to breathe. She was feeling short of breath and dizzy during ambulation for about 5-6 days before coming into the hospital. The night before admission, the patient states she could not breathe and when she woke up she felt like she was drowning and decided to come into the Emergency Room (ER). During physician assessment, the patient was found to become dizzy during ambulation and was also coughing up clear phlegm. The patient does have history of asthma and thought it was an asthma exacerbation. When questioned about medication for her asthma the patient indicated she sought inhalers from a friend to help her breathing trouble but the inhalers did not help. The patient does have a history of hypertension, asthma and diabetes type 2. Patient does not have medications for none of past medical illnesses nor does she seek routine doctor visits to manage her illnesses. Patient said she had breast cancer and was resolved with chemotherapy and mastectomy in 2007. Her baseline vitals in the ER resulted in a pulse ox of 83% and were started on Bipap, antibiotics, Lasix and Nicardipine gtt as evidence by Systolic blood pressure of 190 during admission. She was admitted into the ICU and had cardiac monitoring with Telemetry ordered as evidence by murmur and tachycardia during admission. Additionally lovenox sq was ordered as prophylaxis for blood clotting. A preliminary chest xray of the patient was ordered and was positive for bilateral perihilar airspace disease. Consult of radiology indicated bilateral perihilar airspace disease could be potential for hydrostatic pulmonary edemea, pnemonia, lung injury or pulmonary hemorrhage. The patient was in critical care for about 85 minutes. White blood Count was 9.8 and did not indicate any infection. The patient was had blood culture, urine antigens and viral panel ordered and resulted negative. Empiric Zosyn and Levaquin IV started on admission and continued during hospitalization for treatment of possible severe community acquired Pneumonia-with unknown organism. Another chest Xray on 07/05/14 showed improvement of aceration left lung pulmonary edema. Then a chest Xray on 7/7/14 shows residual bibasilar lung opacities improved compared to Xray on 07/05/14. Doctor came into today to re-assess patient and stated clearer lungs of patient. During my shift patient was on 4 liters of 100% oxygen via nasal cannula as evidence by drop in Pulse Ox to 70's when patient was taken off of nasal cannula to ambulate. Discharge of patient is pending, progress, testing and specialist recommendation. As of now respiratory specialist has recommended further recuperation before sending the patient home. When I assessed the patient for pain, patient indicated throbbing pain rated at pain level 8 out of 10 on right side of posterior thoracic cavity. Patient indicated relief of pain when she laid and applied pressure to that side of her back. She indicated aggravation of pain when she coughs. The only treatment she has tried is Tylenol, which was ordered to be administered PRN for pain. Patient did indicate feeling and breathing better than when first admitted.( 2 PAST MEDICAL HISTORY/PAST SURGICAL HISTORY Include hospitalizations for any medical illness or operation Date Operation or Illness1983Tubal Litigation1991Bladder (hernia)2006Breast cancer resolved in 2007 with Chemo and Masectomy.Patient states 7 years ago which calculates to 2007Diabetes Type 2: Not taking medication but was started on Levemir 20 units with a .2 mL concentration subcutaneous 2xdaily when admitted for present health illness.Patient states 7 years ago which calculates to 2007Asthma: Not taking medication but did begin repirtory therapy when admitted to hospital for present health illness.Patient could not recall when she was told of her hypertension. Hypertension  ( 2 FAMILY MEDICAL HISTORYAge (in years)Cause of Death (if applicable)AlcoholismEnvironmental AllergiesAnemiaArthritisAsthmaBleeds EasilyCancerDiabetesGlaucomaGoutHeart Trouble (angina, MI, DVT etc.)HypertensionKidney ProblemsMental Health ProblemsSeizuresStomach UlcersStrokeTumorFather75Deceased caused by Lung Cancer: EmphesemaX FORMCHECKBOX  FORMCHECKBOX XX FORMCHECKBOX XXXX FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX XMother75 Alive FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX X FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX X FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX X FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX Brother55 FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX Brother57 FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX Sister37 FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX Sister38Sister50Sister53 FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX XX FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX Sister56Sister60 FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX  FORMCHECKBOX Comments: Include date of onset: Father: Father began drinking at 14 years old. Father developed cancer in 1987 Patient could not recall onset of father's arthritis, asthma, diabetes, Glaucoma, Gout. Siblings: Patient could not recall the onset of sister's health conditions. This includes 53-year-old sister who has arthritis and asthma. Which side of the family (maternal or paternal Age and date of onset of the disease process if available. Patients current disease process is found in the paternal side of the family. Her father had a health history of Asthma emphesema, diabetes, and hypertension. Patient was medically diagnosed with idiopathic Community Acquired Pneumonia (CAP). Patient also has history of Asthma, breast cancer, diabetes type 2 and hypertension.  ( 1 immunization History (May state U for unknown, except for Tetanus, Flu, and Pna)YesNoRoutine childhood vaccinationsX FORMCHECKBOX Routine adult vaccinations for military or federal service FORMCHECKBOX XAdult Diphtheria (Date; Patient cannot recall date or year)X FORMCHECKBOX Adult Tetanus (Date; Patient stated 10 years ago which would be 2004)X FORMCHECKBOX Influenza (flu) (Date; Patient stated 3 years ago which would be 2011)X FORMCHECKBOX Pneumococcal (pneumonia) (Date; Patient does not know of vaccine)UKNOWNUKNOWNHave you had any other vaccines given for international travel or occupational purposes? Please List FORMCHECKBOX X ( 1 ALLERGIES OR ADVERSE REACTIONSNAME of Causative AgentType of Reaction (describe explicitly)MedicationsSuccinyl CholinePatient airway closes up and during surgery of herniated bladder patient was intubated. Other (food, tape, latex, dye, etc.) ( 5 PATHOPHYSIOLOGY: (include APA reference and in text citations) (Mechanics of disease, risk factors, how to diagnose, how to treat, prognosis, and include any genetic factors impacting the diagnosis, prognosis or treatment)Mechanics of Disease: Pneumonia is an infection of the lower respiratory system that is usually caused by different organism including bacteria, viruses, fungi, protozoa or parasites (Huether & McCance, 2012). There is Community Acquired Pneumonia (CAP) and hospital acquired Pneumonia (Nosicomial). The patient I assessed was diagnosed with idiopathic CAP. However one of the most common causes of CAP is Streptococcus pneumonia, which leads to hospitalization of half of the individuals infected with this type of pneumonia. On the other hand Nosicomial Pneumonia is a frequent complication people who are in Intensive Care Unit (ICU) and especially those placed on mechanical ventilators. The most common pathogens that cause Nosocomial Pneumonia are Pseudomonas aeruginosa and Staphylococcus aureus (Huether & McCance, 2012). Aspiration of orophayngeal sections is the most common route of lower respiratory tract infection. Infection can also begin by inhaling microorganisms that are in air via coughs, sneezes, talking or from aerosolized water from devices such as respiratory therapy equipment. The most important cell defenders of lower respiratory tract infections are alveolar macrophages. It recognizes pathogens through distinguished receptors and helps initiate innate or adaptive immune responses. Alveolar macrophages release tumor necrosis factor-alpha and interleukin-1 with causes widespread inflammation in the lung and recruitment of neutrophils from lung capillaries into the alveoli (Huether & McCance, 2012). Additionally macrophages can present antigens to adaptive immune system to activate T and B cells. The inflammatory reactions and immune complexes can damage bronchial mucous membranes and alveoli capillary membranes with causes bronchioles to fill with infectious debris and exudate. Some of the infecting microorganism can release toxins and cause further lung damage and consolidation of lung tissue. As a result a person will have an accumulation of exudate, which leads to dyspnea, hypoxemia and mismatching ventilation and perfusion. Risk factors: Young children and elderly have an increased risk of contracting Pneumonia. Other risk factors include, compromised immunity, lung disease, smoking, alcoholism, altered consciousness, impaired swallowing, endotracheal intubation, malnutrition, immobilization, cardiac or liver disease and finally being part of a nursing home also is a risk factor for Pneumonia (Huether & McCance, 2012).How to diagnose: Diagnoses of pneumonia include procedures such as: Chest X-ray, white blood cell count, stains and cultures of respiratory tract secretions, blood cultures and physical examination. Chest X rays help show infiltrates that may involve any part of the lung. Usually the white blood cell count is elevated or low if person is debilitated or immunocompromised. Culture and blood cultures are used to help identify the pathogen.How to treat: Some treatments for Pneumonia vary by individual and by the type of pneumonia that the patient has contracted. One of the first steps in treatment includes establishing adequate ventilation and oxygenation. Antibiotics are used to treat bacterial pneumonia(Huether & McCance, 2012). Empiric antibiotics are chosen based on the causative microorganism and use of multiple broad-spectrum antibiotics may be used (Huether & McCance, 2012).Viral pneumonia has usually been treated with supportive therapy and in some cases the use of antivirals and antifungal medication has been equipped to treat the more severe cases of pneumonia(Huether & McCance, 2012). Prognosis: Pneumonia is the sixth leading cause of death in the United States. Most of the time pneumonia is in the upper airway system and will lead to infection of the lower airway system if the person's immune system is degraded (Huether & McCance, 2012). With the proper antibiotics and treatments, patients with bacterial pneumonia do recover. Usually viral pneumonia is mild and self-limiting but some medications also exist to help treat the person. However every case is different depending on the person and their state of health. Like mentioned before the different factors put some people at a higher risk than others for contracting this illness. Usually viral pneumonia is mild and self-limiting. ( 5 Medications: [Include both prescription and OTC; home (reconciliation), routine, and PRN medication. Give trade and generic name.] Name Albuterol-ipratropium (Duoneb)Concentration (mg/ml) 3 mlDosage Amount (mg) 50 mgRoute: Nebulizer Frequency: q4h Pharmaceutical class: AdrenergicsHome Hospital or BothIndication: This medication is used as a bronchodilator to control and prevent reversible airways obstruction. The patient was prescribed this medication as a control agent for her pneumonia and difficulty breathing. Side effects/Nursing considerations: This medication is advised to use cautiously on this patient due to her history of hypertension and diabetes as it could possibly make her hypersensitive to adrenergic amines. Some side effects to this medication include hyperglycemic, hypokalemic, angina, arrhythmia and hypertension A life-threatening side effect is paradoxical bronchospasm, which is an exacerbation of wheezing or difficulty breathing (U.S. National Library of Medicine. 2014). Some nursing considerations would include assessing the patient's pulmonary function and assessing the patients for paradoxical bronchospasm, as medication will need to be withheld and provider notified. Further nursing consideration include educating the patient and family on the importance of taking the medication as prescribed to reduce risk of side effects. Additionally, the patient should also know to contact provider if routine drug dose is not having any effect. Name Arformoterol (Brovana)Concentration 2mlDosage Amount 15 mcgRoute NebulizerFrequency q12hPharmaceutical class AdrenergicsHome Hospital or BothIndication: This medication is used to prevent bronchospasm in people with chronic bronchitis, emphysema and COPD. The patient uses this medication to prevent bronchospasm due to her pneumonia.Side effects/Nursing considerations: These drugs can cause hypokalemia, leukocytosis, tachycardia, and insomnia. Some more life-threating side effects include risk for asthma-related death and paradoxical bronchospasm. Some nursing considerations would be assessing the patient for signs of paradoxical bronchospasm, swelling due to hypersensitivety. If either condition is observed the nurse would have to withhold medication and notify provider. Finally the nurse would have to educate the patient on tkaing the medication as prescribed and notifying provider if difficulty of breathing continues. Name Asithromycin (Zithromax)ConcentrationDosage Amount 500 mgRoute POFrequency 1xdailyPharmaceutical class: MacrolidesHome Hospital or BothIndication: My patient was given this medication to treat her pneumonia, which was so far diagnosed as unknown organism. Side effects/Nursing considerations: Some important side effects to look for in this medication include, seizures, dyspepsia, phyloic stenosis, vaginitis, leukopenia, thrombocytopenia, otoxicity, and hyperkalemia. This medication has many life-threating side infects including, Torsades de pointes, hepatoxicity, pseudomembranous colitis, Steven-Johnson syndrome, angioedema and toxic epidermal necrolysis. Some nursing consideration would be to assess for anaphylaxis, infection, skin rashes, and lab work to check for increased serium bilirubin, AST, ALT, LDH and alkaline phosphatase concentrations. Finally the nurse would need to educate the patient to report symptoms of any skin changes, chest pain, palpitation and foul smelling or loose stool. Most important the patient must notify health care provider if fever and diarrhea develop and seeking advice to treat diarrhea. Name BudesonideConcentration 2mlDosage Amount 0.5mgRoute NebulizerFrequency q12hPharmaceutical class corticosteroidHome Hospital or BothIndication The patient was prescribed this medication in form of nebulizer to treat and maintain prophylactic therapy of asthma like symptoms related to pneumonia. Side effects/Nursing considerations Some side effects include rashes, otitis media, oropharyngeal fungal infection, dyspepsia, gastroenteritis, adrenal suppression and decreased weight gain. A severe life threating side effects is anaphylaxis. Some nursing considerations include assessing for respiratory status and lungs sounds. Nurses would also teach patient to take medication as prescribed, and because this patient is using bronchodilators I would educate patient on taking bronchodilators first and waiting five minutes before taking corticosteroid. Its very important that patient knows to contact provider if anaphylaxis occurs.Name ClonidineConcentrationDosage Amount 0.2mgRoute poFrequency q12hrPharmaceutical class Adrenergic (centrally acting)Home Hospital or BothIndication This medication will help patient with her mild to moderate hypertension. Side effects/Nursing considerations Some side effects include, depression, hallucinations, dry eyes, AV block, hypotension, constipation, sodium retention and paresthesia. Some nursing considerations include assessing patient blood pressure, pain and checking for drug withdrawal symptoms. I would also administer the last dose at bedtime and ensure that the patient swallows the tablet whole. Name Enoxaparin (lovenox)Concentration 0.4 mlDosage Amount 40 mgRoute Subcut injectionFrequency q24hPharmaceutical class Antithrombotic, low molecular weight heparinHome Hospital or BothIndication The patient was given this medication as a prophylaxis for Deep vein thrombosis, venous thromboembolism and pulmonary embolism. Side effects/Nursing considerations Due to the patients unmanaged hypertension, this drug is to be used cautiously. Some side effects to look for are insomnia, edema, constipation, urinary retention, alopecia, ecchymoses, urticaria, anemia, eosinophilia, and hematoma at injection site. Nursing considerations would be to assess for bleeding, hemorrhage, output, and monitoring platelet count, and complete blood count. As for family and patient teaching, nurses would education patient to report any unusual bleeding, bruising, rashes, or difficulty breathing. Name Furosemide (Lasix)Concentration 4mlDosage Amount 40 mgRoute Iv InjectionFrequency q12hrPharmaceutical class loop diureticHome Hospital or BothIndication This medication was given to patient to help with edema from pneumonia and hypertension.Side effects/Nursing considerations Some side effects include blurred vision, tinnitus, anorexia, pancreatitis, polyuria, nephrocalcinosis, hypercholesterolemia, hyperglycemia, hypovolemia, hyponatremia and metabolic alkalosis. Some life-threatening side effects erythma multiformse, stenves-johnson syndrome, toxic epidermal, necrolysis, apastic anemia, and agranulocytosis. Nursing considerations include assessing patient, fluid status, appetite, and tinnitus, hearing loss and skin rashes. Some lab values that need to be asses are serum glucose, potassium, uric acid, bun, calcium and magnesium. Patient and family teaching of the patient includes advising patient to ontact health care professional if rash, muscle weakness, numbness or tingling of extremities occur. Name Guaifenesin (Mucinex)ConcentrationDosage Amount 1200 mg & 600 mg at homeRoute POFrequency q12hrPharmaceutical class Allergy, cold and cough remedies expectorantHome Hospital or BothIndication This medication was given to the patient for cough associated with her pneumonia. Side effects/Nursing considerations: Some side effects include, uticaria, dizziness, stomach pain and vomiting. Nurses would teach family and patient the important of coughing effectively. Nurses should also advice patient not to drive or do any other activity requiring alertness as this drug could cause dizziness. Name Insulin (Levemir)Concentration 0.2mlDosage Amount 20 unitsRoute Sub cut injectionFrequency 2xdailyPharmaceutical class: PancreaticsHome Hospital or BothIndication This medication was given to patient to help control hyperglycemia due to her type 2 diabetes.Side effects/Nursing considerations: Some side effects include lipodystrophy, pruritis, erythema, swelling and some side effects that could be life-threating include hypoglycemia and anaphylaxis. Some nurisng considerations include assessing the patient for signs and symptoms hypoglycemia and monitoring body weight periodically. Nurses should also clarify orders if they are confusing or difficult to understand. Nurse should not mix levemir with any other insulin type. The nurse should teach patient's family and patient the proper technique of insulin administration, and its use to manage hyperglycemia and not having ability to cure it. Additionally educate patient about hypoglycemia and what to do if does occur. Patient should also carry a source of sugar and be able to describe their condition and treatment at all times.Name Insulin (Novolog)Concentration Dosage Amount medium doseRoute Sub cut injectionFrequency 3x daily AC+HS insulin sliding scalePharmaceutical class PancreaticsHome Hospital or BothIndication This was given to patient to help control hyperglycemia due to type 2 diabetes.Side effects/Nursing considerations Side effects are similar to levemir in that patient could develop lipodystrophy , pruritis, erythem and swelling. Some more life-threating side effects include hypoglycemia and anaphylaxis. Again the nurse should assess the patient fors sings of hypoglycemia and monitor weight. The nurse should teach patient's family and patient the proper technique of insulin administration, and its use to manage hyperglycemia and not having ability to cure it. Additionally educate patient about hypoglycemia and what to do if does occur. Patient should also carry a source of sugar and be able to describe their condition and treatment at all Name Piperacillin (Tazobactim) ZosynConcentration 100 mlDosage Amount 3.375 mgRoute IVFrequency q6hrPharmaceutical class extended spectrum penicillinsHome Hospital or BothIndication This medication is used for treatment of appendicitis peritonitis, skin infection, gynecologic infection and community acquired and noscomonial pneumonia. The patient was given this medication for treatment of community acquired pneumonia. Side effects/Nursing considerations Some common side effects include, diarrhea, rahses, phelbits at IV site. Life-threatening side effects include, seizures, pseudomembranous colitis, Stevens Johnson syndrome, toxic epidermal necrolysis, anaphylaxis and serum sickness. Nursing consideration include assessing patient for infection, anaphylaxis, bowel function and skin reactions. Patient and family should also be educated on reporting signs of superinfection, fever and diarrhea, which should prompt patient to contact health care provider. Name Potassium chloride (Kdor20)ConcentrationDosage Amount 20 mEqRoute POFrequency 1xdailyPharmaceutical class mineral and electrolyte replacements/supplementsHome Hospital or BothIndication This medication is used to treat and prevent potassium depletion. This was given to patient to prevent hypokalemia due to albuterol and azithromycin. Side effects/Nursing considerations Some side effects include abdominal pain, diarrhea, vomiting, and paralysis. Life-threatening side effects include arrhythmias. Nursing considerations include monitoring serum potassium labs, assessing for hypokalemia, which indicates toxicity. The patient and patient's family should be educated on importance of reading potassium level in other foods to avoid hyperkalemia. The patient should also be advised to contact provider if stool is blood, feels tingling in extremities or has unusual fatigue. The patient should also be explained the importance of going to follow up appointments for serum monitoring.  Name Valsartan (Diovan)ConcentrationDosage Amount 60 mgRoute POFrequency 2xdailyPharmaceutical class Angiotensin II receptor antagonistHome Hospital or BothIndication This medication is used to manage hypertension, treat hear failure and reduce risk from of death from cardiovascular causes. This was given to the patient to help her manage her hypertension. Side effects/Nursing considerations Some symptoms include dizziness, edema, pharyngitis, hyperkalemia, impaired renal function and arthralgia. Life-threatening symptoms include angioedema. Nursing considerations include assessing the patient for angioedema, monitoring BP, and weight. Nurse should educate patient and patient's family on taking medication as prescribed, avoiding salt substitutes, avoiding high potassium foods, the importance of following care plan recommended by health care professional. Finally the nurse should instruct patient to contact health care provider if swelling occurs. Name Diphenhydramine-ibuprofen ConcentrationDosage Amount 38-200 mgRoute POFrequency 1xdaily hsPharmaceutical class Allergy, cold and cough remedies, antihistamines, antitussives.Home Hospital or BothIndication This medication is used to relief allergic symptoms, treat Parkinson's disease, as a mild nighttime sedation, motion sickness prevention medication and antitisuve medication. The patient was given this to help prevent motion sickness which occurred during ambulation. Side effects/Nursing considerations Side effects include blurred vision, tinnitus, hypotension, palpitations, anorexia, dry mouth, constipation, urinary retention, dysuria wheezing and photosensitivity. Nurse consideration include assessing for anaphylaxis, motion sickness, pruritus and insomnia. Patient and patient's family should be educated to take medication as prescribed, and education that medication may cause drowsiness, dry mouth to wear sunscreen and protection. Name Albuterol (Proair HFA)ConcentrationDosage Amount 90 mcgRoute Inhalation aerosolFrequency 2 puff, q4hr for wheezingPharmaceutical class AdrenergicsHome Hospital or BothIndication Used as bronchodilator to control and prevent reversible airway obstruction, used as quick -relief for acute bronchospasm and used as longer-term control in patient with chronic bronchospasm. The patient was using mediation to help manage her asthma.Side effects/Nursing considerations This medication is advised to use cautiously on this patient due to her history of hypertension and diabetes as it could possibly make her hypersensitive to adrenergic amines. Some side effects to this medication include hyperglycemic, hypokalemic, angina, arrhythmia and hypertension A life-threatening side effect is paradoxical bronchospasm, which is an exacerbation of wheezing or difficulty breathing (U.S National Library of Medicine. 2014). Some nursing considerations would include assessing the patient's pulmonary function and assessing the patients for paradoxical bronchospasm, as medication will need to be withheld and provider notified. Further nursing consideration include educating the patient and family on the importance of taking the medication as prescribed to reduce risk of side effects. Additionally, the patient should also know to contact provider if routine drug dose is not having any effect. ( 5 NUTRITION: Include type of diet, 24 HR average home diet, and your nutritional analysis with recommendations.Diet ordered in hospital? Mechanically Soft Analysis of home diet (Compare to My Plate and Diet patient follows at home? Regular DietConsider co-morbidities and cultural considerations):24 HR average home diet: My patient passed the recommended grain and protein guidelines. The patient did not meat the vegetable, dairy or fruit recommendations. More in detail the patient only had 53% of the recommended vegetables, 58% of recommended dairy, 108% of recommended grains, 107% of protein and 0% of fruits. The patient had a total of 2,081 calories, which surpassed the 2000-calorie limit. Additionally the patient surpassed her saturated fat recommendation of 22gram with 35 grams and sodium recommendation of 2,300mg with 3,377mg. The patient was within limits of recommended oils of 6 tsp. with the patient consuming only 2tsp. Because the patient's diet does not meet the recommended guidelines I would have a dietician come and speak with her about future diet practices. Some changes to the diet would include reduction in total calories, saturated fat intake, and sodium intake. Furthermore created the patient a diet and I exchanged some of the patients choices like the fried chicken for 1 filet of tilapia and an ounce of tuna. To get more protein and diary products I exchanged the patients three cups of coffee with 1 cup of fat-free skim milk per meal and included reduced fat sausage turkey into the patient breakfast instead of butter scrambled eggs. To increase intake of vegetables, I included a salad in the patient's lunch, 1 cup of spinach and broccoli for dinner, and1 cup of carrots as a snack. To ensure proper fruit intake I included, a cup of raw blueberries and 1 medium raw orange in patients snacks. For grains I included oatmeal and 1 slice of whole wheat in patient breakfast, and 1 cup of brown rice for lunch and dinner. I helped make a diet for the patient that reduced her sodium intake, which is most important due to her hypertension and increased her nutritional intake to have a more balanced diet.Breakfast: Patient indicated normal breakfast included: Small bowl of boiled oatmeal, scrambled eggs cooked in regular butter, bowl of rice crispy with a cup of coffee.Lunch: Patient indicated normal lunch included: a bowl of brown rice, with 3 pieces of chicken and a roman noodles.Dinner: Patient indicated normal dinner included: fried chicken with skin. A bowl of rice and black beans.Snacks: Patient does have some chocolate flavored crackers. Liquids (include alcohol): patient drinks about 7 cups of water a day, drinks 3 coffee with 2 sugars and milk. HYPERLINK "http://www.choosemyplate.gov/index.html"  Use this link for the nutritional analysis by comparing the patients 24 HR average home diet to the recommended portions, and use My Plate as a reference.  (1 COPING ASSESSMENT/SUPPORT SYSTEM: (these are prompts designed to help guide your discussion)Who helps you when you are ill? HusbandHow do you generally cope with stress? or What do you do when you are upset?Patient states" House chores"Recent difficulties (Feelings of depression, anxiety, being overwhelmed, relationships, friends, social life)Patients stated feeling depressed the day before related to her desire to go home as she feels she has been here for many days. +2 DOMESTIC VIOLENCE ASSESSMENT Consider beginning with: Unfortunately many, children, as well as adult women and men have been or currently are unsafe in their relationships in their homes. I am going to ask some questions that help me to make sure that you are safe. Have you ever felt unsafe in a close relationship? _Patient states "No"_ Have you ever been talked down to?__ Patient states "No"____ Have you ever been hit punched or slapped? Patient states "No"____ Have you been emotionally or physically harmed in other ways by a person in a close relationship with you? ________ Patient states "No"______ If yes, have you sought help for this? ______________________ Are you currently in a safe relationship? Patient states "Yes" ( 4 DEVELOPMENTAL CONSIDERATIONS:Eriksons stage of psychosocial development:  FORMCHECKBOX Trust vs.  FORMCHECKBOX Mistrust  FORMCHECKBOX Autonomy vs.  FORMCHECKBOX Doubt & Shame  FORMCHECKBOX Initiative vs.  FORMCHECKBOX Guilt  FORMCHECKBOX Industry vs.  FORMCHECKBOX Inferiority  FORMCHECKBOX Identity vs.  FORMCHECKBOX Role Confusion/Diffusion  FORMCHECKBOX Intimacy vs.  FORMCHECKBOX Isolation X Generativity vs. X Self absorption/Stagnation  FORMCHECKBOX Ego Integrity vs.  FORMCHECKBOX DespairCheck one box and give the textbook definition (with citation and reference) of both parts of Ericksons developmental stage for your patients age group:Describe the stage your patient is in and give the characteristics that the patient exhibits that led you to your determination: My patient is in the7th stage of Eriksons psychosocial development stage, which includes Generatvitiy v.s. Stagnation stage. In the stage of Generactivity, the person is usually working and contributing to society in someway. This is where the concern is in establishing and guiding the next generation (Schokilitsch & Baumann, 2011). Some people may be helping raise children. However is the person does not find a way to feel like they are feeling productive than they may feel self-absorbed in the state of stagnationDescribe what impact of disease/condition or hospitalization has had on your patients developmental stage of life:I think my patient is leaning more toward the stagnation state. She said she felt depressed because she was in the hospital for so long. Although she has older children at this point in life, she was recently a caretaker, which gave her a sense of doing something productive for the future generation. Since she has been here, that feeling of productivity has been taken away from her. She wants to go home and I saw this because when the doctors told her she might be staying longer until she fully recovers she seemed down and somewhat depressed. I tried to comfort her by telling her that the doctors were only looking out for her own best interest but she continued with wanting to go home.+3 CULTURAL ASSESSMENT: What do you think is the cause of your illness?Patient states" I had a nightmare of a little Mexican girl being killed and ever since that dream I began to get sick."What does your illness mean to you?Patient states" I do not know what caused it but they told me both of my lungs were infected and had liquid in the. I thinkgod is trying to reach out to me and get me to back to church like I used to"+3 SEXUALITY ASSESSMENT: (the following prompts may help to guide your discussion)Consider beginning with: I am asking about your sexual history in order to obtain information that will screen for possible sexual health problems, these are usually related to either infection, changes with aging and/or quality of life. All of these questions are confidential and protected in your medical recordHave you ever been sexually active? Patient states" YES" Do you prefer women, men or both genders? Patient states "MEN' Are you aware of ever having a sexually transmitted infection?Patient states "I do not know, I have not been checked" Have you or a partner ever had an abnormal pap smear? NO Have you or your partner received the Gardasil (HPV) vaccination? NO Are you currently sexually active? YES When sexually active, what measures do you take to prevent acquiring a sexually transmitted disease or an unintended pregnancy? Patient states" None How long have you been withyour current partner? Patient states 35 years Have any medical or surgical conditions changed your ability to have sexual activity? Patient states "NO" Do you have any concerns about sexual health or how to prevent sexually transmitted disease or unintended pregnancy? Patient states "No"  1 SPIRITUALITY ASSESSMENT: (including but not limited to the following questions) What importance does religion or spirituality have in your life? Patient states" None" Do your religious beliefs influence your current condition? Patient states "Maybe, god may be calling me to him as I used to go to church a lot but have not been going for a long time" +3 Smoking, Chemical use, Occupational/Environmental Exposures:1. Does the patient currently, or has he/she ever smoked or used chewing tobacco? Yes No If so, what? How much?(specify daily amount)For how many years? X yearsPatient states" NO" Not applicable(age thru )Pack Years: Not ApplicableIf applicable, when did the patient quit?Not applicableDoes anyone in the patients household smoke tobacco? If so, what, and how much?Has the patient ever tried to quit? Not applicableNot Applicable2. Does the patient drink alcohol or has he/she ever drank alcohol? Yes No What?How much? (give specific volume)For how many years?Patients states" I have a drink or two at parties but only every once in a while Patient states" Drink vary from 2 (12 oz drinks) to mixed alcohol beverages the size of a cup."(age: 20 yrs old thru : 2014 ) If applicable, when did the patient quit?Patient state: " I currently drinks on occasion but says she does not drink a lot."3. Has the patient ever used street drugs such as marijuana, cocaine, heroin, or other? Yes No If so, what?How much?For how many years?(age thru ) Is the patient currently using these drugs? Yes NoIf not, when did he/she quit?4. Have you ever, or are you currently exposed to any occupational or environmental Hazards/RisksPatient states " No" ( 10 Review of Systems Narrative General Constitution (OLDCART anything checked above)Pts perception of health: Patient does feel like she has been eating less and has lost about 2 to 3 pounds since she's been sick.Integumentary: The patient states having some rashes with an itching sensation on both her legs, dandruff and bathing at least once a day. Patient denies having changes in skin appearance, nail problems, psoriasis, skin infections or using sunscreen.HEENT: The patients claims having sight difficulty, sinus pain, nose please, and post-nasal drip due to nasal cannula. Patient also claims brushing teeth twice a day but having dental problems due to lack of dental visits. Patient indicated vision screen in 2011. Patient denies cataracts, hearing difficulty, ear infection, oral/pharangeal infection or routine dental visits. Pulmonary: The patient indicates having difficulty breathing, asthma, pneumonia and productive coughing. The patient also indicated having her last CXR on Tuesday 7/9/14. The patient denies having bronchitis, emphysema, tuberculosis or environmental allergies.Cardiovascular: The patient does indicate having hypertension. The patient also had her last EKG screening on June 30, 2014. The patient denies having hyperlipidemia, angina, MI, CAD, CHF, Murmur, thrombus, Rheumatic fever, Myocarditis, Arrhythmias.GI: The patient denies Nausea, vomiting diarrhea, constipation, GERD, indigestion, hemorrhoids, jaundice, pancreatitis, colitis, diverticulitis, appendicitis, abdominal abscess, irritable bowel, cholecystitis, gastritis, ulcers, hepatitis or blood in stool. GU: The patient does indicate having an abnormal polyuria. The patient denies nocturia, dysuria, hematuria, kidney stones, bladder or kidney infection.Women/Men Only: The patient indicated having stopped menstruating in 2002, which is due to menopause after having her tubal litigation. The patient did state having menarche when she was 11 years old. The patient also stated having her last mammogram in 2006. The patient denies irregular menstruation, infection of the female genitalia, monthly self-breast examination and a DEXA Bone density exam.Musculoskeletal: The patient indicated having posterior thorax pain on her right side. The patient denies injuries, fractures, weakness, gout, osteomyelitis and arthritis,Immunologic: The patient has night sweats and has a severe allergy to succinyl choline. She denies having chills with sever shaking, fever, HIV, AIDS, lupus, Rheumatoid arthritis, sarcoidosis, tumor, or enlarged lymph nodes.Hematologic/Oncologic: The patient does not have anemia, bleeding easily, bruising easily, having cancer at the present moment or having had a blood transfusion.Metabolic/Endocrine: the patient does have Diabetes Type 2, and is recently intolerant to the hot. The patient does not have a hypothyroid or hyperthyroid, osteoporosis or intolerance to cold.Central Nervous System: The patient indicates feeling dizzy during ambulation. The patient does not have a Cerebrovascular Attack, severe headaches, migraines, seizures, tick or tremors, encephalitis, or meningitis. Mental Illness: The patient has been feeling depressed in the past days. The patient does not have schizophrenia, anxiety or bipolor.Childhood Diseases: The patient did have measles and chicken pox as a child. The patient did not have mumps, polio, or scarlet fever as a kid.  Is there any problem that is not mentioned that your patient sought medical attention for with anyone? The patient states "No".Any other questions or comments that your patient would like you to know?The Patients states "No" 10 PHYSICAL EXAMINATION:General survey: The patient is a 57 y.o. female who is alert & oriented X3. She seems to in pain as she continues to move and lean on her right side. Height: 63 inches Weight: 84 kg BMI: 33 Pain (include rating and location):8/10 on Posterior thoracic right side Pulse: 77/minute Blood Pressure (include location): Left arm, 114,71 Temperature (route taken): Oral, 98.3 Respirations: 19/minute SpO2: 94% Room Air or O2: 4 litters of 100% O2 Overall Appearance: The patient was clean, groomed maintained eye contact and was dressed appropriate for setting and temperature. The patient did not present any obvious handicaps. Overall Behavior: Overall the patient was calm and interacted well with other and presented an intact judgment. The patient did seem to indicate backside discomfort as she continually repositioned her self on her right backside. Speech: The patient had clear and moderate speed crisp diction. Mood and Affect: The patient was pleasant and cooperative. Integumentary: The patients skin was warm, dry and intact. Her skin turgor was elastic and had no rashes, lesion or deformities on skin. The patients nails did not present with clubbing and her capillary refill was less 3 seconds. The hair was evenly distributed, clean and without vermin. IV Access: The patient had a 20 gauge IV PICC line on her right upper arm. She was infused with Piperacillin/Tazobactim 3.375 grams over 30 minutes at a rate of 200 ml/hr q6hr. HEENT: The patient had symmetric facial features, clear conjunctiva without discharge, a white sclera, and a midline trachea. The patients eyes were symmetric and intact without any lesion or discharge. Additionally the patients pupils were PERRLA and left and right eye were 3mm in size. The patients peripheral vision was intact and their EOMs were also intact through 6 cardinal fields without nystagmus. The patient did not have pain in sinus region, nor did she have an enlarged thyroid or palpable lymph nodes. She also did not have pain or clicking of TMJ. The patients eyebrow, eyelids, orbital area, eyelashes and lacrimanal glands were symmetric and present without edema or tenderness. The patient whisper test heard: right ear- 6 inch & left ear 6 inches. The patients nose did have some discharge but not visible lesion. The patient's lips, buccal mucosa, floor of mouth and tongue were moist and without lesions. Pulmonary/Thorax: The patient respirations were regular and unlabored with symmetric chest expansion. The patient transverse to AP ratios was 2 to 1. The patients lung sounds were clear to auscultation without adventitious sounds. When percussed the patient's lung field sounds were resonant and dull towards posterior bases. The Sputem produced by the patient was small and clear. Cardiovascular: The patient pericordium had no lifts, heaves or thrills. The patients PMI was not palpable. The patients hear sounds were regular and S1 and S2 were also heard. No JVD or heart murmurs, clicks or adventitious heart sounds were heard. The patient was not on TELE. All of patient pulse's were equal bilaterally and palpable +2. The patient had negative calf pain bilaterally. The patient had no temporal or carotid bruits or edema. Patients extremities were warm with a capillary refill less than 3 seconds. GI: The patients bowel sounds were active x 4 quadrants with no bruits present during auscultation. The patient did not have organomegally. During percussion, spleen and liver had dull sounds. The stomach and intestine had tympanic sounds when percussed.. The abdomen was non-tender to palpitation. The patient stated urine output was clear and had a light yellow tint. The patient did not have a Foley catheter, urinal or bedpan. The patient did have bathroom privileges with assistance to her bedside commode. The patients CVA punch did not have rebound tenderness. The patients state last BM was formed and light brown. GU: The patient was alert, oriented and denied problem with genitalia. Musculoskeletal: Patient had full and intact range of motion bilaterally in all extremities without crepitus. The patient had a strength rating of 5/5 in all upper and lower extremities bilaterally. The patients vertebral column was present without kyphosis or scoliosis. The patients neurovascular status intact with all peripheral pulses palpable, no pain, no pallor, no paralysis or paresthesia present. Neurological: The patient was awake, alert, oriented to person, place, time and date. The patient was not confused. The patients Cranial nerves 2-12 were grossly intact. The patients sensation was intact to touch, pain and vibration was not assessed. The patient had a negative Romberg. The patients stergnossis, graphesthesia, proprioception was intact. The patients gait was smooth regular with symmetric length of the stride. The patients deep tendon reflexes were not assessed due to unavailable equipment.  10 PERTINENT LAB VALUES AND DIAGNOSTIC TEST RESULTS (include pertinent normals as well as abnormals, include rationale and analysis. List dates with all labs and diagnostic tests):.Lab Dates Trend Analysis WBC 9.8 8.3 Normal (4.5-11) (06/30/20014) (06/07/2014) The lab values listed are those taken upon the patients arrival. Although within normal limits patients WBC did begin to decline This is the number of infection fighting cells. High WBC indicates the presence of an infection or inflammation. High WBC is often indicated in presence of an infection such as pneumonia. However, low WBC could also indicate a problem in WBC production, severe infection or other factor having an infection on the number of WBC. HGB 14 12.6 Normal: (12.0-16.0) (06/30/20014) (06/07/2014) This lab value is the count of how much hemoglobin is in blood. Hemoglobin is a protein in red blood cells that carry oxygen. The patient hemoglobin was within normal limits but declined by the second count. The patients HGB count is within normal limits. Sometimes HGB count may be ordered if patient is feeling poor of health like this patient who has pneumonia. Having low HGB could indicate having anemia, poor nutrition, malfunctioning bone marrow or chronic kidney disease HCT 42.2 37.7 Normal: (37.0-47.0 (06/30/20014) (06/07/2014) This lab values are within the normal range limit for this particular count. The patient did have a small decrease in the number of hematocrit. This lab value indicates the amount of whole blood that made up of read blood cells. Having to low hematocrit may be due to anemia, bleeding, malnutrition, leukemia, overhydrating or nutritional deficiencies. High hematocrit could signify a congenital heart diease, dehydration, low blood oxygen, pulmonary fibrosis or bone marrow disease. PLT 278 261 Normal: (140-450) (06/30/20014) (06/07/2014) The patients PLT count was kept within normal range limits. She was administered a prophylaxis to help prevent deep vein thrombosis, pulmonary embolism and thromboembolism. This lab value indicates the number of platelets that the patient has. If the patient has a low platelet count this may be due to platelet destruction, poor platelet production or platelet production alteration due to drugs or medicine; this could result in increased chance of bleeding. A high platelet count could be due to cancer, medication, spleen removal, chronic myelogenous leukemia, polycythemia vera or primary throbcythemia. A high count could increase the risk of developing blood clots. NA 137 136 Normal: (136-145) (06/30/20014) (06/07/2014) The patient sodium count did not change tremendously. In fact it remained within normal limits. This lab value is the amount of sodium within the patient blood serum. A low count medically known as hypernatreiam, may be due to adrenal gland problems, dehydration, urine build up or increase in total body water. A high count may be due too much salt intake, increased fluid loss, medication and problems with adrenal gland. K 3.9 3.5 Normal: (3.5-5.1) (06/30/20014) (06/07/2014) The patients Potassium count remained within normal limits. It changed very little from the first potassium count. This value is the count of potassium. Potassium is important because it helps the nerves and muscle communicate. It also helps cells absorb nutrients and remove waste. It is important to keep this balance because this could have a mortal impact on the heart muscle as well. CL 101 98 Normal: (98-107) (06/30/20014) (06/07/2014) The patients chloride stayed within normal limits. There was a small decline in the second count but nothing of major concern. This value is the count of chloride in a person serum. Chloride is an important electrolyte that helps keep the proper balance of body fluids and helps maintain the bodys acid base balance. Any disturbance in fluid or acid-base balance could disrupt the body's homeostasis. CO2 27 31 Normal: 21-32 (06/30/20014) (06/07/2014) The patients CO2 count remained within normal limits. This second count indicated the patient CO2 went up. This lab value is the count of Carbon Dioxide in a persons body. ITs is important because CO2 makes up part of the blood. However keeping the patients CO2 within normal limits is very important as the patient could cause an imbalance in the body's electrolytes. BUN 13 18 Normal: (6-26) (06/30/20014) (06/07/2014) The patients Blood urea nitrogen was again within normal limits. The second count was a litter higher than the first time. This lab values is the count of Blood Urea Nitrogen in a person body. It is formed after body breaks down protein. This lab value could also be tested in urine to see if kidney are functions as they are suppose to be. CREAT .4 .61 Normal: (.30-1.30) (06/30/20014) (06/07/2014) The patients creatinine is within normal limits. The first and second counts fluctuated minutely. This lab value is the count of creatinine in blood. This is asses to ensure that a persons kidney are functioning like they are supposed to. BG 268 127 Normal: (70-99) (06/30/20014) (06/07/2014) The patient's Blood glucose was elevated for both counts. The first count indicates the patient was hyperglycemic. The patient was later given insulin, which help reduce the blood glucose count to lower count. Even though the second count is also high, it could indicate the patient had recently eaten. The lab value indicates the amount of serum glucose. It is very important, as glucose is cells energy. The amount of glucose in the blood could help diagnose whether a patient's insulin is sufficient for the body's demand. CXR: (06/30/14) Bilateral perihilar airspace disease. (07/05/14) Improved acration left lung, pulmonary edema pattern improved. (07/07/14) Residual bibasilar lung opacities improved. (06/30/14) (07/05/14) (07/07/14) The patient was first diagnosed with having perihilar airspace disease, which is usually indicative of pulmonary edema (Centers for Disease Control and Prevention [CDC] (n.d). Haven been treated with albuterol, arformoterol and oxygen therapy, the patients lungs began to appear with less edema. Lungs are normally clear when auscultated and when viewed via a radiology exam. If fluid is present in the lungs it is of concern because the patient could aspirate on the fluid. +2 CURRENT HEALTHCARE TREATMENTS AND PROCEDURES: (Diet, vitals, activity, scheduled diagnostic tests, consults, accu checks, etc. Also provide rationale and frequency if applicable.)The patient had several Chest X-rays to assess her lungs. She was found to have pulmonary edema, which was attributed to pneumonia. A blood culture, urine antigens and viral panel were ordered. Although the provider was not able to identify the organism, the patient was diagnosed with community-acquired pneumonia. The patient was also put on oxygen 4 liters with oxygen of 100% to help dilate her airways and to help her breathe better. The nurses were also instructed to notify physician if patient began to have chest pain. Because the patient had unmanaged diabetes type 2, the provider ordered the patient blood glucose to be checked via accu check q6hrs to 4x daily. The patient had a consult with nutrition, physical therapy, and pharmacy. The patient was ordered a mechanically soft diet to help prevent aspiration. The patient was instructed to ambulate with assistance, as she would become dizzy when ambulating on her own. The patient also had a 20 gauge PICC line was also ordered for the patient so that IV antibiotics could be administered via an IV pump. She also had a nebulizer medication to help her airways dilate.  ( 8 NURSING DIAGNOSES (actual and potential - listed in order of priority)1. Activity intolerance related to imbalance between oxygen supply and demand as evidence by patient's pulse ox dropping to 70's % when taken off nasal cannula and patient verbalization of having trouble breathing and feeling like she is drowning. 2.Impaired gas exchange related to decrease functional lung tissue as evidence by patient's pulse ox dropping to 70's % when taken off nasal cannula and patient verbalization of having trouble breathing and feeling like she is drowning. 3. Imbalanced Nutrition related to loss of appetite evidenced by patient verbalization of loss of weight in past days and loss of appetite. 5. Ineffective airway clearance related to inflammation and presence of secretions as evidence by patient coughing up clear sputum. 6. Deficient knowledge related to risk factors predisposing patient to pneumonia as evidence by patient verbalization of lacking management of past medical health history. 15 CARE PLAN Nursing Diagnosis: Activity intolerance related to imbalance between oxygen supply and demand as evidence by patient's pulse ox dropping to 70's % when taken off nasal cannula and patient verbalization of having trouble breathing and feeling like she is drowning. Patient Goals/OutcomesNursing Interventions to Achieve GoalRationale for Interventions Provide ReferencesEvaluation of Goal on Day care is ProvidedBy the end of my shift I would like my patient to verbalize an improvement in breathing measured by indicating a breathing difficulty of 3 or lower on a scale from 0 to 10. I would keep my patient on a nasal cannula with 100% oxygen and at a rate of 4 liters. I would also instruct my patient on how to position the nasal cannula at the most comfortable position. I would also educate my patient on the importance on keeping the nasal cannula on. Additionally I would instruct my patient to call for assistance when ambulating to avoid injury. I would assess my patient on difficulty of breathing at least q2hrs during my clinical shift. Patients with oxygen therapy help people function better and become more active (National Heart, Lung and Blood Institute, n.d). A patient should be involved in their healing to make them feel more comfortable with care provider. Having the patient request assistance with ambulation will help the patient prevent falls that could cause even further damage to patient.The patient was put on 100% oxygen at a rate of 4 liters. The patient was able to verbalize that she was breathing better. When I assessed the patient for difficulty of breathing, she indicated a 0. The patient did request assistance with ambulation. She also verbalized her understanding of not being able to ambulate on her own. Due to time constraints I was only able to assess my patients breathing one time. On another day I would ensure to have timers set for myself to check up on patient. By the end of my shift I will check the patient q4hrs to ensure my patient is able to maintain a pulse ox of 95% when patient is ambulating for at least 5 minutes without oxygen.I would keep my patient on 100% oxygen at a rate of 4 liters unless otherwise indicated by provider. I would have patient tech care assess the patients vitals q4hrs and verify that the patient's pulse ox is 95% or higher. I would document the patients pulse ox reading to visualize a trend on the patients pulse ox readings. I would then take my patient off oxygen for 5 minutes to see if patient can ambulate while maintaining a pulse ox of 95% or higher. Assessing a patients arterial ox hemoglobin saturation proves provider with constant data, shows trends and allows clinicians to intervene before the patient becomes unstable( Mininni, Herzer, Marino, & Kohler, 2009). Assessing the patient would also help pinpoint any patterns that could lead clinicians to resolve the cause of the low arterial oxygen level. The patients had a pulse ox higher then 95% but when the nurse took the patient off oxygen to ambulate, the patients pulse oxygen dropped to 70's. So the goal would need to be readjusted so that the patient could at least verbalize being able to breathe better while ambulating with oxygen. Setting the goal to keeping the patients pulse ox at 95% and higher will take some time and more oxygen thearpy. Until the patient's pneumonia begins to cure, the patients pulse ox will continue to drop.2 DISCHARGE PLANNING: (put a * in front of any pt education in above care plan that you would include for discharge teaching) Consider the following needs: X SS Consult X Dietary Consult PT/ OT X Pastoral Care X Durable Medical Needs %F/U appointments X Med Instruction/Prescription % are any of the patient s medications available at a discount pharmacy? %Yes % No %Rehab/ HH %Palliative Care I would have a Social Services consult my patient for potential medical insurance plans that may be available to her to utilize to manage her chronic illnesses of hypertension, asthma and most importantly diabetes. I would also have a dietary consult for my patient should the she could be educated on ways to maintain a healthy balanced diet on a low budget income. I would have a pastoral care come to talk with my patient as she is showing interest in religion and having a clergy member talk to her would properly help with her recently self-identified depression. I would be having durable medical needs for this patient as patient may need to be sent home with oxygen tank as her pneumonia conditions alleviates. I would also have a med prescription on her medication to manage her hypertension, asthma and diabetes. I would also have instructions for the patient in Spanish as this is the patient first language. References Daviss Drug Guide. (Albuterol, Arformoterol, Azithromycin, Budesonide, Clonidine, Enoxaparin, Furosemide, Guaifenesin, Levemir, Novolog, Potassium Chloride, Diphenhydramine).Nursing Central. Retrieved fromhttp://www.unboundmedicine.com/products/nursing_central Huether, S. E. & McCance, K.L. (2012). Understanding Pathophysiology. St. Louis, Missouri: ELSEVIER. National Heart, Lung and Blood Institute. (n.d.). What is oxygen Therapy? Retrieved from  HYPERLINK "http://www.nhlbi.nih.gov/health/health-topics/topics/oxt/" \t "_blank" http://www.nhlbi.nih.gov/health/health-topics/topics/oxt/ Schoklitsch, A. & Baumann, U. (2011) Measuring Generativity in Older Adults. Geropsych, 24, 31-43. doi: 10.1024/1662-9647/a000030 United States Department of Agriculture. (2012). Choosemyplate.gov. Retreived from /013;KLMYstu źأ蜐wlaYYYhslCJ_HhNR5>*CJ_Hh.w{5>*CJ_Hh5>*CJ_H jh5>*CJ_HhY;B*_Hph hY;_HhQ;CJ_HhY5;B*CJ_HphhY5;CJ_HhQ%5;CJ_HhYCJ_HhYCJ_HhYCJ_H hYCJjhYUmHnHuhY"/123LMumU$$Q&/Ifa$l skd$$IfsP0*G 04 sa$Q&/Ifl $a$ uv\($Q&/IfgdNRl skd$$IfsP0*G 04 sa$Q&/Ifl  vvv$Q&/Ifl skdx$$IfsP0*G 04 sa     ' ( / \ ] n v w   6 8 9 W [ ] `    ƾ׶׫׾ףף΀h 5 CJ_Hh?4h+ CJ_Hh\zrCJ_Hhq,CJ_Hh+ CJ_Hh?4hYCJ_Hh NCJ_Hh(CJ_HhtCJ_Hh?4hYCJh?4hYCJ_HhslCJ_HhYCJ_H hYCJhYCJ_H2   0 \ u[[F$Q&/Ifl  !$Q&/Ifl kdE$$IfsPF2 *  0    4 sayt+ \ ] w u[FF$Q&/Ifl  !$Q&/Ifl kd $$IfsPF2 *  0    4 sayt+  nY$Q&/Ifl  !$Q&/Ifl vkd$$Ifs0*M04 sayt+  7 8 nY$Q&/Ifl  !$Q&/Ifl vkd$$IfsP0*M04 sayt+ 8 9 nQQQ<$Q&/Ifl  !$Q&/Ifgd+ l  !$Q&/Ifl vkdA$$IfsP0*M04 sayt+  sss$Q&/Ifl vkd$$Ifs0*M04 sayt+    ss$Q&/Ifl vkd$$IfsP0*M04 sayt+    2 3 ; X m r s    " - @ N O P Q R T U d f g o ̻zrzzzhCJ_H hYCJhY5>*CJ_HhNR5>*CJ_H hY>*_Hh5>*CJ_H jhY5>*CJ_H hY>* hYCJh?4h NCJ_HhYCJ_Hh+ CJ_HhYCJ_Hh NCJ_Hh?4hYCJh?4hYCJ_H,  Y s ssss$Q&/Ifl vkd*$$IfsP0*M04 sayt+  ss$Q&/Ifl vkd$$Ifs0*M04 sayt+    ss$Q&/Ifl vkd$$IfsP0*M04 sayt+   . O ss$Q&/Ifl vkd $$IfsP0*M04 sayt+ O P Q f s$IfgdNRl vkdB $$Ifs%0*M04 sayt+ f g .^kd $$Ifl*+04 la$Ifgd+ l ^kd $$Ifl*+04 la 1^kdk $$Ifl*+04 la^kd $$Ifl*+04 la$Ifl       ( 0 F [ i -L0[;X_sYnxƾhxCJ_Hh|CJ_Hh&; CJ_Hh~CJ_Hh#Y CJ_Hh+ CJ_Hh-+CJ_Hh%7CJ_H hYCJhhYCJ_HhCJ_Hh5>*CJ_HhNR5>*CJ_HhY5>*CJ_H4   z$Ifgd+ l ^kd $$Ifl*+04 la$IfgdNRl 5=>FhUVW^b06=j4NYe(:a;ev hYCJhYCJ_Hh+sCJ_Hhf9CJ_HhxCJ_Hh_NiCJ_Hh|CJ_Hh&; CJ_Hh%7CJ_HI-`kd $$Ifl*+04 la$Ifl `kdS $$Ifl*+04 la-`kd$$Ifl*+04 la$Ifl `kd_$$Ifl*+04 la-`kd$$Ifl*+04 la$Ifl `kdk$$Ifl*+04 la-`kd$$Ifl*+04 la$Ifl `kdw$$Ifl*+04 laXYtuyzcdežhQ;CJ_HhCJ_Hh%\CJ_Hhh5CJ_H hh hCJhNR5>*CJh5>*CJhu 5>*CJ jh5>*CJ hYCJhYCJ_H</^kd $$Ifl*+04 la$Ifl `kd$$Ifl*+04 la1^kd$$Ifl*+04 la$Ifl ^kd}$$Ifl*+04 la1^kd$$Ifl*+04 la$Ifl ^kde$$Ifl*+04 laY1/^kd$$Ifl*+04 la$Ifl ^kdM$$Ifl*+04 laY_tuzwgg$Ifl tkd5$$Ifl0*t#0P+4 layt$$Ifa$l zz$Ifl tkd$$Ifl0*t#0P+4 laytzz$Ifl tkdE$$Ifl0*t#0P+4 laytzz$Ifl tkd$$Ifl0*t#0P+4 laytdzz$Ifl tkdU$$Ifl0*t#0P+4 laytdezz$Ifl tkd$$Ifl0*t#0P+4 laytzz$Ifl tkde$$Ifl0*t#0P+4 laytzz$Ifl tkd$$Ifl0*t#0P+4 laytzz$Ifl tkdu$$Ifl0*t#0P+4 layt-./01?@ABCQRSTUǿwj\h}|h}|5CJ_HaJj!h.U_HjB!h.U_Hjh.U_Hh}|h.5CJ_HaJh}|5CJ_HaJ h%\_Hh.h.CJ_H h._Hh.CJ_HhNR5>*CJ_Hh.5>*CJ_H jh.5>*CJ_HhY5>*CJhCJ_Hh$zz$Ifl tkd$$Ifl0*t#0P+4 laytzz$Ifl tkd$$Ifl0*t#0P+4 laytzz$Ifl tkd $$Ifl0*t#0P+4 laytqV@@@$d$$Ifa$l qqd$$If]q^ql $IfgdNRl  tkd$$Ifl0*t#0P+4 layt7>HO]dmv{Ffrqqd$$If]q^ql $d$$Ifa$l .0BTVXjlnprFf5'$$Ifa$gdYl $Ifl $Ifl UVWXYghijklmnopqrs֮֡֔ևzj$h.U_Hj$h.U_Hj#h.U_Hj"#h.U_Hj"h.U_Hh}|h}|5CJ_HaJj2"h.U_H h._Hjh.U_Hh}|5CJ_HaJh}|h.5CJ_HaJ+%&'()789:;<=KLMNO]^_ʼʼxkj,h.U_Hjm,h.U_Hj+h.U_Hj}+h.U_Hj+h.U_H h}|_H h%\_Hh.h}|h.5CJ_HaJh}|5CJ_HaJjz%h.U_H h._Hjh.U_Hj%h.U_H*(:<N`rt   ! $ FfP3$$Ifa$gdYl $Ifl _`aopqrstu|oj0h.U_Hj-0h.U_Hj/h.U_Hj=/h.U_Hj.h.U_HjM.h.U_Hj-h.U_Hh}|h.5CJ_HaJh}|5CJ_HaJj]-h.U_Hjh.U_H h._H+          ! # % & 4 5 6 7 8 F G H I J X Y Z [ \ j k l m n | } ~  }jx9h.U_Hj9h.U_Hj8h.U_Hj8h.U_Hj7h.U_Hj 7h.U_H h}|_Hh.j1h.U_Hj1h.U_H h._Hjh.U_H0$ % 7 I [ m  !!!3!E!W!i!j!r!u!v!!Ff@$$Ifa$gdYl $Ifl  ! !!!!!! !!!"!0!1!2!3!4!B!zj=h.U_Hj8=h.U_Hj<h.U_HjH<h.U_Hj;h.U_HjX;h.U_Hj:h.U_Hjh:h.U_H h._Hjh.U_Hj9h.U_H-B!C!D!E!F!T!U!V!W!X!f!g!h!i!j!q!r!t!v!w!!!!!!!!!!!!!!!!!!!!!!!!!!!ľ}jFh.U_Hj Fh.U_HjEh.U_HjEh.U_HjDh.U_H h}|_Hh.j?h.U_Hj>h.U_H h._Hjh.U_Hj(>h.U_H-!!!!!!!""*"<"N"`"r"""""""""$Ifgd}|l FfVN$$Ifa$gdYl !!!!!!!!!!""""""""""'"(")"*"+"9":";"<"="K"L"M"N"O"]"^"_"`"a"o"p"q"r"s""zjJh.U_HjCJh.U_HjIh.U_HjSIh.U_HjHh.U_HjcHh.U_HjGh.U_HjsGh.U_H h._Hjh.U_HjFh.U_H-"""""""""""""""""""""""""""""""""""""" # # ##ⷮwjjSh}|U_HjSh}|U_HjRh}|U_Hj&Rh}|U_Hjh}|U_H h}|_Hh.h}|_Hh.jLh.U_Hj#Lh.U_HjKh.U_H h._Hjh.U_Hj3Kh.U_H)""""# #2#D#V#h#z######## $ $$$$$Ifl Ff[$$Ifa$gd}|l ##### #!#/#0#1#2#3#A#B#C#D#E#S#T#U#V#W#e#f#g#h#i#w#x#y#z#{#################zjWh}|U_HjNWh}|U_HjVh}|U_Hj^Vh}|U_HjUh}|U_HjnUh}|U_HjTh}|U_Hj~Th}|U_HjTh}|U_H h}|_Hjh}|U_H/####################$$ $ $ $$($)$0$F$G$M$N$R$S$a$b$c$d$e$s$t$u$v$w$$⪡⪡⪘~jGjh}|U_Hjih}|U_Hh.h._Hh.h}|_Hh}|jZh}|U_HjYh}|U_Hj.Yh}|U_HjXh}|U_H h}|_Hjh}|U_Hj>Xh}|U_H-$$$$$$$$$$ $!$"$#$$$%$&$'$($)$0$3$4$5$6$$Ifl Ff`$$Ifa$gdYl 6$7$8$9$:$;$<$=$>$?$@$A$B$C$D$E$F$G$N$Q$R$d$v$$$$Ifl Ffe$$Ifa$gdYl $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$%ɻzmjmh}|U_Hjmh}|U_Hjlh}|U_Hj'lh}|U_Hjkh}|U_Hj7kh}|U_Hh.h.5CJ_HaJh.h}|5CJ_HaJh.5CJ_HaJ h}|_Hjh}|U_Hjjh}|U_H'$$$$$$$$ %%.%@%R%d%v%w%~%%%%%%%%%$Ifl Ffr$$Ifa$gdYl %% % % %%%%%%+%,%-%.%/%=%>%?%@%A%O%P%Q%R%S%a%b%c%d%e%s%t%u%v%w%}%~%%%%%%␇~xjh.h}|5CJ_HaJ h._Hh.h}|_Hh.h._Hh}|jph}|U_Hj_ph}|U_Hjoh}|U_Hjooh}|U_Hjnh}|U_Hjnh}|U_H h}|_Hjh}|U_Hjnh}|U_H)%%%%%%%%%%%%%%%%%%%%%% &&0&$Ifl Ffw$$Ifa$gdYl %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% & & & & &&&&&&-&.&/&0&}pj~h}|U_HjE~h}|U_Hj}h}|U_HjU}h}|U_Hj|h}|U_Hje|h}|U_Hj{h}|U_Hju{h}|U_Hjh}|U_H h}|_H h._Hh.h}|_Hh.h._H,0&1&?&@&A&B&C&Q&R&S&T&U&c&d&e&f&g&u&v&w&x&y&&&&&&&&&&&&&&&&&&&&&&&&&&&zjh}|U_Hj}h}|U_Hjh}|U_Hjh}|U_Hjh}|U_Hjh}|U_Hj%h}|U_Hjh}|U_Hj5h}|U_H h}|_Hjh}|U_H/0&B&T&f&x&&&&&&&&&'''<($Ifl $Ifgd>Al Ff($$Ifa$gdYl &&&&&''' (("(;(<(=(>((((()))))****/*P*R*S*Z*[*z*{*|*ɿ}wl^h\zrhY5CJ_HaJh\zr5CJ_HaJ hY_HhY5:CJ_HhYCJ_HhXKCJ_Hh 5 CJ_HhYh 5 hY5;>*_H h 5 ;_H hY;_H jhY;_HhY5>*CJ h\zr_H h._Hh}| h}|_Hjh}|U_Hjmh}|U_H$<(=(>((rr$Ifl |kd$$Ifl4h0*`0*0>+2 4 layt>A((())))rrrrr$Ifl |kd$$Ifl4h0* 0*0>+2 4 layt>A)))**o77kdފ$$Ifl**`'4 la$@&Ifl |kd<$$Ifl4h0* 0*0>+2 4 layt>A*S*W*Z*[*z*|**|k$@&Ifl _kd$$$IflF*D%*zF    4 la$$Ifa$l $Ifl |*}*****************+++++,+-+.+/+0+C+E+t+u+ºƛ…}i]T}h|u>*CJ_Hh 5 hY>*CJ_H'jdhkhYCJU_HaJh\zrCJ_Hh|uCJ_Hh\zrhY5CJ_HaJh\zr5CJ_HaJ'jzhkhYCJU_HaJhYCJ_HhYhkhYCJ_HaJ'jhkhYCJU_HaJhYCJ_HaJjhYCJU_HaJ*****~~$$Ifa$l $Ifl ]kd$$IflF*D%*zF    4 la**++/+~~$$Ifa$l $Ifl ]kd$$IflF*D%*zF    4 la/+0+v+x++~~$$Ifa$l $Ifl ]kdڍ$$IflF*D%*zF    4 lau+v+w+x+y++++++++++++++++++,,(,),/,0,6,7,8,,,İΣrΣf\\ܟThYCJ_Hh|uCJ_HaJh 5 hY>*CJ_H'j<hkhYCJU_HaJh|uCJ_Hh\zrCJ_Hh|u>*CJ_HhYhkhYCJ_HaJ'jPhkhYCJU_HaJhYCJ_HaJjhYCJU_HaJh\zrhY5CJ_HaJh\zr5CJ_HaJh\zrhYCJ_H +++++~~$$Ifa$l $Ifl ]kdƎ$$IflF*D%*zF    4 la++),0,7,~~$$Ifa$l $Ifl ]kd$$IflF*D%*zF    4 la7,8,,,,~~$$Ifa$l $Ifl ]kd($$IflF*D%*zF    4 la,,,,,,,,,,,,,,--$-4-5-------------------------Ǽ{{s{s{{{{{{{k{{{{hXKCJ_Hh|uCJ_HhYCJ_H hNR_H hY_H jhY_Hh|u5>*CJhY5>*CJhYh|uhY5CJ_HaJh|u5CJ_HaJhkhYCJ_HaJjhYCJU_HaJ'jhkhYCJU_HaJhYCJ_HaJ*,,,,,,,-xxx$$Ifa$l $@&IfgdNRl ]kd$$IflF*D%*zF    4 la--$-5--ooo$Ifl kd$$IflF,*^0*    4 la-----~k[[$Ifl $$Ifa$l kd$$$Ifl4F,*^0*    4 la-----~nnn$Ifl kd’$$Ifl4F,*^0*    4 la-----~nnn$Ifl kd`$$Ifl4F,*^0*    4 la-----~nnn$Ifl kd$$Ifl4F,*^0*    4 la-----~nnn$Ifl kd$$Ifl4F,*^0*    4 la-----~nnn$Ifl kd:$$Ifl4F,*^0*    4 la-----~nnn$Ifl kdؕ$$Ifl4F,*^0*    4 la-----~nnn$Ifl kdv$$Ifl4F,*^0*    4 la-----~nnn$Ifl kd$$Ifl4F,*^0*    4 la---.~|k$@&Ifl kd$$Ifl4F,*^0*    4 la-----....n....!/C/U/0,0V0b0e00000000111]222 3%3Խ{{{{s{kc[c[hqCJ_HhikCJ_HhICJ_Hh* CJ_HhNoCJ_HhyCJ_Hh!CJ_Hh2;CJ_Hh!CJ_H hYCJhY5>*CJ_HhXK5>*_HhXKhY5>*_HhXK5>*CJ_Hh?4hY5>*CJ_Hh?4hY_H hY_H hYqs_H jhY_H#..66.^kdĘ$$Ifl*+04 la$Ifgddl ^kdP$$Ifl*+04 la%3X333333448595q6666666666666V8p8q8r8s8t8u8v8w8888=9/:0:1:2:3:4:5:A:<<<<<<<<<n?|???ººЪЪºº蜺hB'9CJ_H h!CJh7CJ_Hh!CJ_Hh!CJ_H hYCJhYCJ_HhdCJ_Hh5YCJ_HhyCJ_Hh* CJ_HhqCJ_Hh2;CJ_H966666r81^kd$$Ifl*+04 la^kd8$$Ifl*+04 la$Ifl r8s8t8u8v81^kd$$Ifl*+04 la$Ifl ^kd $$Ifl*+04 lav8w80:1:2:1^kd|$$Ifl*+04 la$Ifl ^kd$$Ifl*+04 la2:3:4:5:<1^kdd$$Ifl*+04 la$Ifl ^kd$$Ifl*+04 la<<<<1^kdL$$Ifl*+04 la$Ifl ^kd؜$$Ifl*+04 la<<<??+akd4$$Ifl*+04 layt!^kd$$Ifl*+04 la$Ifgd!l ?????(akdD$$Ifl*+04 layt!akd$$Ifl*+04 layt!$Ifgd!l ?????(akdT$$Ifl*+04 layt!akd̟$$Ifl*+04 layt!$Ifgd!l ?????(akdd$$Ifl*+04 layt!akdܠ$$Ifl*+04 layt!$Ifgd!l ??6@Z@u@@@@@_kd$$IflLF#*0 0*    2 4 layt)$Ifl ???????@5@6@:@;@S@Y@Z@g@o@p@t@@@@@@@@@@@@@@@@Ĺđuujj_UhzsCJ_HaJhzs5CJ_HaJhs5CJ_HaJhzshs5CJ_HaJhzshXK5CJ_HaJhzshY5CJ_HaJhzshsCJ_HaJhzsh^m CJ_HaJh.5CJ_HaJh hY5CJ_HaJh.hXKhY hY; hXK; jhY5;>*CJhY5;>*CJ!@@@@tt$Ifl {kd$$Ifl"0^*{{0*2 4 layt)@@@@@@@@@AAxA{AAAAAAAAAAAAAA BpBBBBCC.CJCtCCܦܦܜϻ||||rhr|hh^m CJ_HaJhcxCJ_HaJhX*CJ_HaJh35CJ_HaJh)5CJ_HaJh3CJ_HaJhqICJ_HaJh<5CJ_HaJhY *hshY5CJ_HaJhNhYCJ_HaJhNCJ_HaJhN5CJ_HaJh hY5CJ_HaJ$@@At$Ifl {kd$$$Ifl"0*0*2 4 layt)AAEEhkdb$$Ifl"**0*2 4 layt)$IfgdX*l hkdͣ$$Ifl"**0*2 4 layt)CCCCC-E9EoEEEEEEEEEEEEEEEEEEEEEEEFFFFF#F/Fǹǹǹ{nǹch A'5CJ_HaJhQ;hzsCJ_HaJhzs5CJ_HaJh hzs5CJ_HaJhzsh A'CJ_HaJhzshCJ_HaJh5CJ_HaJh hY5CJ_HaJhYh3hYCJ_HaJh A'CJ_HaJh}CJ_HaJhX*CJ_HaJhzsCJ_HaJ$EEEEEEttt$IfgdYl hkd$$Iflk**0*2 4 layt)$Ifl EEEFq^^$IfgdYl kd$$IflLF#*0 0*    2 4 layt)FF$FLFqq$IfgdYl {kd=$$Ifl"0^*{{0*2 4 layt)/F7FLFMFWFYFGGG3G5GGGHHNHVH^HnHHjIkIlImInIrIsIIIIIIIIIIIIIIIIIȾަȾ⑄⑄zm⑄hzshCJ_HaJhQ;CJ_HaJhvhCJ_HaJh5CJ_HaJhbCJ_HaJh)5CJ_HaJh A'hYCJ_HaJh A'CJ_HaJh A'5CJ_HaJh<5CJ_HaJhYh hY5CJ_HaJ *hhY5CJ_HaJ*LFMFGq$IfgdYl {kdҦ$$Ifl"0*0*2 4 layt)GGkIlIhkd$$Ifl"**0*2 4 layt)$IfgdYl hkd{$$Ifl"**0*2 4 layt)lImInIIIIhkd$$Iflk**0*2 4 layt)$IfgdYl IIIIq^^$IfgdYl kdH$$IflLF#*0 0*    2 4 layt)IIIJqq$IfgdYl {kd$$Ifl"0^*{{0*2 4 layt)IIIIIJJJ J"JJJJJJ*LNNN N NN#N$N'N5N6N7N;Nc?cDcEcPcVc`cacicccccȽuhuhzshzsCJ_HaJhzsh(&CJ_HaJh(&5CJ_HaJhzsCJ_HaJhzshCJ_HaJh5CJ_HaJh hY5CJ_HaJh hYCJaJh7bhYCJ_HaJh/:CJ_HaJh7bCJ_HaJh7b5CJ_HaJh)5CJ_HaJ(bbbc$c>cq$Ifgdl hkd$$Iflk**0*2 4 layt)$IfgdYl >c?cWccq^^$IfgdYl kdK$$IflLF#*0 0*    2 4 layt)ccccqq$IfgdYl {kd$$Ifl"0^*{{0*2 4 layt)cccccccc+d,d-dBdQdUdffffffffffggggggg g%gxnaxaxaVh h(&CJaJhzsh(&CJ_HaJhzsCJ_HaJh(&5CJ_HaJh h(&5CJ_HaJh(&hQ;CJ_HaJhQ;5CJ_HaJh)5CJ_HaJh<5CJ_HaJh hYCJaJ *h(&hY5CJ_HaJh hY5CJ_HaJh/:hYCJ_HaJh/:CJ_HaJ cc,dq$IfgdYl {kd$$Ifl"0*0*2 4 layt),d-dffhkd$$Ifl"**0*2 4 layt)$Ifgd/:l hkd,$$Ifl"**0*2 4 layt)fffffggooo$Ifgd(&l hkdV$$Iflk**0*2 4 layt)$IfgdYl g g)g8gq^^$Ifgd(&l kd$$IflLF#*0 0*    2 4 layt(&%g&g(g)g2g3g7g8g9gMgkglgwggggghhhhhhhhiii$iJiQiRiYiZibiijjjķϬϢυϬzoeeeeeeeehUNCJ_HaJhUN5CJ_HaJhW5CJ_HaJ *h(&h(&5CJ_HaJhWh(&CJ_HaJhWCJ_HaJh h(&CJaJhQ;h(&CJ_HaJh(&5CJ_HaJh h(&5CJ_HaJhzsh(&CJ_HaJhzsCJ_HaJhzs5CJ_HaJ&8g9glggqq$Ifgd(&l {kd$$Ifl"0^*{{0*2 4 layt(&gghq$Ifgd(&l {kd1$$Ifl"0*0*2 4 layt(&hhjjhkdo$$Ifl"**0*2 4 layt(&$IfgdUNl hkd$$Ifl"**0*2 4 layt(&jjjjjjkk\kd$$IflLF#*0 0*    2 4 layt(&$Ifgd(&l jjjjjjjjjjjjjjk k kkkk(kYkZkekmkkkk%l&l'lJlllm+m@mnnnnnnnnnnnnnnn㪝㪃h]@CJ_HaJ *h(&h(&5CJ_HaJhUNh(&CJ_HaJhUNCJ_HaJh h(&CJaJhzsCJ_HaJhzsh(&CJ_HaJhzshUNCJ_HaJh(&5CJ_HaJh h(&5CJ_HaJh(&3kkZkkqq$Ifgd(&l {kd$$Ifl"0^*{{0*2 4 layt(&kk&lq$IfgdUNl {kd<$$Ifl"0*0*2 4 layt(&&l'lnnhkdz$$Ifl"**0*2 4 layt(&$Ifgd(&l hkd$$Ifl"**0*2 4 layt(&nnnnnnn o\kd$$IflLF#*0 0*    2 4 layt(&$Ifgd(&l noo o o ooBoNoVokolovo7p8p9p\pNrrrrrrrrrrrrrrrrrrrrħĝΙ持shhQ;5CJ_HaJh hQ;5CJ_HaJh&.5CJ_HaJhzsh&.CJ_HaJh(&hb'mCJ_HaJh]@h(&CJ_HaJ *h(&h(&5CJ_HaJh]@CJ_HaJh h(&CJaJhzsh(&CJ_HaJh(&5CJ_HaJh h(&5CJ_HaJ$ o oCokoqq$Ifgd(&l {kd$$Ifl"0^*{{0*2 4 layt(&kolo8pq$Ifgd]@l {kdG$$Ifl"0*0*2 4 layt(&8p9prrhkd$$Ifl**0*2 4 layt]@$Ifgd(&l hkd$$Ifl"**0*2 4 layt(&rrrrrrrr\kd$$IflLF#*0 0*    2 4 layt(&$Ifgd(&l rrrrrss,sOsPsTsxsyssttttnvovpvqvrvvvwvvvvv¸؛͐͐{mbUHmbhzshGCJ_HaJhzshzsCJ_HaJhG5CJ_HaJh hG5CJ_HaJhGh(&hb'mh(&CJ_HaJh(&5CJ_HaJ *h<mh(&5CJ_HaJhb'mhb'mCJ_HaJhb'mCJ_HaJhb'm5CJ_HaJh h(&CJaJh h(&5CJ_HaJhzsh&.CJ_HaJhQ;hQ;CJ_HaJrrPsxsqq$Ifgd(&l {kd$$Ifl"0^*{{0*2 4 layt(&xsystq$Ifgd(&l {kdR$$Ifl"0*0*2 4 layt(&ttovpvhkd$$Ifl"**0*2 4 layt(&$Ifgd(&l hkd$$Ifl"**0*2 4 layt(&pvqvrvvvvvvv\kd%$$IflLF#*0 0*    2 4 laytG$IfgdGl vvvvvvvvvvvvvvvvvwwww9w:wDw@xAxBxexfx||||||تؖͪͪ{wpb jhY5>*CJ_H h %hYh<mhzs5CJ_HaJ *h<mhG5CJ_HaJhzsCJ_HaJhuCJ_HaJhG5CJ_HaJhzshzsCJ_HaJh<m5CJ_HaJh hGCJaJh hG5CJ_HaJhzsh<mCJ_HaJhzshGCJ_HaJ"vvw9wqq$IfgdGl {kd$$Ifl"0^*{{0*2 4 laytG9w:wAxq$IfgdGl {kd]$$Ifl"0*0*2 4 laytGAxBx||hkd$$Ifl"**0*2 4 laytG$IfgdGl hkd$$Ifl"**0*2 4 laytG|||w|x|||{h$Ifgdo1l $Ifl ^kd0$$Ifl*+04 la$IfgdXKl ||||C|G|`|v|w|x|{||||||||}}K}L}d}e}}}2~3~~~~~~~~~Z[ghـĻ{{{{{{{{hg?CJ_HhKCJ_HhmACJ_HhCJ_Hh" CJ_Hho1CJ_HhsCJ_HhYCJ_HhY5>*CJhY5>*CJ_HhXK>*CJ_HhY>*CJ_Hh>A>*CJ_HhY5>*CJ_Hh.w{5>*CJ_H0||}K}vf$Ifl $  $Ifa$l qkd$$Ifl0*04 laK}L}e}zjj$Ifl $IfgdYl qkd$$Ifl0*04 laـހ.Oɂ̂ GPXՃ܃ރ ]}5679:<=Ccm!#$&'cefhi׆ǿǷǗϟϏho1CJ_Hhl\ CJ_Hh9{CJ_HhjnCJ_Hh=CJ_HhCJ_HhuCJ_HhYCJ_HhY5>*CJhg?CJ_HhQ;CJ_Hh* CJ_HhKCJ_Hh0oCJ_H889zj$Ifl $IfgdYl qkd$$Ifl0*04 la9:;<zj$Ifl $IfgdYl qkd$$Ifl0*04 la<=zj$Ifl $Ifgdl\ l qkdt$$Ifl0*04 laue$Ifl $IfgdYl vkd$$IflL0*04 laytl\ "#zj$Ifl $IfgdYl qkdf$$Ifl0*04 la#$%&zj$Ifl $IfgdYl qkd$$Ifl0*04 la&'dexh$Ifl $IfgdYl skdN$$Ifl0*04 laefgh{{$Ifl skd$$Ifl0*04 lahi؆ن{{$Ifl skdL$$Ifl0*04 la׆نچ܆݆ކއ߇:CDEFGxoh]UhsCJ_HhY5>*CJ_H hY>*_HhY>*CJ_HhY5>*CJ_Hho15>*CJ_H jhY5>*CJ_Hjh0oU_Hj ,h0oU_H h0o_H h5_H ho1_H hXK_H-jhJM hJM B*U_HmHnHphu hJM _Hj hJM U_HhY5>*CJhYCJ_H!نچۆ܆{{$Ifl skd$$Ifl0*04 la܆݆{hUUU$Ifgdjl $IfgdXKl $Ifl skdX$$Ifl0*04 la{^kd$$Ifl*+04 la$Ifl skd|$$Ifl0*04 laDEFG1^kd$$Ifl*+04 la^kdv$$Ifl*+04 la$Ifl G'()~ΉЉ,CFHuɶ䭟ynfnfnfnh9CJ_Hh9hYCJ_Hhe~hY6CJ_H *h!hYCJ_Hh.w{hY5>*CJ_Hh.w{hYqs5>*CJ_Hh75CJ_HhhYCJ_HhKCJ_HhCJ_HhshYCJ_HhsCJ_HhY5>*CJhY5>*CJ_HhYCJ_H(1^kd$$Ifl*+04 la$Ifl ^kd^$$Ifl*+04 la1^kd$$Ifl*+04 la$Ifl ^kdF$$Ifl*+04 la()1^kd$$Ifl*+04 la$Ifl ^kd.$$Ifl*+04 la1^kd$$Ifl*+04 la$Ifl ^kd$$Ifl*+04 laGH^kd$$Ifl*+04 la$Ifl E[ŒÌČ *+Ƹњ|h`|L`'jhNhYCJU_HaJhYCJ_H'jZhNhYCJU_HaJhNhYCJ_HaJ!jhNhYCJU_HaJhYCJ_HhY5>*CJ_Hhu 5>*CJ_H jhY5>*CJ_Hh75>*CJ_HhY5>*CJhY5>*CJ_Hh9hYCJ_HhCJ_Hh9CJ_HÌČ1^kd$$Ifl*+04 la$Ifl ^kdr$$Ifl*+04 la+9:;GHIWXYijxyzЍэҍvb'jhNhYCJU_HaJ'j*hNhYCJU_HaJ'jhNhYCJU_HaJ'j:hNhYCJU_HaJ'jhNhYCJU_HaJhYCJ_H!jhNhYCJU_HaJ'jJhNhYCJU_HaJhNhYCJ_HaJ *+9:;HIWXYdfwyɎűŝʼn|o['jhNhYCJU_HaJhB'956CJ_HaJhB'95>*CJ_HaJ'jhNhYCJU_HaJ'j hNhYCJU_HaJ'jhNhYCJU_HaJhNhYCJ_HaJhYCJ_H!jhNhYCJU_HaJ'jhNhYCJU_HaJɎʎˎҎӎԎ [\pqrstQ_&Fpr }v hY>*_HhB'9hYCJ_Hh0*&CJ_Hh"CJ_HhB'9CJ_HhY>*CJ_H ho1_H hY_H hY_H h._HhY5>*CJhYCJ_HhYCJ_H!jhNhYCJU_HaJ'jrhNhYCJU_HaJ.ČӎԎ[z$Ifgd.l ^kd$$Ifl*+04 la$IfgdB'9l [\qrs1^kd$$Ifl*+04 la$Ifl ^kd^$$Ifl*+04 last1^kd$$Ifl*+04 la$Ifl ^kdF$$Ifl*+04 la}$Ifl ^kd.$$Ifl*+04 la$Ifgd0*&l 1^kd$$Ifl*+04 la$Ifl ^kd$$Ifl*+04 la 1^kd$$Ifl*+04 la$Ifl ^kd$$Ifl*+04 la 81^kd$$Ifl*+04 la$Ifl ^kdr$$Ifl*+04 laŒݒ8MR۔789:;<=>?@SUVWvԻ~meZhe~hCJ_Hh)CJ_H! *hNRhY5>*CJ_HaJhNRhY5>*CJ_HaJhNR5>*CJ_HaJhNRhYqs5>*CJ_HaJhNRh.w{5>*CJ_HaJhNRh.5>*CJ_HaJhY>*CJ_HhY5>*CJhB'9hYCJ_Hh;CJ_Hh dCJ_HhB'9CJ_H89:;<1^kd$$Ifl*+04 la$Ifl ^kdZ$$Ifl*+04 la<=VW.^kd$$Ifl*+04 la$IfgdNRl ^kdB$$Ifl*+04 laW.^kd$$Ifl*+04 la^kd*$$Ifl*+04 la$IfgdYl *+,")MNƘ츱xqbqWhe~he~CJ_H *h!he~5>*CJ_H he~>*CJ *he~he~6CJ_Hhe~he~6CJ_Hhe~5>*CJhNRhe~6>*_HhNRhe~>*_H hNR>*_HhNRhYqs>*_Hh`shYCJ_H *h!hYCJ_HhCJ_HhhCJ_HhY5>*CJhe~hYCJ_H"+.^kd$$Ifl*+04 la$IfgdYl ^kd$$Ifl*+04 la+,.^kdn$$Ifl*+04 la$IfgdYl ^kd$$Ifl*+04 la.^kdV$$Ifl*+04 la$IfgdYl ^kd$$Ifl*+04 laMNy$Ifgd0l ^kd$$Ifl*+04 la$@&Ifgd0l ˘ .^kd$$Ifl*+04 la$Ifgd0l ^kd>$$Ifl*+04 laƘʘ˘ J*-.ÚgzЛ#$Z㿶{qihNRh N>*hNRh N5>*hNRh N5>*CJaJ hY>*CJ he~>*CJhphpCJ_Hhphp>*CJ_Hh NCJ_Hhp>*CJ_HhpCJ_Hh)CJ_Hhh>*CJ_HhCJ_Hhe~he~CJ_Hhe~CJ_Hh>*CJ_H( .[lmngd N^kd&$$Ifl*+04 la$Ifgd0l Z[klnq8MNbeflmnɞ؞ڞ||tl|hYCJ_HhYCJ_HhpCJ_H *hhCJ_Hh.CJ_HhCJ_H *hphYCJ_HhYCJ_HhYhY5>*_HhY5;>*CJ_HhY5>*CJ_H h Nh N hp>*hphp>*hp hph NhNRhY>*(n/OmgT$Ifgd.l :kd$$Ifl*P+P+4 layt<x$Ifl :kd$$Ifl*P+P+4 layt<$Ifl mn-`kd$$IflF*N P+    4 layt<$Ifl `kd4$$IflF*N P+    4 layt<ٞڞ`kd$$IflF*N P+    4 layt<$Ifl ڞ "9NO1256gh&()*<=\]_UVļ *hbh<CJ_HhbCJ_Hh<CJ_HhbCJ_HhpCJ_Hh.CJ_H *hph<CJ_Hh<hpCJ_HhYhYCJ_Hh<CJ_H?-`kd$$IflF*N P+    4 layt<$Ifl `kd3$$IflF*N P+    4 layt<iS:kd$$$Ifl*P+P+4 layt<Mkd$$Ifl0*8P+4 layt<$Ifl $Ifgd0l  :Ny:kd$$Ifl*P+P+4 layt<$Ifl :kd$$Ifl*P+P+4 layt<NO12-`kd$$IflF*N P+    4 layt<$Ifl `kd5$$IflF*N P+    4 layt<23456efg`kd$$IflF*N P+    4 layt<$Ifl ghS:kd$$Ifl*P+P+4 layt<$Ifl `kdB$$IflF*N P+    4 layt0)*<=>Hy>:kd$$Ifl*P+P+4 layt0:kd$$Ifl*P+P+4 layt0$Ifl :kd>$$Ifl*P+P+4 layt<H\]^_`kdO$$IflFj* zP+    4 layt<$Ifl -`kd$$IflFj* zP+    4 layt<$Ifl `kd$$IflFj* zP+    4 layt<ʢ`kd\$$IflFj* zP+    4 layt<$Ifl -`kd$$IflFj* zP+    4 layt0$Ifl `kd $$IflFj* zP+    4 layt<UVklmny<<kd$$Iflb*P+P+4 layt0:kd$$Ifl*P+P+4 layt0:kd[$$Ifl*P+P+4 layt0$Ifl Vjklmnopqrstuvwxyz{|}~ԣգ֣XYZ[\j(WXvmdvh V=5_HaJhb5_HaJho>h5_HaJ hY>*_H hY>* hb_H hY_HhY5>*CJhY>*CJ_HhCJ_HhYCJ_HhY hY; hQ%5;hQ%hQ%; jhQ%hQ%;hQ%hY5;>*CJh<h<CJ_HhbCJ_H'nopqrstuy>:kd&$$Ifl*P+P+4 layt<:kd$$Ifl*P+P+4 layt<:kdp$$Ifl*P+P+4 layt0$Ifl uvwxyz{y>:kd7$$Ifl*P+P+4 layt<:kd$$Ifl*P+P+4 layt<$Ifl :kd$$Ifl*P+P+4 layt<{|}գ֣YN>$Ifl `kd$$Ifl*#+0#+4 la$@&Ifl :kd$$Ifl*P+P+4 layt<YZ[\,`kd$$Ifl*#+0#+4 la$@&Ifl `kdk$$Ifl*#+0#+4 la\XYԦզ)`kd$$Ifl*#+0#+4 la`kda$$Ifl*#+0#+4 la$@&Ifgdl XY_ӦԦզߦ>٧ڧۧIWը֨רبڨ٩ک۩ީrstǪت<wΫ٫ޫȾȪ}tk}kh)5_HaJhoA5_HaJhq,5_HaJhfD5_HaJhL5_HaJhDy5_HaJh5_HaJhCJ_HaJhLCJ_HaJhNH!CJ_HaJho>hCJ_HaJ h5>*hNH!5_HaJh V=5_HaJho>h5_HaJ h>**զڧۧ֨w$Ifgdl `kdQ$$Ifl*#+0#+4 la$@&Ifgdl ֨רک۩s*`kdA$$Ifl*#+0#+4 la$Ifgdl `kd$$Ifl*#+0#+4 last)`kd1$$Ifl*#+0#+4 la$@&Ifgdl `kd$$Ifl*#+0#+4 laޫ!M[xyŭȭ#*5678LүӯԯYZ[nŻŻܨܨܨ܌܌܌ hp5_Hhh5_Hhp5_HaJhna5_HaJh5_HaJhnaCJ_HaJhbCJ_HaJhq,CJ_HaJho>hCJ_HaJ h>*ho>h5_HaJh)5_HaJhDy5_HaJ2w$@&Ifgdl `kd$$Ifl*#+0#+4 la$Ifgdl 78)`kd $$Ifl*#+0#+4 la$@&Ifgdl `kd! $$Ifl*#+0#+4 laӯԯZ)`kd $$Ifl*#+0#+4 la$@&Ifgdl `kd $$Ifl*#+0#+4 laZ[)`kdy $$Ifl*#+0#+4 la$@&Ifgdl `kd $$Ifl*#+0#+4 la,`kdi $$Ifl*#+0#+4 la`kd $$Ifl*#+0#+4 la$@&Ifl  tuvw %&45͹hp>*CJ_HhQ%5CJ_HhY5>*CJ_HhY5>*CJhpCJ_HhYhYCJ_HhY5>*CJ h>* h>*_HB,`kdY $$Ifl*#+0#+4 la`kd $$Ifl*#+0#+4 la$@&Ifl ,`kdI$$Ifl*#+0#+4 la`kd $$Ifl*#+0#+4 la$@&Ifl ,`kd9$$Ifl*#+0#+4 la`kd$$Ifl*#+0#+4 la$@&Ifl ,`kd)$$Ifl*#+0#+4 la`kd$$Ifl*#+0#+4 la$@&Ifl ,`kd$$Ifl*#+0#+4 la`kd$$Ifl*#+0#+4 la$@&Ifl ,`kd $$Ifl*#+0#+4 la`kd$$Ifl*#+0#+4 la$@&Ifl  t{$Ifl `kd$$Ifl*#+0#+4 la$@&Ifl tuvw1^kdm$$Ifl*P+04 la$Ifl ^kd$$Ifl*P+04 la1^kdU$$Ifl*P+04 la$Ifl ^kd$$Ifl*P+04 la1^kd=$$Ifl*P+04 la$Ifl ^kd$$Ifl*P+04 la1^kd%$$Ifl*P+04 la$Ifl ^kd$$Ifl*P+04 la1^kd $$Ifl*P+04 la$Ifl ^kd$$Ifl*P+04 la1^kd$$Ifl*P+04 la^kd$$Ifl*P+04 la$Ifl  1//^kd$$Ifl*P+04 la$Ifl ^kdi$$Ifl*P+04 la %&}ѷxwwwwwwwwwww$IfgdQ%l akdQ$$If3++0+ 4 aytQ%$Ifgd5l  5MNŲβϲղܲ-4>PbjrsƸƭϤϤ}ƭthhQhQ%>*CJ_HhQ>*CJ_Hh{QhQ%5>*CJ_Hh{Q5>*CJ_Hh{Qh{Q5>*CJ_Hh{Q5CJ_HhQ5>*CJ_HhQhQ5>*CJ_HhQ5CJ_HhQ%5CJ_Hh`5CJ_HhphQ%>*CJ_Hh`>*CJ_Hh{Q>*CJ_H(rz|}͵ϵ )GQnɷзѷط=L wxúÖ䍁xlhQchQ%>*CJ_Hh%m5CJ_HhTshQ%>*CJ_HhQc>*CJ_HhTs5CJ_HhTs>*CJ_Hh {>*CJ_Hh|G>*CJ_HhQ%5CJ_HhrKhQ%>*CJ_HhrK5CJ_HhQhQ%>*CJ_Hh%m>*CJ_HhrK>*CJ_HhQ5CJ_H* \hiBPuvy+XYegKSZ[\]^۽۽۽۽ϫ~~vkbkhY5>*CJhY5>*CJ_HhE4CJ_HhE4hE4>*CJ_HhE4h>*CJ_Hh5CJ_HhfhQ%>*CJ_Hhf5CJ_HhJ>*CJ_Hhf>*CJ_HhZE5CJ_HhZEhQ%>*CJ_HhZE>*CJ_HhQc>*CJ_HhQc5CJ_HhQ%5CJ_H%vY\]^_zz$Ifl akd$$Ifl>++0+4 laytQ%$IfgdQ%l ^_`56:=>?BCU^_콮젔}si_RE};h`CJ_HaJhSqh(CJ_HaJhSqh dCJ_HaJhuCJ_HaJh dCJ_HaJh(CJ_HaJhSqhE4CJ_HaJhSqCJ_HaJhh(5>*CJhh(5>*CJ_Hh[JhYB*CJ_HphOh[JhvB*CJ_HphOhdhY>*CJ_HhY>*CJ_HhY5>*CJ_HhY5>*CJhE45>*CJ_H_`+akd$$Ifl>++0+4 laytQ%$Ifl akdX$$Ifl>++0+4 laytQ%+akd$$Ifl>++0+4 laytQ%$Ifl akdV$$Ifl>++0+4 laytQ% &,567kdT$IfK$L$l\ ] *    t044 lap(yt$Ifl K$6:>?CDTUcdq>$Ifl K$$$Ifa$gdE4l K$$Ifgd(l K$$Ifgd(l $$Ifa$gdl $IfgdSql  _adkopqnp=>?GHLMabklpw{|ŷ挭xphpx]PPhSqh`CJ_HaJhE4hE4CJ_HhuCJ_Hh dCJ_HhE4CJ_Hhh(5>*CJhSqh&CJ_HaJhACJ_HaJh~tCJ_HaJh`CJ_HaJhSqh(>*CJ_HaJhSqh5CJ_HaJh5CJ_HaJh dCJ_HaJhSqh(CJ_HaJhSqhE4CJ_HaJ>?CDH5$$Ifa$gdE4l $IfgdSql kd$IfK$L$l\ ] *    t044 lap(ytDGHMNbp}N^$Ifl K$$$Ifa$gdAl K$$$Ifa$gd`l $IfgdE4l K$$$Ifa$gdE4l  |}?MN]^_bcijno/0ûóè}pcTIh h(CJ_Hhh(B* CJ_HphI}hSqhACJ_HaJhSqh5CJ_HaJh5CJ_HaJhACJ_HaJh`CJ_HaJhSqh`CJ_HaJhE4hE4CJ_HhACJ_Hh(CJ_HhE4CJ_Hhh(5>*CJhuh(CJ_Hh CJ_HhuCJ_Hhh(5>*CJ_H^_cdH88$Ifl kd$IfK$L$l\ ] *    t044 lap(ytdijop0$Ifgd l K$$IfgdSql K$$$Ifa$gd`l $Ifl K$$Ifl $$Ifa$gdSql  H88$Ifl kd^$IfK$L$l\ ] *    t044 lap(yt #:>Ustijkmɼvnfnfnfnf[fPhh(CJ_Hh h(CJ_HhCJ_Hh CJ_Hhh(5>*CJ_HhSqhACJ_HaJhSqh5CJ_HaJh5CJ_HaJhACJ_HaJh`CJ_HaJhSqh`CJ_HaJhE4hE4CJ_HhSqCJ_HhuCJ_HhACJ_HhE4CJ_Hhh(5>*CJtj$$Ifa$gd`l $Ifl K$$Ifl $$Ifa$gdSql  jknoH88$Ifl kd $IfK$L$l\ ] *    t044 lap(ytmnstwx RST[^_qr{|ǺxxlպbUhSqh5CJ_HaJh5CJ_HaJhh(5>*CJhh(CJ_HhCJ_Hhh(5>*CJ_HhSqhACJ_HaJhACJ_HaJh`CJ_HaJhSqh`CJ_HaJhhSq5>*CJ_HhSqhSqCJ_HhuCJ_HhACJ_HhSqCJ_Hh(CJ_H!ostxy S$$Ifa$gd`l $Ifl K$$Ifl $$Ifa$gdSql  STVWH88$Ifl kd$IfK$L$l\ ] *    t044 lap(ytW[_`r$IfgdQol K$$$Ifa$gd`l $Ifl K$$Ifl $$Ifa$gdSql   !45>?BCJNOPQտyyoeXKտտhSqhuCJ_HaJhSqh5CJ_HaJh5CJ_HaJhuCJ_HaJh`CJ_HaJhSqh`CJ_HaJhSqhSqCJ_HhACJ_HhuCJ_HhSqCJ_HhhSq5>*CJhQohSqCJ_HhhSqCJ_HhQoCJ_HhCJ_HhhSq5>*CJ_HhSqhACJ_HaJH88$Ifl kdh $IfK$L$l\ ] *    t044 lap(yt!"345CPQ$$Ifa$gd`l $Ifl K$$Ifl $$Ifa$gdSql  H8"$$Ifa$gdSql $Ifl kd!$IfK$L$l\ ] *    t044 lap(yt $$Ifa$gd`l $Ifl K$$Ifl $$Ifa$gdSql  :l@A'+?HILµskµskhuCJ_HhhSq5>*CJho(hSqCJ_Hh5CJ_Hho(CJ_HhhSq5>*CJ_HhSqhuCJ_HaJhSqh5CJ_HaJh5CJ_HaJhuCJ_HaJh`CJ_HaJhSqh`CJ_HaJhSqhSqCJ_HhSqCJ_H*H88$Ifl kd!$IfK$L$l\ ] *    t044 lap(ytA$$Ifa$gd`l $Ifl K$$Ifl $$Ifa$gdSql  #$H55$IfgdSql kdr"$IfK$L$l\ ] *    t044 lap(yt$'+,?MZ[M$Ifl K$$$Ifa$gd`l $IfgdSql K$$IfgdSql $$Ifa$gdSql  LMTXYZ[LMNW[luvyzgWXȺ~~skccXhSqh~tCJ_Hh~tCJ_Hh5CJ_HhSqhSqCJ_HhSqh`CJ_HaJhuCJ_HhSqCJ_HhhSq5>*CJho(hSqCJ_Hho(CJ_HhhSq5>*CJ_HhSqhuCJ_HaJhSqh5CJ_HaJh5CJ_HaJhuCJ_HaJh`CJ_HaJ!MNRSH88$Ifl kd #$IfK$L$l\ ] *    t044 lap(ytSW[\lz$$Ifa$gd`l $Ifl K$$Ifl $$Ifa$gdSql  H88888$Ifl kd#$IfK$L$l\ ] *    t044 lap(ytSTVWXcdop{|W$Ifgd8l K$$$Ifa$gd~tl K$$$Ifa$gd~tl $$Ifa$gd'Bl $Ifl K$$Ifl  Xdz{|*+,DnVWXY\]^abfgͽ͉}rd}rd}VJhh(5>*CJhh(5>*CJ_HhhSq5>*CJ_HhSqhSqCJ_HhhSq5>*CJh8hSqCJ_Hh% hSqB*CJ_Hphl h% h8B*CJ_Hphl h5h8CJ_Hh5CJ_Hh:fCJ_Hh8CJ_Hh)CJ_Hh~th~tCJ_HhSqCJ_Hh~tCJ_Hh'BCJ_HWXYZ[\H7777$Ifl K$kd|$$IfK$L$l\ ] *    t044 lap(yt\]^_`aH7777$Ifl K$kd*%$IfK$L$l\ ] *    t044 lap(ytabcdefH7777$Ifl K$kd%$IfK$L$l\ ] *    t044 lap(ytfghH8$Ifl kd&$IfK$L$l\ ] *    t044 lap(ytghijklmnopqrstuvwxyz{|}~:;<=`axy(Ҿ춮h5CJ_Hh|GCJ_HhxnCJ_Hh8CJ_Hh=CJ_HhKdhY>*CJ_Hh'eCJ_HhKdCJ_HhKd5CJ_HhY5CJ_HhY5>*CJhY5>*CJ_H6hijkl+akd'$$Ifl>++0+4 laytQ%$Ifl akd4'$$Ifl>++0+4 laytQ%lmnop+akd($$Ifl>++0+4 laytQ%$Ifl akd2($$Ifl>++0+4 laytQ%pqrst+akd)$$Ifl>++0+4 laytQ%$Ifl akd0)$$Ifl>++0+4 laytQ%tuvwx+akd*$$Ifl>++0+4 laytQ%$Ifl akd.*$$Ifl>++0+4 laytQ%xyz{|+akd+$$Ifl>++0+4 laytQ%$Ifl akd,+$$Ifl>++0+4 laytQ%|}~+akd,$$Ifl>++0+4 laytQ%$Ifl akd*,$$Ifl>++0+4 laytQ%+akd-$$Ifl>++0+4 laytQ%$Ifl akd(-$$Ifl>++0+4 laytQ%<=+akd.$$Ifl>++0+4 laytQ%$Ifl akd&.$$Ifl>++0+4 laytQ%=z$Ifl akd$/$$Ifl>++0+4 laytQ%$Ifgd8l  ſ}}rnh{(h}xzhPCJ_HhPh{(CJ_HhPCJ_Hhu 5>*CJhYhu >*_HhYhS5_HhYhu 5_H hY>*_H h^7<_HhYhu _H jhYhu _H hu >*_HhY5>*CJ_HhY5>*CJhhYCJ_H++akd"0$$Ifl>++0+4 laytQ%$Ifl akd/$$Ifl>++0+4 laytQ%+akd 1$$Ifl>++0+4 laytQ%$Ifl akd0$$Ifl>++0+4 laytQ%+akd2$$Ifl>++0+4 laytQ%$Ifl akd1$$Ifl>++0+4 laytQ%+akd3$$Ifl>++0+4 laytQ%$Ifl akd2$$Ifl>++0+4 laytQ%+akd4$$Ifl>++0+4 laytQ%$Ifl akd3$$Ifl>++0+4 laytQ% r__$IfgdPl akd4$$Ifl>++0+4 laytQ%$$@&Ifa$gd^7<l $@&Ifgd ;zl  (akd5$$Ifl>++0+4 laytQ%$IfgdPl akd5$$Ifl>++0+4 laytQ% zz$Ifgd{(l akd6$$Ifl>++0+4 laytQ%$Ifl _c|}Զxndh[CJ_HaJh1CJ_HaJh^7<h'e5CJ_HaJh^7<h?45CJ_HaJh^7<h?4B*CJaJphOh`yCJ_Hh^7<h?4CJaJh^7<h?45CJaJh^7<5CJaJh?45CJaJhzh?45CJaJhY5CJaJ hu h?4h{(h{(CJ_HhP#(akd7$$Ifl>++0+4 laytQ%$Ifgd ;zl akd6$$Ifl>++0+4 laytQ%(akd8$$Ifl>++0+4 laytQ%$Ifgd ;zl akd7$$Ifl>++0+4 laytQ%(akd9$$Ifl>++0+4 laytQ%$Ifgd ;zl akd8$$Ifl>++0+4 laytQ%(akd:$$Ifl>++0+4 laytQ%$Ifgd ;zl akd9$$Ifl>++0+4 laytQ%">Qz````$  $Ifa$gd}/l  $  a$gd?4  gd?4  gdYgdu akd:$$Ifl>++0+4 laytQ% Q|}+A*  $Ifgd{(l kd ;$$Ifl\ f*8FFFF t0644 layt}/$  $Ifa$gd'el (*+loG}noy56`ab/4<RZGHL˷˷߭߄zߙzzzzzzhECJ_HaJh^7<h?4CJaJh;CJ_HaJhFCJ_HaJhpuCJ_HaJh|CJ_HaJh^aCJ_HaJh'CJ_HaJh+CJ_HaJhPCJ_HaJh^7<h?4CJ_HaJh{(CJ_HaJhuCJ_HaJ.+oa  $IfgdFl   $Ifgd}/l   $Ifgdul abH7[D---  $Ifgd}/l   $IfgdEl kd;$$Ifl\ f*8FFFF t0644 layt}/Li678<=ABFGKLPQUVZ[_`deijnostxy}~6ǼǼǼǼǼǼǼǼzlzzhdh^7<5CJ_HaJhdh?45CJ_HaJhdh.w{5CJ_HaJhdh?45CJ_HaJhdh?4CJaJhdh?4CJ_HaJhZ\h?4CJaJhZ\h?4CJ_HaJh^7<h?4CJaJh^7<h?4CJ_HaJhFCJ_HaJhA%CJ_HaJ'789:;<[DDDD  $Ifgd}/l kd<$$Ifl\ f*8FFFF t0644 layt}/<=>?@A[DDDD  $Ifgd}/l kdz<$$Ifl\ f*8FFFF t0644 layt}/ABCDEF[DDDD  $Ifgd}/l kd<$$Ifl\ f*8FFFF t0644 layt}/FGHIJK[DDDD  $Ifgd}/l kdn=$$Ifl\ f*8FFFF t0644 layt}/KLMNOP[DDDD  $Ifgd}/l kd=$$Ifl\ f*8FFFF t0644 layt}/PQRSTU[DDDD  $Ifgd}/l kdb>$$Ifl\ f*8FFFF t0644 layt}/UVWXYZ[DDDD  $Ifgd}/l kd>$$Ifl\ f*8FFFF t0644 layt}/Z[\]^_[DDDD  $Ifgd}/l kdV?$$Ifl\ f*8FFFF t0644 layt}/_`abcd[DDDD  $Ifgd}/l kd?$$Ifl\ f*8FFFF t0644 layt}/defghi[DDDD  $Ifgd}/l kdJ@$$Ifl\ f*8FFFF t0644 layt}/ijklmn[DDDD  $Ifgd}/l kd@$$Ifl\ f*8FFFF t0644 layt}/nopqrs[DDDD  $Ifgd}/l kd>A$$Ifl\ f*8FFFF t0644 layt}/stuvwx[DDDD  $Ifgd}/l kdA$$Ifl\ f*8FFFF t0644 layt}/xyz{|}[DDDD  $Ifgd}/l kd2B$$Ifl\ f*8FFFF t0644 layt}/}~6V~[DD11$Ifgd}/l   $Ifgd}/l kdB$$Ifl\ f*8FFFF t0644 layt}/6>V\~ :w567hɾzodYhdh^m CJaJhdhdCJaJhdh^aCJaJhdhCJaJhdh;CJaJhdh;0J!OJQJhdh;OJQJhdhOJQJhdhs}CJaJhdh?4CJaJhdhA%CJ_HaJhdhSCJ_HaJhdh?4CJ_HaJhdhA%5>*CJ$_HaJ$~ P<>  $Ifgd}/l  & F$Ifgd}/l $Ifgd}/l  6llUUI  dgd; d-DM [$\$gd d-DM [$\$gd;$  da$gds}lkd&C$$Iflc89 t0644 layt}/67!"?Ah]h&`#$$  da$gds}dgdgddgd"  dgd;dgd; !"o~>?@Ajkl孢trtgPEgthdhOJQJ-hdhCJ6OJQJaJ6fHq hdh^m CJaJUhdhdCJaJhdh6CJaJhdhCJaJhdh"6CJaJhdh"CJaJhdh^aCJaJ4hdh^m >*CJOJQJ^JaJfHq #jChdh^m OJQJUhdh^m OJQJjhdh^m OJQJU------asdfghhttps://www.supertracker.usda.gov/foodtracker.aspx U.S National Library of Medicine. (2014). Mometasone(by breathing) Retrieved from http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0011261/?report=details     PAGE  PAGE 13 University of South Florida College of Nursing Revision August 2013 lE F G ƼhMI0JmHnHuh h0Jjh0JUh50jh50Uh^7<hs}CJaJhdh^m OJQJhdhdCJaJhdhd6CJaJD E F G $  da$gds}$h]ha$&`#$4&P1h/ =!"#$%` 4&P1h/ =!"#$%` :&P1h:p}// =!"#$%` =&P1h0:px)= /!"#$%` :&P1h:ps}/ =!"#$%` =&P1h0:px)= /!"#$%` n#Rark[ LPNG  IHDRUU+XhsRGBPLTEDdd:k:*`*R|Rvv!Y!JvJʸssZZ3f3(\(@n@NjjƴU``KxKCrCͽffƦ­RRRL{{ G ~{@ pHYsod IDATXGYkJm)yj0ds#6?tp*+'~%Zwem*.wU/8Vjxi&gWUhH-/oڹIE;hf jJa̧ow!dlP#tę*]~@ugxzZmtUt(jY QЯŋfvү#XSg;4Rc@jhx>N&3 ?v(I>w]OJzG\ I- 5ݔ9[E^$W 6J&)cl﫼zڈ%.(-eny9AR)=9 gK3\ "!ԣ._ U9*c\0}`#Ywbw$.Y' C[XnZV8ڊ pd[Ԏ&φ%t}^2%PR~ R+׷ýOĿ ½G28ۚEړ;w;1'5l>2x`+:|.^ka<8K}4q.Ew"*fFy,%PIΌ6b=kB zڪgo6]7 (3db6_*v:Э.y`b @)Ǜ+{g`BOy\cmr,޿b@˨1ऊ>㞐E\fTz/w{+QMiM:c$?tbqMfa+)v)v,,5558555h5 5 h5 5h5552 2 4aytNRkd$$IflAT N jV^Jf!(#$&(* 8hhh0>+TTTT2 2 4 laytNRxDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131A$$If!vh#v#v#v8#v#v#vh#v #v h#v #vh#v#v#v:V lh0>+,5558555h5 5 h5 5h5552 2 4aytNRkd%$$IflhT N jV^Jf!(#$&(*8hhh0>+TTTT2 2 4 laytNRxDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131A$$If!vh#v#v#v8#v#v#vh#v #v h#v #vh#v#v#v:V lh0>+,5558555h5 5 h5 5h5552 2 4aytNRkd 2$$IflhT N jV^Jf!(#$&(*8hhh0>+TTTT2 2 4 laytNRxDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131A$$If!vh#v#v#v8#v#v#vh#v #v h#v #vh#v#v#v:V lh0>+,5558555h5 5 h5 5h5552 2 4aytNRkd?$$IflhT N jV^Jf!(#$&(*8hhh0>+TTTT2 2 4 laytNRxDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131A$$If!vh#v#v#v8#v#v#vh#v #v h#v #vh#v#v#v:V lh0>+,5558555h5 5 h5 5h5552 2 4aytNRkdM$$IflhT N jV^Jf!(#$&(*8hhh0>+TTTT2 2 4 laytNRxDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131A$$If!vh#v#v#v8#v#v#vh#v #v h#v #vh#v#v#v:V lh0>+,5558555h5 5 h5 5h5552 2 4aytNRkdZ$$IflhT N jV^Jf!(#$&(*8hhh0>+TTTT2 2 4 laytNRA$$If!vh#v#v#v8#v#v#vh#v #v h#v #vh#v#v#v:V lh0>+,5558555h5 5 h5 5h5552 2 4aytNRkd_$$IflhT N jV^Jf!(#$&(*8hhh0>+TTTT2 2 4 laytNRA$$If!vh#v#v#v8#v#v#vh#v #v h#v #vh#v#v#v:V lh0>+,5558555h5 5 h5 5h5552 2 4aytNRkdd$$IflhT N jV^Jf!(#$&(*8hhh0>+TTTT2 2 4 laytNRxDeCheck131xDCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131A$$If!vh#v#v#v8#v#v#vh#v #v h#v #vh#v#v#v:V lh0>+,5558555h5 5 h5 5h5552 2 4aytNRkdOq$$IflhT N jV^Jf!(#$&(*8hhh0>+TTTT2 2 4 laytNRA$$If!vh#v#v#v8#v#v#vh#v #v h#v #vh#v#v#v:V lh0>+,5558555h5 5 h5 5h5552 2 4aytNRkdbv$$IflhT N jV^Jf!(#$&(*8hhh0>+TTTT2 2 4 laytNRxDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131xDeCheck131A$$If!vh#v#v#v8#v#v#vh#v #v h#v #vh#v#v#v:V lh0>+,5558555h5 5 h5 5h5552 2 4aytNRkd$$IflhT N jV^Jf!(#$&(*8hhh0>+TTTT2 2 4 laytNR$$If!vh#v#v0*:V l4h0>++550*2 4ayt>A$$If!vh#v#v0*:V l4h0>++550*2 4ayt>A$$If!vh#v#v0*:V l4h0>++550*2 4ayt>AD$$If!vh#v`':V l5`'4aj$$If!vh#vz#v#vF:V l,5z55F4atDeCheck8t$$If!vh#vz#v#vF:V l,5z55F/ 4atDeCheck2t$$If!vh#vz#v#vF:V l,5z55F/ 4avDeCheck10t$$If!vh#vz#v#vF:V l,5z55F/ 4avDeCheck11t$$If!vh#vz#v#vF:V l,5z55F/ 4avDeCheck12t$$If!vh#vz#v#vF:V l,5z55F/ 4at$$If!vh#vz#v#vF:V l,5z55F/ 4atDeCheck7z$$If!vh#vz#v#vF:V l,,5z55F/ 4a$$If!vh#v#v#v^:V l0*,555^4$$If!vh#v#v#v^:V l40*+,555^4$$If!vh#v#v#v^:V l40*+,555^4$$If!vh#v#v#v^:V l40*+,555^4$$If!vh#v#v#v^:V l40*+,555^4$$If!vh#v#v#v^:V l40*+,555^4$$If!vh#v#v#v^:V l40*+,555^4$$If!vh#v#v#v^:V l40*+,555^4$$If!vh#v#v#v^:V l40*+,555^4$$If!vh#v#v#v^:V l40*+,555^4$$If!vh#v#v#v^:V l40*+,555^4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4$$If!vh#v+:V l05+/ 4yt!$$If!vh#v+:V l05+/ 4yt!$$If!vh#v+:V l05+/ 4yt!$$If!vh#v+:V l05+/ 4yt!$$If!vh#v+:V l05+/ 4yt!$$If!vh#v+:V l05+/ 4yt!$$If!vh#v+:V l05+/ 4yt!$$IfO!vh#v0#v#v :V lL0*5055 2 4yt)$$IfO!vh#v{:V l"0*5{/ 2 4yt)$$IfO!vh#v#v:V l"0*,55/ 2 4yt)$$IfO!vh#v*:V l"0*5*/ 2 4yt)$$IfO!vh#v*:V l"0*5*/ 2 4yt)$$IfO!vh#v*:V lk0*5*/  / 2 4yt)$$IfO!vh#v0#v#v :V lL0*5055 2 4yt)$$IfO!vh#v{:V l"0*5{/ 2 4yt)$$IfO!vh#v#v:V l"0*,55/ 2 4yt)$$IfO!vh#v*:V l"0*5*/ 2 4yt)$$IfO!vh#v*:V l"0*5*/ 2 4yt)$$IfO!vh#v*:V lk0*5*/  / 2 4yt)$$IfO!vh#v0#v#v :V lL0*5055 2 4yt)$$IfO!vh#v{:V l"0*5{/ 2 4yt)$$IfO!vh#v#v:V l"0*,55/ 2 4yt)$$IfO!vh#v*:V l10*5*2 4ytzs$$IfO!vh#v*:V l"0*5*2 4yt)$$IfO!vh#v0#v#v :V lL0*5055 2 4yt)$$IfO!vh#v{:V l"0*5{/ 2 4yt)$$IfO!vh#v#v:V l"0*,55/ 2 4yt)$$IfO!vh#v*:V l"0*5*/ 2 4yt)$$IfO!vh#v*:V l"0*5*/ 2 4yt)$$IfO!vh#v*:V lk0*5*/  / 2 4yt)$$IfO!vh#v0#v#v :V lL0*5055 2 4yt)$$IfO!vh#v{:V l"0*5{/ 2 4yt)$$IfO!vh#v#v:V l"0*,55/ 2 4yt)$$IfO!vh#v*:V l"0*5*/ 2 4yt)$$IfO!vh#v*:V l"0*5*/ 2 4yt)$$IfO!vh#v*:V lk0*5*/  / 2 4yt)$$IfO!vh#v0#v#v :V lL0*5055 2 4yt)$$IfO!vh#v{:V l"0*5{/ 2 4yt)$$IfO!vh#v#v:V l"0*,55/ 2 4yt)$$IfO!vh#v*:V l"0*5*/ 2 4yt)$$IfO!vh#v*:V l"0*5*/ 2 4yt)$$IfO!vh#v*:V lk0*5*/  / 2 4yt)$$IfO!vh#v0#v#v :V lL0*5055 2 4yt)$$IfO!vh#v{:V l"0*5{/ 2 4yt)$$IfO!vh#v#v:V l"0*,55/ 2 4yt)$$IfO!vh#v*:V l"0*5*/ 2 4yt)$$IfO!vh#v*:V l"0*5*/ 2 4yt)$$IfO!vh#v*:V lk0*5*/  / 2 4yt)$$IfO!vh#v0#v#v :V lL0*5055 2 4yt)$$IfO!vh#v{:V l"0*5{/ 2 4yt)$$IfO!vh#v#v:V l"0*,55/ 2 4yt)$$IfO!vh#v*:V l"0*5*/ 2 4yt)$$IfO!vh#v*:V l"0*5*/ 2 4yt)$$IfO!vh#v*:V lk0*5*/  / 2 4yt)$$IfO!vh#v0#v#v :V lL0*5055 2 4yt)$$IfO!vh#v{:V l"0*5{/ 2 4yt)$$IfO!vh#v#v:V l"0*,55/ 2 4yt)$$IfO!vh#v*:V l"0*5*/ 2 4yt)$$IfO!vh#v*:V l"0*5*/ 2 4yt)$$IfO!vh#v*:V lk0*5*/  / 2 4yt)$$IfO!vh#v0#v#v :V lL0*5055 2 4yt)$$IfO!vh#v{:V l"0*5{/ 2 4yt)$$IfO!vh#v#v:V l"0*,55/ 2 4yt)$$IfO!vh#v*:V l"0*5*/ 2 4yt)$$IfO!vh#v*:V l"0*5*/ 2 4yt)$$IfO!vh#v*:V lk0*5*/  / 2 4yt)$$IfO!vh#v0#v#v :V lL0*5055 2 4yt(&$$IfO!vh#v{:V l"0*5{/ 2 4yt(&$$IfO!vh#v#v:V l"0*,55/ 2 4yt(&$$IfO!vh#v*:V l"0*5*/ 2 4yt(&$$IfO!vh#v*:V l"0*5*/ 2 4yt(&$$IfO!vh#v0#v#v :V lL0*5055 2 4yt(&$$IfO!vh#v{:V l"0*5{/ 2 4yt(&$$IfO!vh#v#v:V l"0*,55/ 2 4yt(&$$IfO!vh#v*:V l"0*5*/ 2 4yt(&$$IfO!vh#v*:V l"0*5*/ 2 4yt(&$$IfO!vh#v0#v#v :V lL0*5055 2 4yt(&$$IfO!vh#v{:V l"0*5{/ 2 4yt(&$$IfO!vh#v#v:V l"0*,55/ 2 4yt(&$$IfO!vh#v*:V l"0*5*/ 2 4yt(&$$IfO!vh#v*:V l0*5*/ 2 4yt]@$$IfO!vh#v0#v#v :V lL0*5055 2 4yt(&$$IfO!vh#v{:V l"0*5{/ 2 4yt(&$$IfO!vh#v#v:V l"0*,55/ 2 4yt(&$$IfO!vh#v*:V l"0*5*/ 2 4yt(&$$IfO!vh#v*:V l"0*5*/ 2 4yt(&$$IfO!vh#v0#v#v :V lL0*5055 2 4ytG$$IfO!vh#v{:V l"0*5{/ 2 4ytG$$IfO!vh#v#v:V l"0*,55/ 2 4ytG$$IfO!vh#v*:V l"0*5*/ 2 4ytG$$IfO!vh#v*:V l"0*5*/ 2 4ytGr$$If!vh#v+:V l05+4r$$If!vh#v:V l054r$$If!vh#v:V l054r$$If!vh#v:V l054r$$If!vh#v:V l054r$$If!vh#v:V l054|$$If!vh#v:V lL054ytl\ r$$If!vh#v:V l054r$$If!vh#v:V l054v$$If!vh#v:V l054$$If!vh#v:V l05/ 4$$If!vh#v:V l05/ 4$$If!vh#v:V l05/ 4$$If!vh#v:V l05/ 4-PDd    A?> ChooseMyPlatePicture 1Description: ChooseMyPlate.gov"bOcz,t}N"nNcz,t}PNG  IHDRPtEXtSoftwareAdobe ImageReadyqe<NhIDATx\U;umlͦ5Ā+ Š _|U^ E^PШ$$@zn6{<ϽΙ;Sssg9󽿧+7IK da/'?buanKwh4aQUJ6S>SV4̶"4p͢`j'QȐ!ڴ|hTʶ n馪zYEEũu6x7;y:k׮=><RriS7ڵk8>Yu}x;ԯv5gF= .ڻؖ<LFtvv饗җ=͋,r`#*)7}s?}kyhxr ʩ]CI m~wmݶ=Q &u4 E#\pAoVVV^7:Tjm]ѭm_ ۷otd*>U]* sժU3_R;AjSm[n?r#S=>ՎH]U<^O^{UV9cZlٴ^x/x ҩ6Y-\ U&X/k֬Y AV Q\l~`=Y!uYQ$k}'kn= SdPֶ >+zJmY۶mu/!'CTPffB0u`5L{#h` UW?<]v3а @,m*WSK3o馹< ٷ Cz2N_ƀȰ pf3Ga=Z?:gvj´ݪ *(@e15j+Qa‰  ,t4hQi>? u>?5G}+*ʳs~8W+$}TSyٷo+Wjf=7T@"}ge `z b29kS4>tzx~t^U=<A5trهY{P޾~`0~'LgF0!:##I}sddCNvv|4?6J׫柧"2J VZ5{qSӕeo`.웡yhsgeA~~lc줫9S٥2sI{=a=A=f%`Qq?Gq ^w_hMJURlwOM W@Yֵbp@)Ѣt䥱;F+0e)Ս"rRAy*ȵ/LZz+Q}R@ --CAxlo0@C㨱άʄ3!\+tJKJ?YS@AXk2w}nm M_o9☈D  ʢn2U hAxP2(\}8kbQ,l  a>Y ߑI+ʼ){C^`e%mˡ>3=쳹0 Kz";m*=c,x vwx@-p-iN`StP*3H9ˡ2fr &4z%ovڇ{`-0:n+Ǫh@,K<= ٞ)Px<Ca%ZT s>c w'B닐e= Hׄoa'ٿvE(N:J@.\8 ^DS5ieg6}za[AB8F0axЊʊ"YSSS"Ryy!ߎyH!](t]L?bGgx< (3ςu!AYY5r\9^K[F%-i#@[ly=mi3hIU1 r¬Ǡy'0_v9/Z[ eRSѡhef:s$ ˂Fv|n `P`UזΝ zT/SMP]]`u`WWªeܬfӘX8Eaec^G~UWW隂W׀m6W/8 f1JS(d1UsbDqљFW+rxQi{vBsrp_6OVu+۸nE&HIp+`fi&5 "3 >*dh@_+*l?PQqGG7̀œڥeߊi`g[yup)5 ޽J۵2g>(`kI]S=ׁ=2P,^>B:RwA loiĪ<-@X<0*EEt| _ZZDAI0$Q8XMpғA\#Lr .u p\2AEh텟SSMϞl"b梅l/)2;7ofD }J&sI=X؆j[ F؉Ѷst< p0w U`ܞbXLppusKa@u3EkJp )&~(vUKc0Td#_yqVcs)#Ke7`{'Ǽ?jbJ:~|;{<ަ`̫nL=HÙ@CJ5n6 d&)-?Y񽗠/1 =C, jdʚNBX˲D~~є}P4@@+ )$ 꺣ݰ2udeeR${L#?~Ȕtn}`484HkgCt8eUp' E@;~7AIc e{,Ѥ*Ld6TZӆ-,z(]=m\ q߫rVӀ kaA]F`Ɋ}aP?DԨ|3e ' >XY+k?~pPiYYߦͷ_B~zIM1? PmVuB`bg~쌥GTԇ Xa y'#MT44BoTt SծL)=̽b*)SitT[+\]~ {Aoe@XTc2F  A- \m8ՔbA MCdӺ聪DőÍ}>vbWG&T[ł 8}ŗ 6 )$i4HQ}T]O #]ƿBu6{7$w#>5Gݡ@`)h~iQN:8ˢ*"&P8uVrsKn4(0d(r^:i9MJHo/ /()禾y7SS0RLI{L`̼1#FUQǘt3WS)ǑJv#W350 ] I!<3ma1P8~T.VTCW͂UAM]GyA8a@uحLquG2J?Vz "? fUԹOomMy\q R\9B*F B*ܛMKjnGbѮL9r6fv )+h u?C_ꛟNZ*hfKlf`6!RaCpye@En}yl<4b>G] ;僴"O{ r,sʳoςnSɦ-$ 2S(ԗ~GlKfڰnX?)(ҏfqnXybF6*?_%+OKNl9].U1 P]|M P'}X!$U"AJ9 0B_us'EVmͪ/ʲg9psQ~0@ DaFJHꇺr4󤨨@l }l3 =79T}U a yV,`U۟npX9j:L@Y؉^2O< RXܗR&] Bpd*nCOO?4sՑSFJQJaTBH \˙*KD`Px۽<8$@zN)NcRQD KHPU0jE̽RG-c> ە)7Xb?n,_+1gAyBێnudèhCETJذX"ys=xl%[Af]!5A Ysz{608HE#ROYMs.jb`cUT+`J!~7Ey`Dcc S\+R1"]4EM'e ^RSf1_\>KjVa]Pj!󞒪ڽ{r313S♵/C)Ă ˟SM5 N0tQ KrDGScWYQuZZcX{}%$CCC`Bi>:x4#F0:AQ1jW7te٤)R_]`$#w3#6S Rl g<;=mV<͘0-Oÿk k~mc LdB;vݛ +L9UedˤOZalp`~+U\-ڂ%=~Kp@k[;`(HϹ*(ζΝH]3&T,JS p)f,ʕvppULMUH~66\*ei+YD`珼%+)_:N~c*- n@5˙TQXsM _ |l^Lʪ}` A* ncj/Bpv SAȴ[Ε$.@ěq$K cָ[yqd:Mۡ$V]21kOu* BQK9iIo"TN\ЁttB#C W^̻L!+uu`eBF5DL*XKoz2fF "ʖ}RYA5]%*_  ٌle(횲:/E kP}X~`i4H+ puKy n4tR}Դjmy%,sR%&SN*K`uFZQMCG| dz.2k } }`zLbe4~<'shm6<78φH-]D{[)@Q{X˿Vb2$|QwvWtUZ}o@_NAݷΙ nysK/{;[`4 a < > <@徫( ;T57þ}e3Ӱ- ?sBCgo64s7=:NUKUͫ]^gsJ {#L{թu%tQF^}*DvלζUmx Png|KHUm^ S/5CPU9VI7,8MSTɢZĨ: jՓbBnm$59K+;+3H8aӏk" j 0J/9BSNHs ⨓)Q'\APRn%cPu T)5F[&p{"> @)}Ufe݀ è󩇘{JA .y\x7V,X~lݺ#fߌ`aBpzB;ZӰ^R5}SYǾR޳1Q'0T)iQ'qJʃ*CyTRT`_ i>#;ւm u~0Lee.oLAO'PQzNMɜ1EJj sq -ϱpU@toQΚYOs,΂.O,h6LcfѴtN||t8Fip;Zo{vZ!+Q+'kMg1-a[k,EU r Qujsb4{XuKOAyT|}T]ȁ 2OD_hh:W?0| Vw6mf.@ CN VTX3nhӪW`{Tޕ/Jɢ"iLN9eX~Nq:pUBpc>h7\6 dN'#`o (*~Nt,e[V=MH7o)geW29@(,u2d$NbZTL!t+gwCq!d&08hS2@{+A :S+t@yy).n0sV=LFh X\WD[RW)44k #kPXl ';BsǸR[RF\HId],`!_4ݬ3&VcFAR)h\/ԺgS|Nii ~hl<v? u0bk3섰Kc F@uWYpe ֌#˄Qԏ8!-3FnQP٬E03W)LQ&8):iƫkB >BVQ@I]Q]6d*)ClIeXI!V%WFXehu=wwûi@e9PV21@Bvy&((1Avuᑯ$s) 8|y8PQMX]dzW^lյ`)˜u9$c @gᘔp? stg*SQ S1=V$ɱIO*ofP!6x j1UU^63`Xy̌@jhzFBWi(9 /VR(3 p|j$&iIͣ LjQQɋ,|@iYlRKqw:()%qdIQ`ͽ36s@ҙ9U8)ּz;C^ܯkE\6[㎂W) ,إ% RY {-Bj$P-CK"*?+jmk cBr ^֠Uz4?jVUTVKfp S}=r2Q999Fe 20O.hEEaPIMIQ;£Z|q'S  2:. 7ݱےXł,oTTy_u],5P=}IՎ:r)?uPy fXToM.Cp7(#>WW41e䃿m*0s@ 2$-ȊKv5,ɧ>Q2 )/ l.!EߤSLjĔRt&>8緎HTʲ|L:f8&8G9>zM yT(1?[qS[ *vJ/v,>qϡTcl1,I>2=Ӊyy H(&Adm3 E2]nMRrUi&>|Nzj*O`2qkL<}`8hbQ?6AƄ&Gٗd lx5>\XmxT_TԔR}V(^6DB(.l(:b:WR@&pFԱ2ʒ*IaǏ J}ğ ma*| ShV* "iF߷N'9_NcP,Tr!AY!R`ݦAUfe TKҐ@DO|Pq?NQcՔUdY ? Yx6x7J 1u59ow%?9.`/ʂ{~$*&$>jIjj $oIhyn^}):[+'2$(dX5UnWӡ5YB8rE?me =q1^,6XR'5@f^̱`Esn+wD0%Md2[^&H9v3{1 jOOTTO#;N.UMRZU$g Ct4#3rκ ~ޭp`p;|fPY -xU}P^2}80?uG(N%$&qEfwPsSoI%ޗy݄,cs}=+vOo/Je:. {թ)Q_ks*ችjG?첏.?BxᏰ0;k o}L#n W-= ZpZao_2g)<2gOϿ:$+m+.9y \q|O)y載2(6ݗ}Yx:OX|-'scϋƁkW$ǹfίLQ]Ld".pؒ_M쒹pfۣPTֵpÜ`cBemmW޷U{7y_}}> xQ {z^R 23f0,EjܜS$@wߣAZũ59+GJm&4 $@*䊜 [N)Jm;IP'}4sv-vYQⶤt.=Ozf wz: oM P3vl^ө~:,%ȱAEιJ O_ X z"xax"!a=ԃTE!rWAC ]tA:eF)Hу'\_*Dr!e N xLϫw+-kVk[@ҙ-#`c+c>%8P.0W|Α-`1,\.&-%vk<(((_@IA ⱔFejx:  1?ՍA7p};`tϡ&^izX ȥhe.oKFxv`zxP{4 gn@1n!6 _%0BcfE${4K\\#Y ʢOTx/-S ;iKg$uk='i0VH(e3aG^i1E!M0r,ܗaC; x,nuf \^# o4? Lqq ]*`a}C[ TTA+pʪnXвv< j62Eȱ*ʪ"7;^O$$T xfV g#pMekfzM1B;Fӣ&)++oC z"2f=np` B%U_{vu/_[ VcDcQ6ɋ) _;z̶skOW%Ƭ\;d:vU}\Ef;!'I!-pBͬԟ&@Z\6^@)RFXǨ?*:xZU{\D5/:{ZJ Rɪ* }mM^ryV!W9a [sCpұ3*an!PYWwCIE.,|bhoϝ6~[Ë7-?SJƞXޕjQy-Lyq4{'S4d$@_NRoeeu7U>YPVG}@UZRF%*l )zkDPYMqUe%uՔuK+gNڹ߂C{uֽ g^s>6^}f 4|[>| ȁQ%ſl?o$PW}!!h?+ Nr R˦{#±>2?TUTR^TՏɂ節>i"ռXE,Pє C:*bUZIP5Y2ˣj4ހtg0P6"9H{m<(ePI;C^ ]=lstRՕeH&[0i,WVhL-zx;)WQYJo>~@s:}n`WOj߄Vf~ςa.K>r]}|N"4 'Gڵf/d[Uω{ٴԇ?2X*`PCUGzUNʂO[TuE+kJtV" ϓ+⊮mmր YI9Mǥ^& ?{=MPWolxmwܐ5N'ZUhjW{ER5wXo T4fgأ繡"TTV?WBv Z)z;7%4*dUV;>SR X  Z2AZ1\.7ݲu)%[ u]V~<ݓI?~Z6k|1^_ԱiB9n4vj5ÜYZM)XЄ3IW|v)\wˊq' :w.t9) 0ц);xZ4@^X<뿠`Z.XٟÏ6|q(W6+=R^e[@˜H'q4%QԤ,bR()DH-&C_y֌ۏ==m;1Vc. V`-..-u ֺI]1# ח3<7-?*;&遑Qe:{;&nv)Wd: .p( yy9][}4t,TE.mA^AtE":@I!Ea`'rs []7 -*Ʌ[Y)i: ; \?eOhwӱЧ뿏YuBA;;p?0Þ.Z0x m(siT[31h ZocdoafQa. Lǘ` Cj|R JߝA'€wtzHt *}0 kBR[۾MYh%nߏa\C;^{-EXaA~6m}뱲K !wb{;\(@qjz B 5`Ӡ҇33XUisٸo wŒU+99ٔ(O}aŴ պ-z A%`QX2fb(aZWCE8< yTH2Eh cTvf=kdu%(4=}srL`Ξߨ*v9mղ7pE.X "\ܱePQ0q-?4`_?64!Fh~V$ʈމ qڍT0U[5*}CUP]f1umni|¤j \l[`(WݰEa4_]_6)SN]ݤm'2$xbZO:/e:^>(fliSZMA/4 :߅y5׳ẈAXRPXqAzi~GWTԡz ^ $xhe,QZx@Uֵ?t(>~C#dgAaaa4,` zGXD?dc} E&'4<9WFA6If@0AF߃ޅe0?YȭdgCvv1Ьc ~ =AJe'?zBp(x; !dv נ(L.$T]-;E('x` K%vT\dx|dY~jo[؞].XM Pw288D,TZN8jO N\7 :_h^2jdX]uɦ' f+2Q VIƩ.,{a룰#Ue*l V[3H`<pL9.Y$mȽ2a-6u:KNDuM'UXUQ4 J1H5X-9͏@r3A^\rTCf'kXk3LN6f'pF|;ir[u W U#'qZuE5?ІԹY+c*‚HujLvdr@&3ݏ-;0[Q_}TM}iƸu,$UOa PX0B) pzY-l^e]ud_U}:)hV6LTXbEW&ގ@Uc 7N.RhF"p<t5뀷ſ'.UuExaߠǶ4_G#ܟV{7;di4,yURP#PC# ] G9Up1@S98<G:-0~*B%/z)BS[IN}72sx?⥚6)owlrLWN*FR>qg)v 2ް3QQeq| WI睽:۞;LW: ³̚U4A m3XLn*t=Oc2g;!F0Tբ2 j"M |x,SփcD>Ha/5q~x/=U=Cc7RZfPڡ{U7Һd}}}ƻ~A;Z+` >v?ӹ-+j*D/6zf_;Ppm|=nvb@}wt!F=r{檠FE+oJ0@ 0:އa-YINw⏎;2r^4+<Ǹc?#h,xfN5F=pmbhj}Y<` en|xS/̆* LTW~Ć}T?ob;>*C%> !JBj "LQ9Z` o>%%o`(R+|>wΪ5EꉂE8I AC9US%ZRH1eK11Va5ok'ﱏT1@ 7[5<~ }R=T#=_?QP[ZZU͛7Ylٸ'W .W}Iv $h9)|?,?{`,Hy;9zJ{$+Y&I\)ᯩ6kTeדRUU7V j#<H1z_~h9զj{*AkQh fD89զd6^rsu}}jPa%PBAIV;?~V,ɸ:Tj?Blk{>LVSƍ݋->m.43T;)(6Qd : K|_EEŮ3HI%̵MXD{}R4"U|(d0`Z#|b>NOP^4__fMrHC DX-{K/Wj'oÔEsС0O6StA}VSM7Tr ̙Z|dOa/vƓO>oT%q@#A.y\]jeV{ϔ ˖ʲ,6؍O}CCѡk=t&npBIUWTHm ډdaXg*O:Ep 5EDI^0фGڤ,SNz$P/.i IENDB`zDd|6t  C PA8Screen Shot 2014-07-13 at 6b)2;-O,n)2;-PNG  IHDR|KiCCPICC ProfileX YgT,˒sIr9sX2D"(* `"DTH0TPA{93LuuSU=ӵpH11("nT0?.F @(Od(o` ~q_C!r BN[_XdK: blc ݒ!!AW;Mo aM)/ lAJٺ 47v!G; h3$. 3vrjb1Lj+Đ'=1b"q;SC )-rM(>B4!2-h!ֳ8\9> a_U@1h(|!1;Ԙ yK#L)r!O%:{7DøGH 9b(1!0 ~ Ёx@ [VK<;TDA ZA"o+Zzw .F czPĨc4g3™Lp$%l ޑ9þa slYOh+*0bQ`F V`!Æ2e>FGa??z(ETW0"Vi P?5y^mt7~u d+:pCJ JLFǤCC*(`/M@Q^AʚNZ=Gp~ # ;@c< _0 = "|sh=` ,-pF=DBI`'e(8N3<@' ` pl`5A:DQDQDBw Fd'"%Qi@."WH2\5w 7-SQQqRISiSRr*QݤzL;5-5?" uuu9u# hhDi4ilihRhhNto.>>$˾X_WFu-gWo>@/4`6P;$}vPILvݐPУKafaþۆׇoFF4GRGF^b NɍՌ-]$[␸q,?A"aOdNbe$ɌQ)R))SMROaӺv 9KWndtg2JffwdL1s6Kݫx&/4o _)"gA@B}Wd恠EEF)->SXZ2}Pk@iA2rO:^!RqbhJ*oՏk:{'՘ִ֊ՖĝL<˩ 6'8nPkhhi,::pv׹Fۛdjٚ / .^dy+WZ[ Z֔ŶvW::Z^쬼zF΍͛7oZ|{˧;Oz,{5{W={}}Wo{_ÖՁGj5;x'w?}0l3<4@ x=זDF.1JqT4ƀg`ϢZ89Uy   E4D#%$ xn Ֆ{-߬h$AU{5MɚZx'۫t|m۩o`@0xmxèѸڤt\ׂbɲߪɺڦƶnvYw]s4D/S>H+ SB Bä#8#Q_bcOOOMlIƤ vL7L:]Gytn^<|PǸ_NAbCn.eNmXV5ԩҨV:&s\|emɉuE*:odzbȥIWvdik/ZQv=7GoMj}nRoн}X>4pz;xbڧrÆ#ԟ X}93񓯳''lؾ}g^c}fb`NynbB>~^.~7bN1e9'%Ȓ:RROo Q){W{&DemDG@VY}DBSWk /NQzbkÆl7e4}gi^fhhgbmigo(LtAwqYU#;׈$ vׅEGEG035N0'"vҳ锅՝vK d2^gdes8 ί.8_زul(>]rPeiYYQy#)G+C2ol;-ojwpHRC!P8 MKD_EĘbaJ6EIr{LZ.ݕl={ Eh)f7~ՂB@Y1/qe엺 bE2ٲ; Jʖ**Kz[5j5inOid`XhTgjru>I+6G'jq7!0V/G}z|H]~ yAf!Y"";bRc_7$'$?HLK9[%T&wVi~OZB)0u|૒ʇ?W\Lzmj+W4qxzZFKT ~a`L`rg6g`g`WTNsq/(yOjvlQE.f55;u , aL:Mo YZZڞuhu2tqt{rf |R.!?:q'y&>-/i}WZAⓙ/_|e<^$7އϜ77QѢsB_4~vwﭫlյz?r~ S'_\p(ٸSg?yd %E X~"U śk'fc [ϡ(S'Z?2(w[P ZJiTXtXML:com.adobe.xmp 380 692 v@IDATx] `T~d aH 7 "lc[lZjVAmqbX4A  =Lf;y[f&j]=}w =(VGE""D0NP(^@N:SkG]P(9:?o#@Iۈ(9tO6}k:-Q)1XQ 16W^s'JկT,cUM4MrZ_U~?&'\%&/ rX_#/o^n kr"\sa#2BYO.鴊k 2nyTe M9=ĭṔ\*W73Z ?>Қ/zҘgET]yӃS4 ̗'+w7B!q\a >nOT_{Y3ˎ'/N]ǿ?,.8ę<.eMͺ1^7/֝rIi[_`{*FE`LՆ=je 9?#&Q e#U) C|m߾9X:c"bV3wv 't[?;[tOވ[CəvoPl묯׶mobXTLFf*\_]jO;wu-ióz'\Iψ> 0Y<^~UW;M0(#.!5-^ojkn5(T) qRUsM 4Ad|l#Gݑ/6;*S×ݔrBchlxW[WK3,.53-T[g텪̬(}k{s̴̰8c}-h4*CFeD#^{8y {Z4J㕻z-bkՍz+9B [xfjj;aQ#X-WvRb"yOjY|]U商ѩkm  KKZzP\F`@ab o^ 1r^2w0 }}ȱܖj46nyjCZ섉~8&?Vݾ`A76~XxKN/\'sZw㔩? :r fn;oqA_/l 3S6fnPoGWwIc<l47م䍷d@Bf#CbF$=&6mTA*p8 fןh[ZO(c[bfR_yplҥxq8V kRuC΄=Í6c~ތtJ@yX-,YY^imzm3yß\eLJ-e}<} V+5Ka*FcԳvΞ+?D b3/ۙ [:S#ĉ;HX&)We=y]5<9kijV~K_98ge:W}plvTs~?6&5at?=+ FΎf;3g|tđ9iΒ$,_֨LQ3;OF߲ԐtURf>8EGνW=;rCc{󏏷t,8MUտ9;VQ){:9 907_hKHNOe*gp<':l.N8qݧʋ F]O~FrN\xJ>ZvΎRV1 GdeejUcbSbR{re8Zk["(g5'FO KMdD8p p8*%@c()I3tiOpӾ-W`jf N*1coSYƁワޔ6i+=[vޒVYv C"aq@y3*WD` zh(p\0p!z0-jjqMړ0n&Ds0xtv*b8L|amovĒ谸̴D}3fv$:JhHL8=̦:URmʠFulƋ40mnOiYT̰u9LB``H V}S޳dLN#6ώ9=;r=RcF gqgS7y$wjSpw,V7vd~C?FumQb{ LbjSÜҧT |a}fsc%0I_k^ҭ)㸻1lu48VKycM,g9*Rx Ggk>*!"ʭFF]A\zlQBNaaٽ)1ot數zB:G me\3$WZ8RXB+=aFvyl%~tN2BfglUKJ.]WXm3 c/&-Vk{Fj iٶjnzX>fMa>RC|q:Zѭ]>C?h2(]8||XJe5b~1^6&Hmc` 20:X1c欑Phb{x _.+~ jVYzTow.XȂezmiQAIaW>O W7߳nt"c⫊K~O06V؈`bԾ00gW a01inQ]\NóR,p^9^2.u2t DLdFW*fWeobnLP3ַju7Eب}w~ԘHC[}Qj ze "-{D~-H@;ֶ?_S!%=4[M JKJma4 WKB ~U(cH,Ҕd›awg7JLvTĬ=$TSun^j鼹5qir[[脜7Pwo٪Qy99Ks4FRƾ fw:JkbRעl/jrkTvSymO9%w¿5fyG1=;e kK?ۄ?VjF$ݿ45'#>[XJҖ_s u-]bW+2gf1>q68ݺ~-|pq-\>9ÓqЄƪ$W+ww61q3M?4_jJq N j6r/CY} CQw԰b\ob:Uf8'1<[{=X>gpլO0?sd({, R`SkcO d^ek>~_^\w2NNɼ{hyi JkC[Yb%M}ԟ?mrˢ%+ nupR_eȬ0Q{"fũOZ18kC~Iz>Xx!UԘ0BU`TOJ ESG[_}⫴ K絘qޔtX[p1B$'E0NiTxO1Љwʔ:0im@ ݇H cAߙ[' QD:GOV=Yٳ#Cۧ;O{ֶu'ݶSSCtzrҼ{XwC[;eXg }]3=>54if]q<:>%k.Ƈ2g4^lJ5sAluYLJuku[uQI5R핼-"@yzuxO]PՅ&gA;\HΘ$v{=({WœjP@jEPq/TE"0k:sw/GWܭP !DqӶL>_'rڢ7\ntc?kg_3\4ǏH'EAXL.֤d~FKx?7KtK'jVY5eemf alU0=&kU=#æh&Jp_BA=آ=֡墀t=T -~X>2 Ψ!TϏE++ etfDr"ePZĎl@狥 +`230(˵LF0ɶ}X6uJrXL~*ٌjkGjr6~D:f~|>?:/:ѷןIS9i?Z+wZ_vmk'1^cNO:vlz҃ؿo)39%oe/W =aϭwϚdk$ex۾01mY9g$${ =ztnsmƚ7kf#9?!پ2J lųX==lw4ܓr̥~d.J.+ˤ4)l/R_Gk%Rg/R*RAҏHsGwUf̦Ԍ >7rw+dG 7!D`pkqAˆaQd%HW &1cW\Pޚ5iD̥ům]LPuDYeՑ=fCO,[QoOWB+F 2#¢~c`bYRR|3k{!AAU_U-sձO52"<"ڦb#YztWߨ֩[DXP㻝mq!t2w[lv窼);Ku&Qc}10rY߂C 8`G޻}(?!flgln*iܠ`æ:OXŦX5OABã,Z1$tX\v1VUxpmGy~F߽xь֥kk=n O70]|Jk*e5~XR%" cMQ!D/bkg!p_yZxxb•FvF p!&p[}멖<6\Mw4ۚ\,U=nuPפkf!JWIMMw~a[{gjFvxG?/JamO쑛!VcGO¨]'N>vۤ#)vNғ?5GaXľ Tޕ?1[h9uK8ޣa~)SD^ǾnF{>~lG/?Uә/ `1r.x̌Z󶢖{5_g{}p,l@68,CW^b(kZ\ڏjVL& EG8E]/^ąs4w#fF7V?;V&'B~> `>zFzCa~,#K+չEv,Ydh2{N"\39 Q`1K7klWhs_I&S{/[&'6=&@o樂?N?ݩo}O2OD':a$?n̟kPin(_(>!ْsҧ/TWyb!"KVWWE礨R zJ??-;}z;37L3]qJT;~ÌoXPUoǧbB4Y7'joIMHiy-FwpysrG}E#ָ174]W]A[BqZOJ}KKzܣ%*+`4vbU\ײ֫,ߜIB;`6(|3"џ]ɍ1<zJH]$qN:{؀}W Zõbbc#Ov(Ȟ4>h{| lY{[wy]9=}NZL~M4X6N ܇X7T3wmʒ|s*:Lj|]̢3f.&3¸[%t~ r󚙯"`Zj|ܬ3nL /IGg^nk alt*86a9&KG忚F6,41{Ԥษ6*acdeg>iS1Ֆ+Ø=@guwYaLwӭkЅuk!1|.Oc0du-}Ѫo 1sΦ1n,`WvLͅ˂U_A1f%eTE-{Cͭ1wy}]_rg'Bt7~VFi|/juFq4Wk 5)9"M`U+rS_6墒`%rR-^CAkWt Ղ䶫S'΁YL72͏Hm'kʢo+g:mBB2ؙnf GTSg?vfꠊ#]w{- K7Ԟ<s ROmOs:}w.M> +[?~Ye`BϦ,\6T'$~^φd9m 髵(\{wK;^?%= syw}}ܔ|R‚9#ftT}쬳VtۊOKXV،p!K2.OU`8C c̓g {xafj'J{(#0M9z_ٰ| =V$`8? P-wƝj|Cx8>Õx~7#AT%ONs}> O9oqSȞ!m4U<}C[9W]fЄ#}}S.0ͪ@4-~AtRD/1~ZTR^2 xywN7hj$?"++pZҘ|(9/'oy`99&Ǹڈ`b ␰ COG{D)PfНjodH]t/i,X}m:q S 2 <Y HtBd0~Y~b7o]&KFL ?{0i~tokѤf:  w_06tY[u~ ]s&0M#Nmp- F,G.ܕjN`5 L +K!9uq?Ze*V~ ~,8݈/UWgB]S~~ݗWkM|Q5" \R(a2ݨ(YߴgWU? v$)$ dnLˇ]5\C^Qnd)G$y F<^t鵲4 RN39}'!7LiONlشZVILʜL#ۄ"+׸9j{}ha% HgjXgƦUxs6llOk_s`ŏVV~s6 vAwjKsyoŒÛYw]R {77{ Б]9R#Y#R=i=o_9:hNޢcNJ[.)0S.G:D}aS é>E<*>u'5eeƂc;`?q4a!78aV.y=e/ѹz^ )웞xӌfH1Lɶ{z| ohyɹc,{t%{+ tP{x;*6o`kknR%OzbG@ &L*x,h<HƚJF)+Fg8|v GtS1)2ʸ)s ,H j\mxgݢ-yQzoHX62OZ屭[/+ysǏHa3y%TylhyU[&)7/)XsUWgTUYѸ\s۷Ѩ-EƦ&6eljn㕥[wZ ɗt9joQο]ST4[SqG8`V'egg0^jf}@p`967Uc&mžyQ?‘{zx-S朥w.echl?*WkNW-JbI{VuTZLzh+aB Vdi^ԁﮞy1 Y﹵%Z 0ˊt2ƒv@s&)cb2mn~lόv;^`|vcMrㆽrђ'٥9 3m_%@@)ڤU9G1mcؗ6;"UKY7j*kǢ5 Ǜ6yjsKFl+v"J]#t)[}T/z|S% V{_ɸ ~w`k̫ݗW\ GLBoVZ\QSe"yꊵkf2o6GKSv`ߚViV?x԰=-󑴂;Ɔ;˔q ڊÌjԹKYЖmoN\-ٓwEGǨՒs#n/e5.^:fr#WsME٫1Ԫvj>?_F;V0w-yRS?3*ϱso~-[tx.6,Z9I 58: :#|n0i ug-)ϫ"doulvtgDMꊑU'IY#ϵ,Td:t ksƖ3 @ƂbACo ]&BJKsS}5[ rh8z)]._$: aO#'Kw;Qc{8vٰ.i!4xY$ g8"HuPYf3,'sj\6P9*hm)!^ [H5GE`# 7ӡA!|:Ը{Gx %O;h:Km7Erʀ w="ZDo4X'Rd|i*W%EHN#;xN"cś;o\`j68CIo^YQǾ }# ;W3-m_ N7>k G:>3 v xP"[Mq6«hL-lRdodz:d]E*v>rϞJi1oD׽UL=6F^ BgDtp_x奄[40H+b}1=ܳ +($]9#(EJxW↥jFK FDԤȟSe> +"Lꗔ#R0R3iΜ9kJdrL EvԹ[>wBp7)w\R4tph+|^[VV5T|}#cib6cD'#RS}U[2x$F^(wb;R0=0#fzg^|o0W6/!!oLNSu*rV"h@QD:C^Pκ u[Uf0ڝ tr5ϘXF~7މ؇_CK#⹃+ifFX,zpQ.8+7'bS/dɷ_9,^}bPB"W`( ysV2ۏ-I=Tx/gL]>?5w1pQ/ip?a $.`]BQLl3řou/ xre5UzUØ#|[4W("qcn%o.[&o_dgT?CI%{}j)%cPfD' ?أ(<:9s Q@:,0yĊ x+]8ėm[' r$(rdB@Ar,y'#s7+ԝ_΅ w5,[KNֹ@HؚzG^匱bMM{ܱ-I-˅n >i oH1jfwvK6 0dF$/9ܴرMO>ԓ}Uϕ˄쒩U)w|hƳWjIK-m~vԨkJ[Գ.7'Xӧ/\8 wcΕpc "P6<(.| +&gh4 $o@H3>ʜdD2V#QmO!S%,֔%a T>hF=?ۏ88_4^;^yhˮuaś+ZYyuK\5*<~hƥr@=K?.-}&LK8@@H@_ rO`:Ci!E*=gJ S) }!6sd?*;AD)Xvi_4U^U߯T߯3<߮:2gC߿uԩn.%kbn>0)|tqE\S~ YfI3ab,UiG>[PtsM皘+)^aaRE1hԬZ6aQνłlw>e/Yobt7a,y瘥K.qQv:Mf<&6o9"ti+Zu[fW"3PFZVѰ%U^Cá4"|HFA./;>p>-s5iwi+ǝN]ڧSW|QѼYݥ3WlZ[F=xhQcmΪzfZ u&Z" s$R])GnDg9_Șo~>$yr3oEG^EKQ0qLiŧUs&2umMhT(ۚ,\4/j򇲕_ӗQiqJƢ ??}O'AO܄{ùXR G\K3l2p?GFn/Drr̄j%K7"4iKFZ&ċIU|Cp}(2L>+?]Ѽh|/>4O#nYzJxG@\wtBu u"@$r ɞPS$g:dN!nS(Dx]"@ @IG -P<%OKuS(tc"@;_vb"@!@oPe1hbE@ EE\Q( /ڔ.+ )CxgziJ%j`񄺻y8Kk1h m4Hp;OtMG -P<%KUS(B(1%ApjE@%!&"@ t<.UM#ĄP(D)! N',P)R#;껬&]  IsZk4bB(~/j nKaG$Zi^ 6|Pp{BX\3GI 5,pGm82REBGw$=4H =G< +PJBg$0GpCuGZQ^oMsD:@7@:DWd @7@:̉tJh!E" @,ef+2goω䑥(@:BqvE}Ԝg$/i-ƀ;} }윈4Rh3i?}5<3|u9+8B afXh"@p v;#ayʐR8[Ui/XT1JW+,|u DR}–krC&(yC:x2 AS!a9.x:gqBP@pJ rC&(Gp8ғ -(qaNsZZB#t< r KG%(M VdjB @  `?!;h<} /:':]kv +!ٽNGd@>x: %잷C&26JfRxӑ7,:'=Zg3.֒a _Ixw"[iƓ'Tpk CDd5+;T"p"5<a^֢k} ZC[X-MP(xtV477<x*@`tañ- %MP( #OGjajXDPc!D'SP.x EAttVD /+lVT"?YX܆c% V*wAꁴì'YXW"Exoñ-!"@B H"`їȸx H#2KXag? ]~.; Etn +Z"x xM5-PD HڀSu@ lI ^RcŠ d^2S(!o8 #kPP 2+ZED@i2]i&4)4l6gN"mT0+򇄄ئpe*3Zr +22s1)^aBAWfP{yBIB2R2%Ø"'yz-±c^#-ZKhCW.a_h$E,A j iyp,C44Kt^D({(M27JUb´+2AfX깘k&P($'R;Jeb8"jEQwR\5b7EȢ iZ :te~{"Jl]VRP%\A^o"_@}}}jjk^txF  W}g8}zMJKm̓ , ,q^hw쫕E/>O 94^<ڑ <3|uqfϒb!ʅ2 WdOBCLL ~ ZZ~i"@Af1RԃNsxʬ))/NQ  h !a3VMP(#f_%`h-*x(;"F쿷K9$pSgtZaf0]j:i"@$]qsQ)z( e>H!g:249bͥ^BR^X[pe*Zph!eyg;/KFP5l`fٍ7 yoU:<-a!l%,Nfyh- H Ai_3ÇYlGCho\(Aw(@2/R%2p,|k]p,kX9MP(##tFw\C.⠶+2 zV8kB "@"tR*X?Gwó-3Нװ /\41pGw]^L:_0 pHnÌoa!pWr϶l=BY'%(A?"#;)S~&%HDҾ2gB#SR`qZ{  Bnd >@@ k:2eD"x΂cr$&|D_pD PHDfd?20, b0^9B/x7'G-MP(#tѵ%Xx:hIՊE k@4PܠqZk&(t'ؼq'P<; B0*z<^C;(C!Ͱ$k®i E"@"k:Ő;xל'"r1I=E q,0eȥ׻R3OpPD Hky$ym@pE" D Ho#=p`^rˆ&4E" d2I)ܘm܆c$Dy'Ofɶ$ FPP&8‡J4y 4$$D<%+S?Ux:0W /R`7@{G#P(5p$|כ/Zn\tE@YvHx6F֒" <3|u)8BQ_qpe`xW~)@0#FEfa/_-(R@jȗh. J=rxv,E" @+2 \5Qpi!E" D Hօ[.VZBH!Š 8-xM YZN"Š 2k&)-Pdҁ/21 FC[4EqIFcm/qTV(A+8^p HZi&a^V#^msH:aVG*g$/KFP5Gر׬Y}@>YlN`P[&-Yi&- myAˊ6By^/LϳYf .xdG2#d:v֛[i&HOJHx&{<}B^XLŃt{ R+04E"A:(B\^r PA H .tT"@"l</44d%Gq*VV^st*CT</412&4P(<tD鸰 f`YE@ #gNqñ IK)!J$,E%t%wc=w [$8X'-oЫ! m_hsHHyʠ jFĝ."#t$k R~Dy?$w7{Vj7|܉ hZZ <Xyf{<}%Oy`IIߦIYq|`%vvXfEFjO3"k"Hdt2?'%26{PxV yy`lLwk:<:xKfN3f_ S`("YP%L8HjnD8 my"`Zk,0kQW`Nt"zdzf @7t cqu"H# gWahaq](0s")NN!&"M@WB _KJ4@^ƝpvEyc-?$4}]!H8BbP+q6f:Hnv|SefҜ!?B(cO5`NT+1'Il"@Hq@UJטB-Dx9"TAVЖ<!G%@[G nsvEftD֍?!I͉DD'ܯpd6 v\ү1@: S*]wt={7^Xw#M/#bޗ{W2JF#*k֬Aݼ h".;v,(A'хW}En8&M4 #_̦Lr_eIx6H ZJ!/om&{'wfw^!BA$~zD(DP|څP-׶[Nk)ܧ#dxCVt#sjl}9퉞oN;f^Q/#Nґ2G=(+%,,/dF_}Jix'8'yl "Vy/Br7jpe8t hp@e&e/)@yTC 7A]žjJ"7"`QLHSu^KgQr}'&^PRWAʱN:Ot0`L% #&0Y0J(e1 t eQI:rMT5k֠;v@bdjQTsZN̽1Ah>#5"@p  yC4GZKbx/0; Bء49re!ȳhU~xQG8oJ|#=(~=2k֧Ľ.ar fǛ_! /,"l"/X FDDHpv0B6c,;reɮQz0 OR`4 ےofot!Y86"0$%d5'+++p2ة>$!pC)"(I6^9YzF~`ԉy2 G -cfՂH 5$P!.^ȃ9#$\`6NeyZ$x+GY^mpp*ގd0C[6R3N$aH~1dޱD[ynVt+c;cE WNgc)m9&HD嚾B\{OHL܉g3_0iҮs==]mlmu !Dklk̤uصm۶>ehu?2+Ϙy _Ĭ{tüϺw`KB G˜sД3/[zX/&=mLٻZzB-wv7?{fb7{eu-_!;@3 {{#ɪ3qpcF&d }$h)CC鑉 R[~qj!ʕ1Yo}x~APn. ۞Ί eO|(W7,C+ eJs}׻>^dhCH<~'s(+i#yر`uJIdc rR5")N<<5%??KIa"/̕oLmMPK@0!)hjыeu\nkWSSP-_) XXȢ(3"sggauf=s||̜IPCs!\+8{ 8WV=ʽ|MRQQW|kVc=ZDtC '8ݐ|AQg@B/B1W)M tM `*@tL'@HIG@TJOB;ьή@FN>lkBM;4"MJ@St V0 & :@<BDSQ 4Dգҋ?Ab>v˲>pX`(cZ@;0uѹWvݹ):o~򡲸D֝u aQ쁯r^Ьa&T1f3-+<>y 'Rl=s/^w%r;5姻H67?9&P*-k3vև_?@*hQ&H@$a ؒ+&|'x!yBWHyMH$TJLyo(͒j"!\XyHG6q؊#,זQ#*Q>YKmdæ'ǜSБ[3{y@ѝ wJbۣNx_Z悿 l2WZP@&k)tJӃ]Wz\0i$z|4T'k>B,8y_475T"䊅Sf A5EJp;ߖg0wy[%)ʔWˮ_n:aiuiUydAb<SqHvM<:r-nDC]#O[, OƊc}iÛ-WB<-w3v}}^}?FNl2"ǐW/S"2љ]~t"HxWH0yXBQEH@`S-/㭠Q^$(,ͭs?Ғd,{T`+;_$"|AX[s,"d+>>G#>BO ! &-kر&H$5Y4~JΌQ^S܄רoY Ex)gevgwr,@ ]u~:^.#nZ~OB9 v\XWKcqtD,iDϠêi$k^8O!n8h-{pTǖGϠZ{ŀho[ `X+"H$`OZ @t2TÇgh_WQHu+0A&=ZZZYCt:#X@@O :zl@t VГ CDc8 $'(@`>4׀ XPAwdBTpp\Hr*'%\VWW`\3 MR͊Uc_c E~rdɂ_;Lmϥdt{e}*> *eQ#o ˨fL+(.?TK 4͎d',r;~zhDSeTA: ,}Ow4U.NH\ qqxnĂ:K2i #Sy Sb8^ ý/Cݹ0Gd /FW,_Bi q7x[]o wN )]e dU,H_wnSş)5T{Bkߦ67Wg]L@:Ї[$ lbKe~"p.YiXDi!:RDT3,"CĿ|2qy4,AnxR"+fe!~ (ȗjDߦҙ~3|>mtOK.G4替DaUg?MbLyx_[AF#FYU?e!e'[dvQUBe-~uUaRZ=yw_\s`ˤӚQ8n0! x75'\+G{w*SjnWA=Mx!"?dnr^w-?3HجG]PZ ޕũȍr5ek=WܤI["73w;QX%@1T䎯P."8q N.SuGgTnNƞ ,l)7XL5+n\5YYba3gW;Ξ*B,+WÆ{9وJIfTN@Vo9ZU`_gf!+pW\Ad0(-% 梶j/ORTνQgO1"Kü [',GHA;";폺(Ki{+:|yydgRITu?3p[Xcw`+a'* OƔ ظH{ T9u?5 4;-nQI>$ _S,숐7).`Y25rP]2>-5t|N;SJ3_~-fըrc"*PZJt4v Jm:+qBhAұQԚ{W =q2"DlJACx~?RkA®#kȞFEjçOͰ(l_dED"ۧ%8zz[E軙^X9z{J̤ 9gؐ %p +W8O=VM-FR,jYOTNSf~xƇGS1O-@;3p Q`j}fM~asH5?n$/>o%Z:@5ҜWL~Wi`]FU h_S 9f̭xV@yS_ bSc7mY#㜑HCWru!:^aVGFJі[ɰާb^bqAT_۲&֧^yĢFM2PSU3W$=X,]JQS(-**Igglt /fJuwRpZڮolKh*WMSi;Ŧ~CPU)dZ1?~Ǔ+s$$x_k8՞AE:F: 2&QN6t@tIGC3.$?&ND; Lw04C8`h04 :#0q :&< `h@t G `@tLy@Z?@ xC󀀡11C#ch='c FDz&ND; Lw04C8`h04 :#0q :&< `h@t G `@tLy@Z?@ xC󀀡11C#ch='c FDz&ND; ӡZH$@`R5US ῏=lKS@QHGzbX!Z1}LC zȂIxȂGgpJQOi2 }`5+  g=|qtf @-jjj899iɃ G;#H@@XI444hlfcc= $N{f3}~T MZ(jafaQ! ֓&-p<RПٳgϴ燯Ah@t0 N@ӂN/nmEEًVcxQ]Yj% A|_rz#\e%{9zlrp+63 2'V6Id_ f^`ڄ0D#!N]g͹EkO(>)[O=#5? : ٍ l& ʕZB&)?gnmDDG2 $Vj0AGWƫiݥ̲,(},(UŚ$s"x& y.V1L#7@@#M#yAj "QşKD8է$AD=*Xɿ:|droZTV,6^x\_W%D6N;Ԑ =PZIK^ď/Xڲ[5@@4g#Kdgɶ{q˼snRP3w]ݟ&V+sT>`5EŗGf K?]\2E_P4IΔ*ū3 B/^fۼ\1m3#[*~Gp_0H'8di4o3Q#V? N|B[=űc?x@JS+Mll,-=F VR\%Wsa=5P~d $V4P> Iʕ66X<zrQ-rQI ^#Yӡ<'k:dHhhn@Qqp"ۙ%:>h ΀@! ՏV4K:@ͨ$13r>VKv]] JJx*aiҶԨ+kY?=vw kU˭2" z?\K^V W$R`sy4Okd!,@zm1%j1 Dչ[kkP=OZ[]S#ɮOq#{P6Da/ !ʷ91n%K˨Y1v o=-wkzpx+3lzqh{P<` Ϣ܂(}7~%ߐ[&$l/NV:`  ]<}ՍER4Z+{aytꮨa>5Qt?$IDAT/ tkMki57HHщ]큨 C,_ԓ#nO>zڼԖflgڦëRM=PFK W[N?[cA.tsϤcV?g<ʖ dqEj}ISS-lbsk oΒΜeU>r 4~YOْ${L/e  ӫG-ۡ|K'oI@- F_-9Mܕ{0ҧVMk`9%?^*~Ҙh{7f]_-5)}Z y!-:wW'^~]_`H,Um>zB\Ny>5Z:ycj P-ojjCUc;&F2#=2t@KDcy5 tP:A2ݞC[6R/:m Lt3@t  MDG7#@@` @tt3@t  MDG7#@@` @tt3@t  M@ tA@pIU=dcoFM;OU3v>}KzX6<ȷnf"y|8St8Gyߗ/L`lӊ2~ǴarY߿* cN yߕ-<ȞEyU$imf"\p:L:Z낼CظnoySqH|ǁKNCWS'LwLD\A‹cS]d-GxᣟG8NH CZIYẢVanӆ@M$M-U24AA MWzꨌ[ ?WO-z5QN]2B^diCF&2a:l)SAպ[$SBxqnR$Σ櫯55=n9^g~tND"{Kt,|1/8Zz/+>rP! eA%NV,*T{%͊Sלq<} CF:ז=dWԈF?0C,3~$]`P`*鿪[O?=IXfuĬ]L;0txDRzpy^^E~*>YWXH%#Dxn#k0ٴrq+21wShlc&-5vŰCzQe]f97sᄑ @ Ԋ85 kGIu5f>pP] Vo)@ ~ۛ􍇭(.0rTu9qo \V4i ?3r4w;Lpw16Ikj\cz333,:?gff^!'P%~MgpԦZTtrǙ"1=bv(i 3ZcHFŊwrv >ۣhcgfM($ UCŰG̎l@fc.q (EN~j(aBo\b㷳Es=Z1|_*=AXwp<Ҳ Tnj7f,?@,YdITTf%U(J\O g;ܦ8hdpzZBV6Q6gGfʪԋP^ KqZR8vځ,Q[x`d* b͒%X|Ɍle7lZTmG|OIPP}3WHDG. gVC8|ݧb8?a`SU[:}٪I/gmAޖs VEei.6B@%M٢T/І붳d{آC=HS>Ys,3bɓ.ʌs.[z+N LG[>7[KYuҵEUUUEh^|YP,~ɢǦo:xrOę͋6](-<)|Q38ֱ5]y"-R/@U TtXᚃ9[EaRR2}cM]2(eƧc"H'ZZVK@J&56H9 };=SsӅS =sQ3VEH^l8"'xE{_W~0ۡ.=dX|t#_Ut\YK[MRё$U<,ڳsFYN= h^)ڠhY7.D{ ,Y].~!aCiQ "{Qjw`l27O_}o9C zEj 28iDcNJvVsg9ύ̜{O'Rѣ粪44n׮ťJwd5I, jx{Mxj,\q8g>/@| /6P/),/) ګךⱙ__6^|Y xfn~`"t:Q|w,"2{/k't|j5P@P~8P3^X0.n=Š= {@e+քےZٻ׬תQ@̼hD"\WUɉS`F8b -[yœ,[be ϰ(X--E9ede1"8J&UV `HzÒ4emZVVRSJkj*hUtY6gLTz稂+bղJ1U\`Zw+1|'7£?}ۨF齏}_ТE¢:m1Lðw2L@5X}XArQ H(ɕkk][+^wf׹^}j zAл d8y, k=*c!dUa0읬NF-# 33ZqURD5J[#q~Ư>wjjՉdjaƯ%=F{v4?<ڗP|Zx砏3{{hOO*7%]oob^}=>T$s{;YJ^K@Lh1,5q(ő )mELpw$©5@7oAx|2ݩh726cv4*ssV9 !wc{vH t~̨(˕o [xeq6>weF;I$Ж?JA41զ/6\xfL(Dg]Ո_ 1J1@;*"~ 1BSx͏eI3 Lv n=/!1j-Oz!+V םm>Q;K!J1$4 NmPBb#?T/Y!J(mE,.}zS*De韐C.De:w'hG;!2B98+c;Yп5vG"ԠW)O0읬NI-+Ttڟw93M7J[3*A=T6nѦYP5Va3f`s[x+g06=R1ӵz<{} ~H#4f_azpI e$EKnN||J0Dq+_HjR6!zBrq+b6xf˻RȖɊo;1N׎!ЖJN n~q~ѭ?9C_§=^6c_:Ͼd{{/\\[zW0k?&PP`fJTtRF*V0"(~*B6p+ݞJ2ҩH~KjqNdu筣q$nIj')ɔuqTi+/&(3VS5Qlذ5 ohHӜca۪%=:aC~wJf@t5Nt~#m[3 @P\FP`  JDG  Љ@t:.@@*@ t"\0 *U&@'D`U :L N$Ӊp4@tT@ HDi T 2 :N'@Qe1@t"N P%bD :L J-{$U A J<<8m愷&R:sCڥ x$)9831fr'aL73%k8}Nď!oOv upȣ2UIKDho=wG6NYh;*-mb[|(u+Q%&;wFZv@r=}Wܫ+MMylpT]oe_qbu_Mbm|I<6r:zzD h{7pN'qUHM̏{׮=%K4>,83 ssY_6BbW®+gEnِ淩.M_cҏm"Slu Nj/!+S姇yyθH$W"FޡN-2xEnLhCY8Q*$nenBJPBE!j-[#hѓrtLY i #A5XC׌ƺyĶ%$/].H(uWI|'v냝>9z0Q>Jʌܫ{R ^z8RPS&N!CSwPm /n'~_wtqNdqxpZJr6lH8%emɏǚK dY.Cn~6u7ޅv^ؐKƤ~-4iU-GN63>y1Ut4)Z#jQSpv>%Vqd9I&.Ӟ͊%6jK]lL-Vs)+#d"mI>1hat(V+';c0Q1灀1>Q1灀1>Q1灀1>Q1灀1>QY6@-LT{0R` :  v> @``@tT :Ns@h'(>k?n[DpOMAKwD[\&HS-Y׬Yo3C}3pDml-EdQ{d\j$%_:сdDGuߗ,KKE׳Y,KX^`ny",[F?D ze3òHI)thuÂ8)6;X%U;?,xd]1A+SǾþvj^E١4[4,K K|baQᎦ5F;(JOJQbr>z.p"*GNMe (((4u->1 ׈+Od`gin I!xAt ^܅'z#$H|b!H52SGGSZ~Fȍ ƑG9~\FhwČ|sjtbXj3~桒˙uS?cѧ ]+Sz#v]<ҷX#N|/5#={yqBЍؗy KYxHn颣~_$ ]_jR侌Uً8e׀X5m\|+2n:yb]Uk@)6 KXJP~ EhuÞ| cئ/dLJoϨ\?G[xqaGЉLe󔰹1V:2l4eSg$`(doɟXu?w\h:b";a2b3D w;]thɼΓx!ZZe2J%Mޙzb:߼KCgH8=?_H_e {/>x'/Bs3Xs7M& \;xޅd^nҭwyeMjP?i'\9a,+>n27Ǔ)iQu={ҧMxceaQ?𺆼 |z*p!egH}x '1CIA'#Ӿ8jg02DL4;]t&"8Kߌ;XUJ#CCQ{v!>wdknHN!#v( dOQʯ,Iy(diG#_ӑ\J&$x~^Ie/ĕi!#Vcn;w~sY0C*ǹyޫjDqhu k q Ϲ*?ZucBSrhB<&6җ p@^}DBn;klZ:)$l>q"b!(g7g J qCACd+A𪎀3vx- #y_uj/'S!qHvGg\5zrm>K]L9u]}Iڧ[W±c2mOK~ f:DUʗ|R{Z^<6f[=ޫ/}2+KVj! \yQɎ0^;Ozwu徂qQW?yPv9\uXmnp{I Q>wGwy&Ze;T7#_ǧxȍ$%7o2f/.(ϖ~Ph觭)#DDS@~z SiL$ЌY^3wj6_tE'ee{#Gd{|QEIsyٕ$w_t>֘\Kj*#,p.MYJ&=l>>!*l?}B}~SN3kH\1kHj֨^;]i҃s-q8?mQj*v):=4"Gk6RiS PCgϚ=r$Hͼs}R&}_d7q^O=~o’NȎ,B>CȖ*KP`&![cïf.vZ|+4EW[_iq}]Л]UU5+]=?rlޏRLߎ|qz_5Bէن$ ij K+:w=o0jC$Ͼv}>8NJ/4!>}gP'Ԏm7$k~+',9^y>[Y^c,}NK(glV$ *vV eTUcdI^htɨ:Ȥ!_|/*I9Fj^4](~b )!?EҘiT){S?*Q5-V64]S7I-{Ӿ&V]}dkH7:Hez5vpkP__ߣ5)Ug=_)>1 e70RW!s\^ &Kv϶(2Tða䍒+JFzjJF/J^%n `@t  Нtކ c.DD;6.zz+5V5=L;@t(}*=^?@(8@s t._% p @\`% :J@%ӹ|:J@t)K-ӹg[j?P!j0`4ސ? ׽70\Z@n j鰚ftX @04k:فh@N+Av GD}4$J`i?( @+ d@}@tJ J :فh@Nvvw=B;fb0IPA)[E^H69&nL(VJ!# O:);?p" *SH2\â+5<|Y RJɤB좌CQΞJ)jl{!~Gtx$0.Ur1蘍c"BQE~ܡ</5}$;NȍyDeJL.2Y$~.ٗ=ϓS!?YZ(U^(R2JΫDƸ&ߌKgؓ6׎Vv}VUfWO4w]*_5ƨ.!0]H>!Ry55%.$t1n!:H,H_Euѕ5KCEKq2<~mDž xҔ}F}Wv}^"q&IK$]6׈ŕ!a(5n '㣀QsW~eG3dω51S#|͉߲Ϊ3q\CSC7I Ĩ$s;Zwa|dO\O5zwT~=DGr`8;-Mp, jt}_dbl|QrtJٹC'掍xATbJ$5"+O6Q7d^36)?*>8|Q~-hL3KInaKD̒ڒM,"+(cb!$j+,A<3IA7>.u9!?,7'V戥޸# h܄б9#pD/#ͱhzmXlm9U,(Hr^֩ۑmTfncL#d)U[ӕYq#Q| jivKW)RcMu#CBmlEFB r ƽ־K6fS5Mʊe9$ ,J| \8ΖK .Q,a4'‚ALe )kE،@gqQ}RTOI19UNAw]"ZbdjxaaNadI'KGF–(ɠ=^6&I)13a7ˁs[%R/ } 47v!G; h3$. 3vrjb1Lj+Đ'=1b"q;SC )-rM(>B4!2-h!ֳ8\9> a_U@1h(|!1;Ԙ yK#L)r!O%:{7DøGH 9b(1!0 ~ Ёx@ [VK<;TDA ZA"o+Zzw .F czPĨc4g3™Lp$%l ޑ9þa slYOh+*0bQ`F V`!Æ2e>FGa??z(ETW0"Vi P?5y^mt7~u d+:pCJ JLFǤCC*(`/M@Q^AʚNZ=Gp~ # ;@c< _0 = "|sh=` ,-pF=DBI`'e(8N3<@' ` pl`5A:DQDQDBw Fd'"%Qi@."WH2\5w 7-SQQqRISiSRr*QݤzL;5-5?" uuu9u# hhDi4ilihRhhNto.>>$˾X_WFu-gWo>@/4`6P;$}vPILvݐPУKafaþۆׇoFF4GRGF^b NɍՌ-]$[␸q,?A"aOdNbe$ɌQ)R))SMROaӺv 9KWndtg2JffwdL1s6Kݫx&/4o _)"gA@B}Wd恠EEF)->SXZ2}Pk@iA2rO:^!RqbhJ*oՏk:{'՘ִ֊ՖĝL<˩ 6'8nPkhhi,::pv׹Fۛdjٚ / .^dy+WZ[ Z֔ŶvW::Z^쬼zF΍͛7oZ|{˧;Oz,{5{W={}}Wo{_ÖՁGj5;x'w?}0l3<4@ x=זDF.1JqT4ƀg`ϢZ89Uy   E4D#%$ xn Ֆ{-߬h$AU{5MɚZx'۫t|m۩o`@0xmxèѸڤt\ׂbɲߪɺڦƶnvYw]s4D/S>H+ SB Bä#8#Q_bcOOOMlIƤ vL7L:]Gytn^<|PǸ_NAbCn.eNmXV5ԩҨV:&s\|emɉuE*:odzbȥIWvdik/ZQv=7GoMj}nRoн}X>4pz;xbڧrÆ#ԟ X}93񓯳''lؾ}g^c}fb`NynbB>~^.~7bN1e9'%Ȓ:RROo Q){W{&DemDG@VY}DBSWk /NQzbkÆl7e4}gi^fhhgbmigo(LtAwqYU#;׈$ vׅEGEG035N0'"vҳ锅՝vK d2^gdes8 ί.8_زul(>]rPeiYYQy#)G+C2ol;-ojwpHRC!P8 MKD_EĘbaJ6EIr{LZ.ݕl={ Eh)f7~ՂB@Y1/qe엺 bE2ٲ; Jʖ**Kz[5j5inOid`XhTgjru>I+6G'jq7!0V/G}z|H]~ yAf!Y"";bRc_7$'$?HLK9[%T&wVi~OZB)0u|૒ʇ?W\Lzmj+W4qxzZFKT ~a`L`rg6g`g`WTNsq/(yOjvlQE.f55;u , aL:Mo YZZڞuhu2tqt{rf |R.!?:q'y&>-/i}WZAⓙ/_|e<^$7އϜ77QѢsB_4~vwﭫlյz?r~ S'_\p(ٸSg?yd %E X~"U śk'fc [ϡ(S'Z?2(w[P ZJiTXtXML:com.adobe.xmp 382 686 Y@IDATx] |f7 rBHn ^xEh*Zж^GmmVAlŪxr)C @;c73//d{|͛ٷoe@d Ƚ J2ςH2 xn=:GdgoL@0ұKd@s@|@]&s7*Th( HK좩W\Ĥ^bK[7U]SbUڊS̸9J1SaHeBESM ˝ ÆD\csa3T!*V?n.r=IWRZs2⤽OU;gkrxך񵡿rxV~ !ۊM`>e]{g?-<0$%xW)W95'Fqԩc͛{͐g i4[J"g7tY˔*02}/Z][mGCC[+xUs81k;Zڋ^}˜Y{aPc+2"S n:_札$2~zPli4-lhdtzF \Zz`mMVSxۤ+>"+*GlwG^ku_ݠc ) zCK}e}+3Sc#*}SEfX+ҒwC;רmx⤭OKH U1-MؔT(K{ČH.|sk:cЌX}my &kl׃Sӣx3_|˚V,Ѳ6DlVkH`U"@nld?*FQZ䑣Ftۛk*V2SSb#@kX~%eQ)˕-u!CS@-@pEzwç9r]1 Icsץƌ0'.^s8 $(N~w:Ͽ>%䛳5+{x{KVr^tgM5V33=^:+eJ){]iɃ;2ZOzhvd9 h7a"[{t-::\1ɚڶarWS}ͽo^}iŒ?sqŧөMuh_~fKfR8+K&ߝ|RFaI9 sKwqQ}ǾdɅ+X|$~#S͚ YZ+1/uM%%;y)?>3s d6o:mqA*?&cI:c腦,Qjs&rC1>y{ZF=,tH(CCULȐ^]\2¬#dBv& D*03hk5jlյfS?tҨ5ԔiPf|8P^3~pE7}5;]zcBi&pGfS+Yӗm[VӢԝor&D1D2TOr!8b71Iim CGOA͸K̺RlvSQYNS엍IWdSqAk>,WخZ2dA(=r6IO߸*CWS_T2Փ2&(gu1af˻}'-+F0LgkϏ6@ʂNiणǟ}9c5)aDNF0%/9*vk'R"ïY\p_JhjZS_i{Sg68}]|rՌ6t-0jφ ;߉R"w|R<t+ a/9g\[1\<{o \p2N;ӓrbGı'?t{̬Hl%sun(,ktpd-[)g 'Ƴ%MQ]ɪ!qC@NJX݁tIQS) tjo[6p”54vtjqS/4͠N*10 ؚ[|8>qU)IaB;3тӧxU5$W_zV~?;jWBg3u$ /PF5|(/Çk*u% NU7vD2ןQ) ˉa0 sk}r+Cc3RNّTDLLbJj:A]ԡc3 ?`Mʼnʮ(hQCs2kU뿿1{xzDFMNVϘp#.I[o,-KFz\AV;+2bİDBw{-(7?TFdc ;~hI|صe1?]%ƣz,0‡DTi0{3埮T7m5^bZ[l:'Z|N^5gpr*cǵ2djXmhmHOydO^sg ka OЛLII `w%I|dVzw^`{҇`e?Z 2rW%.[VV-ә񣇝+.5F5bѰo\=1*sm,M}cE}2J֥Y>=Kw}Ҡi*aب_q0bi9b\ƽ|!(X0auzYiuB>c(40:lb?/)|;L^w/ [)\mJN Wʸ?m1qB,Tg֒)O ӼImbqߔq]&}} 锍u{Jk(-ońEĠh GYDYxa+w LN0њб)MbX"c&1b9S!ʔc~Ԉ֖N&&wO=R۬w4b=`Y?`vvDq56Ҵ>W3C.9Mʫ:R_2nS~JҫO.ć~\qHS u=wO?^ An5 oI*TN Wզ)fͿ&ωfT->]?2k^THNΨ✬6ALeNFEpR:ٔ.{Edo!Icj2TgGT7]r [2;b!MY)0L\{YG& swJS\ΰ^N0,ii9q L/f1#r&_;{ǦJ~KfKNzGDD[31]8"Mi[ (nf].ւG_x6SwiG5*`@K]86/ Ƌg5m0W礁iǓյn^GzҦoMiEΛ8i4gduh\\C[+?!.a;]ţBr%:(,U.$DQlJ9URcϋ!\_x 2irN9ݱT6>'x6(ؕ2A)Sr@wz} F/::G-X[yWc\̸`Rm _1$!2QQV68J-L b" imbGruJpjCfMʽaXxWgŭ!J==FU\ʃ3FxW\nBJέ=),| _uFϧjy1 s]KipXmi#_wiዢU<.52YU]N=3SDDF̌Ui _41;&s]{4iYscG)#G1+ <&@O&̏2c۱oRc?*ikoq39.1OVJ:ۋՋǸxNN#L C)Wʳh,t+>@2 /p<(Ly9tlkV̞5D?Yx\Uu5?s<5yؗavܒm̳l͚aq9ϲޝ3uie9}3'%5e*iozƩٻDȀS~  `@ CD_0 uuqŘ` `@JzF'/ Ȁ.Sd9(=9B dp;(=n"ȀszvůFx/:CcȑQ*iUk ok_7F5%֍\jFͿGLÇ`2Vk*; L*+9:9;1m[ynXJSvCYQVݝ5o1q݂&!#Zæ]`&8}r{p5&͑6 [Q4̴XܢS _M0|~tlj[.†jp(2" *&fd1\,ƪ&~+ΐСIQ1 ]+Au.2 Clv͘˛R sѷLɔyQጶܧgrM57`vvT W;3XvGu7o}zq׿8xWn2*w MUr`~o.Sxa]϶ =_ڛgN _60i:cFpac&O8[y:m2[?Ff?8W*}{[gtOt:v˴ųnɘʏr+ұFߒzԅ^d, fE{dҮy(FPhჽ=Rųz?ǎRbIשb^t\c44Ԇ$/g|lo-+xxl8ŮfdG 3aSVCGcNe1Lii3I EYPŸ{u`8ߞ17ҋfNf>uNFc1^沪!F]wLKUm>MؘE b߫ND5&D)gؼoCJmɘfvwvlh:L*;%",uZa;s]lLf1:.߸*oFUw(ַµ9?&) =6^H(lhԙ!!#F߿bG~ >z,gQP|NCNU3%̋I6oi?>AXGGeŢTGG4:}zh;|ZY3,*\VROQ7/^4=W{;:c[ϵaqizn</_jnTtFFn\f鶘BuȘ1 Ӱ=85<b͌˖M` ǿt5m0q0G]zѢ̩?Z10(;*,2o~"nHc1bFT}ņC]wްbnaӻ'X7>9dZG =fwܓ2~Xw]c`$N+&A]}g\3<R/k?\XQ v Ϟmo+,qh=nG3:& Л1`seqg`mLDgD|B*i7ܔG0Tx5l_gZ CT늵>Kip.{i/+\E_9l\eKG+rşZ{&Uھ,?()䦱$(9zH dۊRVd2YWڔ_)L%uS&C~7LJ:Иd7o=ο i>q"qx:ꚦOn֦Xfv-i䯷d\V u_ hۍvR݊[{r:&7ZLk!g}xб[ό<ܤkfWO`<6 {Cr%Rj-]%5-ƴ٩UR#6oK/Q1FuP5+ʨt^QwTٵY#+)kj+:!E^35!x*DST ϕ\LL~s;^izfekIyv/= GOH e2Aw4'O نhϔIOUz7&6J6$%Y!oR͟WäS;Qȹ泗 tR+4gjuoo"21t9vt4^_kvᖒvrh{C^ W-msӯ x#Shia=G/wΏ,=s&Ϟ7 ,; Q<20v{kcinzoǪ/L9qDm(/.vrnD%Ui2ių@iwwKWYtu  =]uܰg~B1\Bl>Y;ozMzJ15k[C켬6j+ #3r" hoB={Ra}١z܈۴o/]_T˞awzo+ GcŮOY7Ozn2§[6N}\@= 8˞$m-Tea2]|' #fnz4˅?3)a9eTZxꂫ"h0x2qiGUb.79O'R#(ʍd8እa߲:6Y jꎗ0oz}'%==3=)5e9ISz }J.k8޶rNvt,Ej:?"CSTLgętRB5[ETtq3Ǩ32SU8|͖kf[.3a(deM`:N3LҤC;^nw6iq?o3߆;xh?swʆdk:)߱\m&UntNjw@xxy5KuwW=?ouIV?sڬ]pPĊ(;4UۤӇg3t e?~[l+n w%=2'}{d~0X!HGo32Q,%=r)@>d9-Rxݰ$Zb$a ǀOXxKGKKKVV:@7eee$hb @`t)'xoiu-@Uǖ"Mӹ)Pt+Zȝ=J &cjH̋}Eo?86O_s扬׊4Vc:SSgc>лwoWXlE5mA4XL:}>?[v']K_Ó-v?XⲲϟyvգpVQymy?@?$XjTٷ>ѰRw\] cKfQLV؜ꖷΎaWm {ǁ#Gxv U:Dx&=uN8S_|LUu挾-hx܄bBtӦ-c0X edTڭo 0g4z&>tz#h-W}X@x oi@|Eu/ a.\Ӭ3AU\ J_U [3-kܼJU=[⷏r맘)=Ă>?%]g)@_uQij`\>DzAS1qdgL.X [lQ{s^'ͽ.5,}펍cVvq%=祵sW){^)ʞ7/N׮[|~?ҭN/*,,*U*~FƳeG~~zL5o8 sVBp%,]j7~xWq>:p-wp4-fAV%fg36w֬U1-+PzU ]+󲞰 O'\0_4b=}Иƥ@S^WCEVuKkKL dJ]{Nm~+vdj*SLgÍI+a+~4/rÞsy|Ǭ|fMˊeE;R͙ ehr4gO_u둣{7D]puZ\ZX6g=`E/@M\K|џİ_9dZ1JUz$*kG׌ZL_%l#NZsc ǟ1;T䥣K,Z֣ʯ $*}Z2zW^a[U']8Nf=m=M+j(+%MYnݜ ӰqJ$in}t`ņ צִ;eDy6.V}s)|vnZpØpk'~s3Zt?.U҄gwp;8hlnLX)ڞwgFCϓW;w޴+ij-*ռǞm8jU@*a.i9gβs"MisSgʲ S|zYQk߁Eoa<& o1׀B>٢*J_[hEsf7G#qׅdc7vւؤ$÷^-rvUndNӢ`c:CQ |Ow&.K*&Hs#}K/X86k#T9=9]΃ SU/~ ds֖52ӟ9-{aޚ-gҭĻTgփg}bo'X\^9vfҨy "`bۣmztǑ܆\۞z%N{qP|yKW˻QƄ1sVs,k;Ɒ3N7{ś[DW!|[V-X؂c>q6sHоG<;^M'yU|#K|S+Ä0»On:2ƕy$2oRfⰥI\ocs?8ʕ?n>e/L*wPUQr7yW2d p r7BC ʬ#kX{؆-gWg>J,;L!i@h1$UwȧiWb Fwʹ7\2D1s`β}ږU!%_;^{m;eWܶz|dˮd3E/%%ܰw_Ĩw 9on̢aM 7b%3NzC}D}ڱ~ #}XvJ`#ܡ #g}RE @DXao}qF{)9n36A` $RuxĶ2, 8`@3dGd 8Va"hb @< X '~ᡥ Zǭh|4":~{➽܃'ÿ"蝿9*̞oV[ b;3n]/ƠVaG_,q0nUAUX%ҭe0l&ӝO~sg/zJ$s\iUn&8%*^jkLz:-VaA5qٰiEIbNwMRUni7s&F1 Wx*;g_B,з sma1|Ƶ7xҥKo_:7-T&k?wNd:i]/?U=Ήd/6xnV?摥GŽ|hm ʶU؞%6s k̚G*lIzu[yHӰfݶl;>ۮӭح1٭όZl"\Hܳ9g-?#nVVyle!wRZfW?}GMg4-̻淃mg%ݳ A̿.פzzl-gЏ6 +0%oS í ۽r.ȒDkYyO&MH8]l~ *lٟܲglf[Xu쓻 gQ}㲩isaAW~ íسƭVao߱>qkUfޮ]>g}o[i6`3f,]<>6&L3vvټu`d#1>͘wMTUOO dIkU5,8h Z!`A0:f.W_ol~0ʶX(P+{ [m#QEU;9 *C,8sA] t%\0 ,|9(`t,.EWe;\R[_Iƭ¤u[)s7fQDc(twQ({HNf+T^-e15f@a+=1r[?t'6쌝H{'2 fZC2 88BdN!2'* Tu0=X&8т)'zz;S M QDzz 9-HxVؼcfݱ{ڦ?Zִ7Mv $%i& F'cq"=?ޮuWZ;/]3wyã;D]4g;1J#<># /j'4 t4+AK8Y=j~_upgz. ?^j&lےhtgOq%/85ww魷d^g>(5/ua?=6AK豸4i/ 1y;%wvn_;$lh$ͥMK`M%Ѳ-0g@T%h ̥Y d)r{ORY{,[nWY;( V[M ]5ͭe?1L_]W?ޯ{E΂{v }iUTvc14$f@Y4vӑuف4hb @`t='~e9~9%_OK񲞍jdISV[7')+|紩jTaufpk11{AwsX0һ:Oص|SaW/zgKiN¢(U=f=; | t4{AK8ӔszdýsJn{m ƤvW_=XN&Tb0R*UΕfD}oqIMM3Up#3,x̵tWŰ%}D}pw)]/@O4M 0:K7\ w:^\s3XaPs;h*m^5 v/Zemi/)j?F2Ob~㙥e2lJ{gU겣|=X䂁-w:~Р%h X\Qdn٘}}eLx~,S\6 LMN^- &n0d+oXcR+_'vbGHkmy X&wzm{`,ź1aZ3ELLUEA~'D04^Wn &g}3EL#摁Aƀ /O p@b'\bE@`ɬE@1"@0d9pA2H HztH Vdp'p "AJO & (=3V"zEGQh 2 /=Sxa"2d.+A( n˲X @Yq>##Q#eƕp8 wkiff84!lZMdK xh@hPzh60 ^bKDc72@3CidΟpy v .V0 ?-mC&I̒]m271&Cb6' If/@\_m~b*JzGLa,@IǦ ubnحm'W$d:ԝ Evd07\6?90K g-5zI) y[171aU7v~@=G72*F 30ByLZ4~VΏ̏V$x_$&ͫ!ij?* 1h<7FY2<ͬmery0{"&J LD (/:X/z~Dn&V/o6!ȂqYo00 deR#w/c_KhH-/@:wbI`Jhb,ebi|>>_/+s%׳V%k[EhHB oӃee;wL԰/R )4鰉_:ſa #f='פMR 0َ\1MM;ߩ{{Yԁ~qG$,<՜Gf9">'v&^\E㞢f>ړԻ㥷7l8y (@thB(~+0"޽3 )xxצ<2?} WF|?b}{Ko3YgAJ@Pزe _'N*ї#%UU bpE @ѯseep&1ˎ&E1{N Cn >1 1~fP\eei݁}Xfp \q<o"_E.$c",Xo>~y}|駟=C~TWW3]^2k Hy0ec 1Zf1d"nK`p|"T)V^.]˻7\#9\E7HXH}CWJpλaEAmmmJJKD}! K,pKҀN37I@Rh4/7&$$U!;FCE\w+UrRNAw z=oFT@@wNha&^9Q'\ҺS:'ƫœڃ W:5e\V0&YL3"5 6<ɂhi'5D0) 2p xi#Ȓ:O@P(Zp\#`d `C2 Zz R(~X?cI#͕`Hc$MO9f+"/)z.`:B{ 1g7|-)= U~$\B`$"YQoһ(~h(!E1{i) 18m2 wd2D2"b)5Do3 qKv9'4~Qx932 8d!5X csܢgdpJCj@<JE2`2 xqd!(= d_)4 _tZGh_N#͕ң4fZW{Ԇ&t NH@ o944Թ83O>$ zΥ&~41w_3~GTޡ=N*AS(i჋~GDO9fv_vB\1AD?, ]!Ȁ/+oNiZwhFQmid8| =A4)2 ^xY <V{9Z> i3B gy}DYY:WZ)]1MkkkSRR$#"K'פ_%ѕ6km!Drr+̕ڊ&zRW QP,n#;`.{YXꮨ?Rd|,=HkDɅ@op} E~s]Dd2Υ-%\g`oV d}IcwnirtF'8%` YXCt.=,4|VO h 'D)ZRH@a@10f=@@9_k WPH%f~UG¡KH}'h$g=Ez^K%23tF I}BW%*kנ;}?JA=*&Pv y'FNt.$iZb68Υ^6l ޞyHGYƠ Yڲiڳ}sHAK1Kt^nxk!d> 2!%t!!G9樜4tW‘8ߑ)Q.#)«ΥBgnٲ]f  YHAdI[ tHx&6ID&G t-/܍v%Cx#-<^q@P?b#($MxqTK !`-]I:#{O௽Q`bzyGtJ% x4~QΥGejи y1rޑvKQ7%1艏#] %  -ICkyV!,t Tt^/@Q#X|̀xD ic1I+7~^ḧ!&beJ*RftژoN~~"Cxy&~C`Y{ȝ/:|VPhʣ%D# ;A"d.5u-RHIE7 %tzuËݽ+ih%. O#DԴ֐+ Ch`dkG<'kWWW,9; Y \n](K00!x# J?_KIgØ $$y\􂱨1_(\!*++#i&@_`vCnKT;*sTE+ߤ=GwB7uMIIʫ86)QEhZܻw/w*%@sbC0&HEkȣUҮ Z?$''ӏHmID D3)az*GIQO,~A!SBH4obgҺN-=.v; _w: iRNC.'ny/EБ}!LH!?40:C%^=#*%.|h$M\dJZ *"#DqH6#(!- G{(zs"CD:!Y޳coLJV1]lrҝwNlIxWzda6\z\rB|V _H)Dq1ZR4A 14mXWC!M"rmfE(1M"'E¬2IqZH\3&RHQа!b{=^_Нi!f$7h"sԄK@J9̃NI#oDH‘%7\}r ĄVhJ4-) H20(%Ā$~r]D -#e" @|VPٗZpPˬgP j bdu> R[6^&h<%D_r{RB%iZb `Y^2Zbo'qH\V\WXBd9(79,K`{%Dfhr)LKcu[4O?LpBB?J4~{̡ΥG.ǥhC:Щ h N\z@]mGc_>OIs~^`~(~(hqFC7dK xh@hPzh60 ^bKDc72@3Cid(=^"A L#Ȁ@ 2 8|]@$mZ{>)#R_;,]׾kr>po8%ޯ<@ sЙOں×fc}y Q_PV9NV?hˍg BW@q)C72F22 JL2 7dUPz\e d Lt 2*Sh nd+:DY+؛UrYo"w_Ҙkݩ[:-щN*7+HA^8t.=[4யk֬<|[R[l!YHC dݵto49YDo3 qKv9'4~Q^e 6aC!_$A`@7Fk)w$:7d8:qH NBL @01YO,g=ܲC> i`cA3ޞRBHBb \hU2 xUzt@ _(Qq`&|v$AҢ̊j%"@@0UVsxBš`%Ă gy}DYY:WZ)]1MkkkSRR$ݹ G}U駟T%?"iJq+p܉; 8 Rt.=rW׃Ëwz t@3;P,GW4ul(Ԣ_yD4c&8!!%=fX =ܘF/1%d@42 x/ JdK xh@hPzh60 `{e@p 1ׁH>៵8}R" G v*Y}6G}$pJT _wydjsЙOں×fc}y n /`-YGҋ1[,\@2@19n32 8d!5X csܢgdgKd daG,BO3BxHJfA֛Hݗ4f~wꖆ9*wKnt"SʍJRUTΥ~+Qa49\ttK,`-YGҋ1f@2@19n32 32ipi?2 0#B !Ȁ@4@D@!d 8`08z&G+csGiҵ M>1\.w.=`D3it@s,ub?U-i:i6|QE/0h r?LpBB?J4~{Fg4pc@Jndff2%PzD4v 4(=4F/1镗uf>eHlذB-_n3d oË@] .8>A7\:Dpn%?Ӥ ;w,l1I%^C`"oZ|#~d̜={HS% /:~ -1?g). <8pD%H_9QHnq>0 :~-=>Y A h@;7|poC?r4!\fŋs<Ђ=wn8|62pLڏBv2( 8_fH\O)3(tS7`4NHT0_HdQu|xÿJ(FK .GJB1d*: UQxN 9c&ةsOӗ1_ExO(؋$ QAy`XB/cW}P3ɾGR xb,!xc߾D6)7?X(߅דK]id^0}"x[:AK!3~{%|^%DJ&,*I@$ Jfdcirr #I|8y'%g)?I'R"x K@ڃw *:LlJ t:-tM'h?t9k=~p?$$Ĺx\Qr=/E{&i>A MPWiE#-mXKBҐђ0I?!iOtCZ'0i|9]"&{g,/ɯK{pG+$ `  ?Z}BCWGdy{a}=mo?]AqZQZZ*QىdP íj^Ա@JרƎd.0 ^ckTcGa5_#; 6Co'D/Iݶ{OD;hc0\並Vxr`I(9}sc PPVV.(Ĭ'е2jݑ9xtQǨՂuVEk/GX0/w7&Zkt]\Ϧ'3LgO mXlLA_`Fv~vgclcuťNȎ|ERbX65w}RM{P +fomgއ+l=R`BSӇ(&-o.c&n]wv6B-w0>=w6Φo{ Em&Y^j 0-|mHa7]] ٛ>1bnJ؂W7@˼Ŭ|Xz^AAA^NWp5ӺNvvNHXZc2u1VfA!s}ήO`.R|o,:ʘv+, fmA3f Y]*?a6y ,3^iHBa&%77V6aNL<{䋵[4yqVƐv|B0ZAz̻ƂÉ̉+Z'UײՏ ﱼee%4KM[0^ `jVl,(x;\2Qg]O<ۡ:ݽkGaN٣N#>=S`V];nINkoUAĘupk=nV®MMMqDC־l,'lV{5%XKldZcl_I7S띫e DO[ԖYY6Z`(z, |5qOb[+@+B;{5[woEZO Z@a4(/çܞzW@9˗/+</3 6lI1v v'** x;,G~3 e/6Dd >J-@~3&>v d+ J#P |K>ww ٴ4Ȁ( d Q9fX 8b ++Q#d0 d@7 2 x WF9v  >w x2 Ȁ7z' v&UtfOĨ"#3Cc>6kԦtC "?Xͬϟx^K0>,mߥ_ O6cOk֯!$, ئ1މ"YO+ 싅h_yQX1svq[k,'KOkΝ7FCC%766=e:op2NwޔN$[}MޱVZzZm] U*anJOn`?p4VnEUi 6]PF7m1;-}!_3OUnեFFqZ6{oU>ś /J"GR^+MoZhE+ z~77#Ed3g2v3|fsf3>'5qcf]p@H;N5}@ڪvE,`z@nk imioYkCgVOwډ/~3`HK+ !?zX0=邤ߞ;چI*0`׽WO\?) H|O](¦q'7G8a)'Lh!qgdtTgnԔ4OeVN-_^}x7G.o>zk3Ⅱt&"Vlp~V"AyJU1zBkKUQ};/`wB\w=e]4:"Ƃ+l%&>&4XXYpIW*?%qLh2~kW#zoc?V⦛e@TM,Py!VW3Gsa*X͈$SOHce!~bƵ1>>]rm4* Q?fa%Ń#o?&&NI9-" vgHQ/PD@|ks !n`^# qTIª+o|~33U^{4P)boBM8hātUf׹<۸]+uOʂx99op{:ԇ2c 3!bo@FO[=q#2 u/wzn: _C@]iWlc97Gki)tES?jܸRY0T Ҫ]l$y4YBBC2ΐRZF%kiEpx۶1 o*.(:.N8iup~`5+-e0yM56[)++svvҦ&Z.m҆&br%HZ3[ & GN4`VacǎԪXq]QÝ7$L F]dnVX[/l ~r%wh*=j\CcG{छ[ LL--NÚȤm@~=ZGO< CL< ~rNr"U v~mZ.*?CLmLI69V hzzC+`?}Q ?Y1ozLɥcz40@aV$t@ӣF"$ 4=pEH $G'DH@hzZIMN<0jG tAGZjqȤjfW- rvhCiEjYYiAظ$8LR,Gr+olY|qM4TܯH=tAx]5Ғq$kl0ƦVH/[)OռyҡyD Ii `ܡSd^e9^Vxw6lr:ZFWH( oe 2=tOsr| ܽȂ/ '(ȜUG^ NpOdFP-DVGOEςYWwJ2R GugWn뫖a5`s_ԴkQӶIUa)?JHLа`49GyTױ|M;w]y5I{e.<$d/f{RGO/$ffR 8'`Lf ` KViuIƅ}_g!D2nUo;BZ0Idj:7vHrIŠՌlH֪\`[JxLIHUg?KKβC_Ą|oz!cVW|3FO ڤ"`~ +Hb!-Gד !?,!j6DYk;.gHW;/P> {kNe4Stũc ڜYPPYR]QGot7|//Zٸ?f_|/&8W lZ]]8ec&{bwm<";MX37t[:~Mz)7v{u.\}JȐ%ڜܹ>U uU7y*vm۝ 2mf>O{)R-))y-MR}{oվ\`k_*y &< ZBG[du0XԦ͇ &Z;\ 2pJ\&.X1fHo{[QM R#Re"j;#"g2I#!LLRW}0A K#ga!~>ϯgv%ʏFZey/..06ϔ?_O2IXTʝ!n|FZEŪH}EdLZhU̝1, eZt*J?/y@jiR *ZCyObſ\[Nc,ry:҇u-v 6qq=ѽE\{xO W6ՠic [MJ%z434B#$2$N`VT7 uu!5&'(axYfGG)@Nx]w7?ֺ-$~(Hsq$SA6O0'?f\3$\]'gdzfJ}KmoLyB!m˝{1[>'Q6Tz||+vjg U?fq߬ﳙ)ìxz3tȎٔ؃F0rZD#tJQg>\hnp;ʿԧL"]\T2f\Kw5,6"_6!6G%)DO/,yX$G1| ߦl@zH/9,@3 kePl :`֐"H'Ɇ1HF&m "fLm{90"4=FY#%0޽{[{9@F"#li@c폵GF"H1[$`vc푀Э`c#"$`hcq ˸1w$`hcq 1. (4=&Xm$`\hzsG&JM6hqrr $A(0R8pA̔80MԂ$6 \jjj6ӿ,6#mn`7zKozaUX$/vczafggǫ @K $czmll WH U=q#F!$%MMMDimm0.XGa$L*Pw=ZEH@ hoozLyN$H @q;y5 S]jKC /t(0ꃖJp;)l{3O ;G`د!425L95Ե=?]v >XF#A@G=*.l>n2cYk%eRzSm䯐DS5R֓io 2b)(-Mf"oSS.e IٿwWlmE֚p%яL@A"bI,Ev q:jY8g4!猴k駤uoTb?n/ Eħ?xNzZ~F'=jd 6ajCȣX/mɖnZͼ ?^ 7L, > U/0=?/ t]z=r| p;J*/ff0ZQ']Bvi>#OoԲvÞP ChaN3ӖVZ07joZ@Pǖ.0f0%k=t]I5+ S; r]*}->҉ ()T߃qf]+}Ugx-E|Oţ~밴ڽɋB0_,DD8<렬Uhr0QsOtKAV)hnWBm_AF&\ àMJ;xz}W6u&CvY x‚TE;wq$U)C+oi.oIg䣤Y1q',; ?hA=/3^(yKW-t4R$g7=6=' ' zQ]!A>d£1waetGWҲBl.\:h)Z]6Ǖ/t拑H1v ښҘ9Ζ[n_peo]& yeP޷$`˱kwM 3I3 |O1>b}|9Gَ6n*WKOܺ|n.]U_L12WzףpI(qbȄS =H? ]Q@|/ޥfsh;vU~T2"|$C< *ST󨍿 Ɏ;^˷X)CMo͙ [dw 򯯽#Z!D$`t=`z߻뿚ǜ)N2* ^/ݢ=ES3UǙ\6zaEL`k[;6O>#C{&D>ރ_j% "NBZ~nP (V=7jA}@MS,jfkmD=Rp7G3dNC6nWyl6"O]YQc*gKwD[3Ʉ4-5fCn xTs킒D*qKŞWŪ=#czKEzVZz+1ꃂE +Nnskfj0p4+sUUيMoL%yll8!.ܞ蓏pQŎ?=rDH0Os)?8QQQɭtYYF7p?[:ѿ@ï⯟'K"34vhcM-1Y RG90b0cGkUm r:oIE(قt*kȦ]! C@_'L`ibe u5aR$zD/( _pnlKlmN'aH %c9vSwu/,,+I(z`$@}@p XJ$DMOp0@=C{L KMizthfH pJT %1hzz %*BHphz gH 4==!$`84=BI$zC0Y$@=FMODEH NMP #)z,T@CRupbDiw@ȪiSLHA yP¥/38LmOSc* zsF3+Q)xVԴ@aƕ L$SpS${ROCiv|\ vOq#|2y98=",;pZViD`vIEI(jV|pjUCЈ&yNMOי *;@# Q50R/ՕCq8I05RB+;#ȑZ("!,jP.Y4ndn9dǣNIܩM _6^WCi(Џ<8Þc}[xpNW3rD[8TL5RW('pӂw;o6 ${G=puc6IDAT NX>)=%oQbV'ipq Zi靚+% $x*ܢ 7ꑥ^U,-%@OU(ҏV#j=?-WB'\ 4rQvWΪ* z'rVVeo-X܃1QIjœb5FJR*i ts3|Y\L);D@d5g }0!x\V?}&ˆ?8*~gY#kg0i Qt\:IƔsZ\aX re{̟P6Uvۗ9ٹ2gWxY."|P,w#~{#)*p`=O{Qů.^lY0(jŋ_D;zUn:P[Eדqtlĕtsd|$;x!@)sjkԩ!$;6OݱibE +V,^ó+"dĤҀ+CUS꫋CШ~Z b<^gGϕG@eUUʅ`q4pQU㕭Q Ef)G ssi^ŀxסr0$gz3C{ϳgOmޑD#{kZ5N11gxб VM 9k6LNl\X+;W$\UW5wP f4jGq"ŠYPdB X%T0Ts_d*W>$޽kggǪTڲ2nl'~e!H˫сlѝVw*m!*iOF,jdAH`ʃz(AU4'UTIu34\87W>$8zrH ]袃qH DM@`Q-@E]fH;EH Q/ DH@Xhzڑ% "$ ,5=q>C%}}BA6*=y{ԫz XS ݁;Nͷ[Sڛk}k@@s 2[@$36(6XeKN7*Cʑu2q7`IY>GO]Sna먬'8AAtSU0>ڪppCBfH׫1D'a̍1a?QVdX1zW|rhE+VL`? p+2?\4zOFiH>,'+ּ[Ҏ[[1 <&,zg)B T/? c 0:l_@)ѣ'"l:vlфECz1)ǚO.Rg nɸ$dsy"/"q4bLXe eKT+*UJ?PQ/x@UdY0Q>f:iCloxTvjղUkDS.:Zs=;9m\lXG٘]O9RԎcӞQj@xhJ͛aӂ%ǯ6h5!d;yꬨc'8{z)9q$Ob+4j'ɃOksˌ~$=LH=wəfnݾcv.w6W<ܽRjCʱ"L ^ /`>j+ߙݨNUQ ؇u]z\ f!i&F8{r,;iprˌ~$=zZHUwR(/OpHys5U߇t?h C~2cQ5kDF@ wRg`_V D{6`e6cuuOUSpk\E#4BeE?xptT[ŐRc;nmJL i{rpҫ?G>ӻ{-|8ǔP}Je UWiz`b].6 ``#$[sˁ@/%6  ohzwb@/%6  ohzwb@/%6  ohzwb@/%6  ohzwb@/%6  ohzwb@/%6  ohzwb@/%6  ohzwb@/%6  ohzwb@/%6  ol ;ojX;$#4>#:ALT?lh[07kmokiiP|7jQao# E;+[(?׈5CLb>l@Gk[{KK{s+io@j)+*EH@N@(CXYwed@yKmBPFEEH ( fzZdmƶ&Y0g6AF=UB@BV`faNd!D@j)+*&X"aS*=zCy[[o ,J(aQZlghKdR\g]aV]]Vf;c5P(CԵ5H쬥mIJUץRaJ$7 pkYk+ihYGk0Bs;6wh#JYfFt(0LOP{r_:L$jfm90W$`*2=͂XɀGjn*>#VT% {Rp4Z-ڑ@" iiYX hmk@mՈXX$ez,3iK;y#66¼H!ھגXb$Чez,`s/pdmk{_&ׅ #Z!:M@ë7̼M(iUKdGJez@k=v|5)~#v6J[ZZeD,"݊HmkjM2=Vv֍5iBTMmeAPLl%N{9hn,+BzLOkk+q*DaD!ԢN$% ikn3E$%Rf J#' !-VmSFﰛH, ss{@6-2[XZ[BLBu"$$ iikiA6VV2L-R$ !`wNأU[Q56fHk7K^KW8;Uw!y_2=RXlmni!ו,sB@HEE&s>ffCδ/f' I;H{ 1cf bzq P9{X6]H }(QRK3L=V>T?LO[ϰGCLϢ=FeeeXX |"u-̫k%Ci$w]\;0 a+jEH@'4=:`$@@# WԊNhztH$!G ăH CM0\Q+@: щ#aV$tۦ@g0 Ru >hzx$ `6n} scdy"^FGV!p;1o\(\?[Yyʺc%茢Z$lKyctA ,^ISq͏C7KftFG{iw?#vDV2u1$ZsÍizdEq!+cf{q gћ283t36;K"^8s7-݈\yXf;oۥ;)0UgR5B4fZ^g{=\wRz4S щ-Ä 0^]+ˋi٥ ! h,-DZ" ݕj^y8KDȪe̓%P'hmCCcޏ ̟Dv<ɋ-e|aɡSB@wZi C:!  __:tPku!:ɋ 8Ζ] B!!:ˬ4鹴m&=\+\؛N;V}3iUB?9mksBW;NYecŶj ,8>3czܹ_`o˗6>n\졍w,u876Bx[B+.=1WmlBbl.DO} @ ܩ 'x_p_{7Lu8!ycBiQK XNW^䆼w3X.tVr:԰3!A/:Lɺf@E2V1WLqzf?⼹iS q yRr#sR.\73͌K$4|\3+!k#btXYTA Ν0\PNC%P:_qXYsII!ݙ v癕 L@#9==4WQ*᫞y_vvRw&rz5e~,p݉KL'tCmt/*  {PX!eڱҙK6N, ') SPQCIJƶy)Ixw//8gGM%N3Һu),f"'Sf 2F^pz/7 ԙOH ^Ȥ"/l*̇B;'Q Jg9C?ߨ2驯t89qijsse,W-O?: b;naq N3#?'yMN}nTI`d"RĞ(2i%)dZDSTTC/_3t$0n;gWL'7}ᜉԍ SB~F #Ak٧{EG흒O^Lғw3iKL9d5ԮCt~ ozxw"+&Ey"#?"ЅO ôޕe\ܗYl}ȶ! jjd~ӗgNLd:&te9ᄏmKf sKy(zI\b4c4s^&xKKA1/j-44"= K5]Iй *89fnPXW芹~^!\?GG$'Y>Ҋ}}k \0"Uۻ DgLhi`m[V# RTSyz5$tI/[^"jG5 VHE;w Kq[L̶mn[yBfJc#bOu<0|3q., x9hcM?o*=. 47bkz>bA_mmAvھD Le5pKwPAnwܖ/_'[aT8#Ec5EL ^3TBG{%9 wΙD͎u^CȜs|Iz^[}I˽B44yᒅ; AQjʶ[wfTJCC}B?^"kg5  **&LO|B k k0 @nt "Ernzݻwmllׯ_=ự7sa?eܪ7aMh eOHxt2< jfC\3-zᐿjh͓@]`gz(H N5=LxW6\( 02 @*"$IgF=b]o,dALeՀdܷ|I+.|7!dM]wde$C#i~(R=ֵ~T) d6WY}ܠ(BY 5-h!LZwDAlaLee΅q2i> W-vi0)ɐo}4a $LMWSef 8! /9}aKUDʾۼm0p?S=sZKW.OTKpȐM]OlD,`tuaqכ[ Z9I~qq[ag}YzfYA'}y;w}=ͯdä5^%2wRh1w֬¢CCy|Û}c).M޹"9~ I[kȒ%-]5[0vG2"d߽HjvI46یMlOW"4}t e}Wp"[?(9tn)x׏_ܻג[ L8CB;ŞLVYTRc^od!v.bqeIq4*";7JP[˒5`>$4DxNNͪ8 "E__HnᄌVvGT[[;o;7?=>~bn}:Sh0S5Aq Y7I l׫Zos~Q9hر43""UVWSW;+~dr2D_\l\q/l2LϜI!^r$}r|ЀIˉ B&8KZGB}:7/ Z2V*_rqtT I [|%[pfC=IDVx|QrO  d ˡ(5K%dFbYX5Oh~ :a5yR(/{<^%нBf\eN+L:iIKwWDx50#59%uR!}UIkyA%ɒ>L빣q'EF"vgũE| wD PCt&kh} |[1<,؞ &.a@E['oR\NϑF+ɿpѣK%N0pz\JT+bC bLl2aF= MP'1"kYLҊ*cB ^T2kt/;Lv#We>io@@~=ɕ:]gz8E>{QfD]Ԁ +։C j-pV \ttz ٜi1{X)A0NrK{^޷#-ɾzw51b£fAVf̉wy&uZu~dz dƄlP p6zȰ"k,97Rh$I44Þ̭~WK%ao wa _zkffH(aok2\?cXN:gv,GNzagKC\pnToz vڜu&ɭ_Xlf~{{gLZ<\?tO;AV:Y8a:;+b;+O ᝮ9x?Ikn.}>+t7WO p; $`hcq 1. (4=&Xm$`\hzsG&JM65B6 ;9NtX$!G 惱H BM XQ)@ cAR$t@ӣ"$ 4=`EH &G7EH@hzJMMn> LKKFrxJK>>p"W!PݙXuahu7թוJMYjhbbY;Bjd VG#;2L(aaNdC6uXM M/ [F-Kv.\QБJ%}= .oߤ55Eɨ %aIVߴ "74.2+koZ OTMV%~PXWz߆`ӧً u9d]tTZ$k^:\9H3T*> A@JsL\=ri>E~+9gX, \YB:\GNW]BSn)#9dMdw%>ЋM3eukb5~15%.K!Y {akVΒb%K ܆ _)UƉ')RUYA6d59 C9cPR=c:+C HmCC7LZ1Kskd @Le_A$IvŒ{_7R,'7Sp{ XCpEpq&$nn \ճBb{!EL&$4ZIm-X?Z1ge*;$y YsqHs.Oޗ= dRWf0(6qCJW[I]\g-$k♕"I+2t¬7-i^ʊC,iix y–JXYXɓXpZ,,z)c!fum*vya7+{6)&`akMIXY3~Z! C+&x_e\X ! EK>=bҊb-qaOm4%f76K E95~MvSW]';MR N*WRiqA1W}7 MdV*7!nJزԳ )`XfUXw6aϼeAb-z 0diq؝gEӦJC-*m$8{=Qo^J^4U$\ApEfBvHed=u  r 4Moz8X;n\*E ly QS}Fpm;QfffQ~RHevq1 a0fё>` A?=GCJO8dك>ִ%jO9xHՄkM{/Ƈ@}OWez@88bGi׵ufYveɩmfw޵a랞ܦ}5B;%70 MLu H4̱WWk\;U:%v7 $w95-S[]"tBJvngL:Ǯ(y2$``GcبG) )уh Rȗ IENDB`$$If!vh#v:V l05/ 4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4xDeCheck221xDeCheck221xDeCheck221xDeCheck221xDeCheck221xDeCheck221xDeCheck221xDeCheck221xDeCheck221xDeCheck221xDeCheck221xDeCheck221xDeCheck221xDeCheck221r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4r$$If!vh#v+:V l05+4K$$If!vh#vP+:V lP+,5P+4yt<K$$If!vh#vP+:V lP+,5P+4yt<$$If!vh#v#v#vN :V lP+,555N / / / / 4yt<$$If!vh#v#v#vN :V lP+,555N / / / / / 4yt<$$If!vh#v#v#vN :V lP+,555N / / / / / 4yt<$$If!vh#v#v#vN :V lP+,555N / / / / / 4yt<$$If!vh#v#v#vN :V lP+,555N / / / / / 4yt<$$If!vh#v8#v:V lP+,585/ / / / 4yt<Y$$If!vh#vP+:V lP+,5P+/ 4yt<Y$$If!vh#vP+:V lP+,5P+/ 4yt<Y$$If!vh#vP+:V lP+,5P+/ 4yt<$$If!vh#v#v#vN :V lP+,555N / / / / / 4yt<$$If!vh#v#v#vN :V lP+,555N / / / / / 4yt<$$If!vh#v#v#vN :V lP+,555N / / / / / 4yt<$$If!vh#v#v#vN :V lP+,555N / / / / 4yt0Y$$If!vh#vP+:V lP+,5P+/ 4yt<Y$$If!vh#vP+:V lP+,5P+/ 4yt<Y$$If!vh#vP+:V lP+,5P+/ 4yt0Y$$If!vh#vP+:V lP+,5P+/  4yt0$$If!vh#v#v #vz:V lP+,55 5z/ / / / / 4yt<$$If!vh#v#v #vz:V lP+,55 5z/ / / / / 4yt<$$If!vh#v#v #vz:V lP+,55 5z/ / / / / 4yt<$$If!vh#v#v #vz:V lP+,55 5z/ / / / / 4yt<$$If!vh#v#v #vz:V lP+,55 5z/ / / / / 4yt<$$If!vh#v#v #vz:V lP+,55 5z/ / / / 4yt0Y$$If!vh#vP+:V lP+,5P+/ 4yt0Y$$If!vh#vP+:V lP+,5P+/ 4yt0]$$If!vh#vP+:V lbP+,5P+/ 4yt0Y$$If!vh#vP+:V lP+,5P+/ 4yt0Y$$If!vh#vP+:V lP+,5P+/ 4yt<Y$$If!vh#vP+:V lP+,5P+/ 4yt<Y$$If!vh#vP+:V lP+,5P+/ 4yt<Y$$If!vh#vP+:V lP+,5P+/ 4yt<Y$$If!vh#vP+:V lP+,5P+/ 4yt<Y$$If!vh#vP+:V lP+,5P+/ 4yt<|$$If!vh#v#+:V l0#+,5#+4|$$If!vh#v#+:V l0#+,5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4v$$If!vh#v#+:V l0#+5#+4r$$If!vh#vP+:V l05P+4r$$If!vh#vP+:V l05P+4r$$If!vh#vP+:V l05P+4r$$If!vh#vP+:V l05P+4r$$If!vh#vP+:V l05P+4r$$If!vh#vP+:V l05P+4r$$If!vh#vP+:V l05P+4r$$If!vh#vP+:V l05P+4r$$If!vh#vP+:V l05P+4r$$If!vh#vP+:V l05P+4r$$If!vh#vP+:V l05P+4r$$If!vh#vP+:V l05P+4r$$If!vh#vP+:V l05P+4r$$If!vh#vP+:V l05P+4$$If!vh#v+:V 0+ 5+44 aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%$IfK$L$q!vh#v #v :V l t05 5 p(yt$IfK$L$q!vh#v #v :V l t05 5 p(yt$IfK$L$q!vh#v #v :V l t05 5 p(yt$IfK$L$q!vh#v #v :V l t05 5 p(yt$IfK$L$q!vh#v #v :V l t05 5 p(yt$IfK$L$q!vh#v #v :V l t05 5 p(yt$IfK$L$q!vh#v #v :V l t05 5 p(yt$IfK$L$q!vh#v #v :V l t05 5 p(yt$IfK$L$q!vh#v #v :V l t05 5 p(yt$IfK$L$q!vh#v #v :V l t05 5 p(yt$IfK$L$q!vh#v #v :V l t05 5 p(yt$IfK$L$q!vh#v #v :V l t05 5 p(yt$IfK$L$q!vh#v #v :V l t05 5 p(yt$IfK$L$q!vh#v #v :V l t05 5 p(yt$IfK$L$q!vh#v #v :V l t05 5 p(yt$IfK$L$q!vh#v #v :V l t05 5 p(yt}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%}$$If!vh#v+:V l0+5+4aytQ%x$$If!vh#vF:V l t065Fyt}/x$$If!vh#vF:V l t065Fyt}/x$$If!vh#vF:V l t065Fyt}/x$$If!vh#vF:V l t065Fyt}/x$$If!vh#vF:V l t065Fyt}/x$$If!vh#vF:V l t065Fyt}/x$$If!vh#vF:V l t065Fyt}/x$$If!vh#vF:V l t065Fyt}/x$$If!vh#vF:V l t065Fyt}/x$$If!vh#vF:V l t065Fyt}/x$$If!vh#vF:V l t065Fyt}/x$$If!vh#vF:V l t065Fyt}/x$$If!vh#vF:V l t065Fyt}/x$$If!vh#vF:V l t065Fyt}/x$$If!vh#vF:V l t065Fyt}/x$$If!vh#vF:V l t065Fyt}/x$$If!vh#vF:V l t065Fyt}/|$$If!vh#v9:V lc t0659yt}/DyK yK thttp://www.nhlbi.nih.gov/health/health-topics/topics/oxt/$000H02 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~8XV~_HmH nH sH tH 8`8 *Normal_HmH sH tH B@B  Heading 1$$@&a$>*CJ>@>  Heading 2$@& 5>*CJ8@8  Heading 3$@&CJD@D  Heading 4$$@&a$ 5>*CJB@B  Heading 5$$@&a$5CJ<@<  Heading 6$@&5CJ@@@  Heading 7$ & F@&5H@H  Heading 8$@&^ CJOJQJB @B  Heading 9 $$@&a$5CJDA`D Default Paragraph FontZi@Z  Table Normal :V 4 l4a _H(k (No List 6B@6 Body Text5CJ.)@. Page Number8 @8 Footer  !CJ4"4 Header  !>'`1> 0Comment ReferenceCJ4@B4 0 Comment Text2"@2 Caption5CJ4>@b4 Title$a$5CJjsj U Table Grid7:V0PY@P 3Q Document MapCJOJQJaJmHsHtHJoJ 3QDocument Map CharCJOJQJaJ:/: (0Comment Text CharH@H ( Balloon TextCJOJQJ^JaJNoN (Balloon Text CharCJOJQJ^JaJ@j@AB@ 8Comment Subject5\FoF 8Comment Subject Char5\4U`4 ^m 0 Hyperlink >*phJ^@J ;0 Normal (Web) dd[$\$OJQJ.X`. ;@Emphasis6]/! a:/1: fourgen_highlightPK!pO[Content_Types].xmlj0Eжr(΢]yl#!MB;.n̨̽\A1&ҫ QWKvUbOX#&1`RT9<l#$>r `С-;c=1g~'}xPiB$IO1Êk9IcLHY<;*v7'aE\h>=^,*8q;^*4?Wq{nԉogAߤ>8f2*<")QHxK |]Zz)ӁMSm@\&>!7;wP3[EBU`1OC5VD Xa?p S4[NS28;Y[꫙,T1|n;+/ʕj\\,E:! t4.T̡ e1 }; [z^pl@ok0e g@GGHPXNT,مde|*YdT\Y䀰+(T7$ow2缂#G֛ʥ?q NK-/M,WgxFV/FQⷶO&ecx\QLW@H!+{[|{!KAi `cm2iU|Y+ ި [[vxrNE3pmR =Y04,!&0+WC܃@oOS2'Sٮ05$ɤ]pm3Ft GɄ-!y"ӉV . `עv,O.%вKasSƭvMz`3{9+e@eՔLy7W_XtlPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-!pO[Content_Types].xmlPK-!֧6 -_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!!Z!theme/theme/theme1.xmlPK-! ѐ'( theme/theme/_rels/themeManager.xml.relsPK]# }E6l# jjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjm  U_ B!!"##$%%0&&|*u+,-%3?@C/FIccc,dfg8gghjkk&ln oko8prrxstpvv9wAx||K}9<#&ehن܆Č[s 8<W+ nmN2gHnu{Y\զ֨sZt _6>D^djoSW$MSW\afhlptx|= Q+a7<AFKPUZ_dinsx}~6G      !"#%&')*+,./01345689:;=>?@BCDEGHJKLMNOPQRTUVWYZ[\]_cdefghiklmopqrsuwxy{|}~0@BRXhr&(8<LN^`pt%57GIY[km} !13CEUWgv(*:<LN^`pr  02BDTVfhxzRbdtv ,.>@PRbdt  .0@BRTdfvx|""""#-#x####$$~ *:HXiyх*:HXʆEG$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G G G G G G XG$G$G$G$G$G$G$G$G$G$G$G$G$G$X !m!!l,,,b$Rark[ L+b@+(  \ + C A #" `?B S  ?/E+M:tCheck8Check2Check10Check11Check12Check7Check221}""#y##$F"".###$Fadil ; D 6:PW%$-$!-!$%,%u'|'''''(()))))))) **,,,,X0_0b0i011E3L3O3V3333344445555R8X888====>#>^@n@ AAsAACCKCTCCCCCD'DDDGG J JqK|KrLyLLLNNNNQQQQQQRRR*R,R;RWRaRcRjRwRRSST*T,T3TUUVVW WWXX XXXlYsY [[[[m\t\\\\\\\9]=]^^^^^^`_k_$`/`````ta~aPb^bbbffjjl&lnnoo~frQ]^a(4ǘɘ )1grQXJMǯɯbkEO.4ôɴCN39 &o|is&)O[y|2=?FHObf"-Q]oxjtCFlt ;3E333@@GGJWZWXX \*\\\``elsldmymEoMo$t)tttnp+-*\e79$(`cFNOUǯ ̿׿$,o}U]%+5GRYc/<bc"no?`juCF:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::BSH^Ou-8$qePqLHlcp ^`OJQJo( 8^8`OJQJo( ^`OJQJo(o  p^ `OJ QJ o(  @ ^ `OJ QJ o( x^x`OJQJo( H^H`OJQJo(o ^`OJ QJ o( ^`OJ QJ o(h^`OJ QJ o(hHh^`OJQJo(hHohp^p`OJ QJ o(hHh@ ^@ `OJQJo(hHh^`OJQJo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJo(hHohP^P`OJ QJ o(hHh ^`OJQJo(h ^`OJQJo(oh pp^p`OJ QJ o(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJ QJ o(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJ QJ o(^`o()^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L.88^8`o()^`. L ^ `L.  ^ `.xx^x`.HLH^H`L.^`.^`.L^`L.$qeOu-qLHlSH         K$==DXdI_lF~dT?qI 5 JM ^m  W + K l\ % &; #Y {QJb|GrKL;U%7L~t!NH!Q%(&0*&;|&' A'o(x)|M*X*-+B+q,&.h.?/}/50o1?455>7`789B'9f9/:2;^7< V=ZO?g?@]@>AmAfDF 6FMIXK,YL NUNPNR5Y`^anab7bd:f_Nisl<m%mb'm0o -p^pSq\zr+sYqszspu|uvmwxDy ;zIz {9{.w{}|GW3M)e~\}={(* ik!+YTs%\A++Rquu 7A%Qc`y~7uhU d'e}xpSNoBwf.sjn)Q;NYvdWv@&Kdiis}[{;Y.ZEs@p" PIC (cxt=y&(E4f<|bQo1|QPmiu[J[K]xnN oA'BWf|)"F0 E$8YTNj @=z4E@@@Unknown GTimes New Roman5Symbol3 ArialEyPHelvetica Neue3Times;HelveticaC  PLucida Grande5Tahoma? Courier New;WingdingsACambria Math"1hъDъD4uF$~$~24[[3qHP$P32! xx UNIVERSITY OF SOUTH FLORIDACandace Burns FrostMiguel Martinez       Oh+'0 , P \ h t'UNIVERSITY OF SOUTH FLORIDACandace Burns Frost Normal.dotmMiguel Martinez2Microsoft Macintosh Word@V@$@>-0@>-0$ ՜.+,D՜.+,H hp|  'usf~[ UNIVERSITY OF SOUTH FLORIDA TitleP 8@ _PID_HLINKS'A(B :http://www.nhlbi.nih.gov/health/health-topics/topics/oxt/,(http://www.choosemyplate.gov/index.html?Screen Shot 2014-07-13 at 6?Screen Shot 2014-07-13 at 9  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root Entry Fv9Data D1Table?TWordDocument SummaryInformation(DocumentSummaryInformation8MsoDataStore?u9Gu9VGSRGSS01TFYA==2qu9u9Item  PropertiesUCompObj `  F Microsoft Word 97-2004 DocumentNB6WWord.Document.8